{"name": "perturbation_10_z", "predictions": {"real": [0.22745668419357143, 0.7927879239217075, 1.7930416394457513, 0.07854278838689917, 0.0, 0.0, 0.4172665604057937, 0.9448174633960607, 0.0, 1.371317698966367, 0.4840695302230745, 1.0008861320316003, 0.064948012299897, 1.4830726191711066, 0.0, 0.0, 3.048545440390447, 0.12770314597922153, 0.2746640348407265, 1.776457263363395, 0.9667506072954024, 0.2537467499591542, 0.725398829857081, 1.461776643649664, 0.0, 1.265842501853039, 0.26015545629891246, 0.40938260370569757, 1.2366823901621034, 2.544839722492707, 0.21561652180026178, 1.5246865504793288, 0.7168732484924827, 0.0, 0.0, 0.0, 1.196039802423017, 0.0, 0.0, 0.7964536702764158, 1.1551469496493827, 0.8473525191945356, 0.6967989623749111, 0.2328492667264752, 0.3371342288012672, 2.375058961945353, 1.1705052940653735, 1.0930471177377192, 0.0, 0.3306341893678973, 1.2274785066843548, 0.0, 0.9836768632535695, 0.651525573637134, 0.46958045173464286, 0.19354141170114392, 0.35628209684275974, 1.2110681934131513, 1.365100967442105, 0.5061495847392408, 0.28904262119363117, 2.1373511324906453, 0.8893146217125605, 1.9432922486140272, 1.0764234146098062, 1.0798410730829429, 2.0526396221777006, 0.6846971712997211, 0.18526933744822502, 1.1171637292245664, 0.9690557696137676, 1.4834601204880415, 0.751979433707998, 1.0391005287139408, 1.453144073855583, 1.3243899116643139, 0.18288513544128251, 0.0, 0.5435193928846741, 0.933245903390226, 0.04292731406299213, 0.0, 0.0, 0.0, 0.997602631462204, 0.3031676663914297, 0.0, 0.22447751889742878, 0.8545907688104342, -0.17959325972349788, 0.0, 0.0, 1.484054797512569, 1.496930672168486, 1.2002800628934682, 0.0, 0.9752219950140125, 0.6580460775574959, 0.9652720044987573, 0.8060744037511204, 3.459138838352504, 0.7203735417718462, 0.5267087210908854, 0.0, 1.0400048481972137, 0.5800829436209484, 0.7955112195619928, 0.28957387980300947, 1.8717121089311326, 0.22937803585565933, -0.12009829913646959, 0.0, 1.0015829858140481, 0.0, 0.9891605562571415, 0.7269649692572578, 0.0, 0.0, 0.0, 0.0, 1.0062204903402867, 0.7948516649814859, 1.0777112918944536, 3.526675420299261, 2.189504381044026, 0.38335490574150133, 0.0, 1.971761047358591, 0.9883581914512062, 1.8625151030822917, 1.0252389103839787, 0.38782215168236855, 0.6674626738129317, 0.7381937906475193, 0.7857299266499445, 0.0, 0.9733847756243772, 0.8124390298943773, 0.3952988858026246, 1.3348559155815434, 0.5449314718366108, 0.20342886846692967, 0.483478095110048, -0.2231142215796102, 1.3785383269001596, 0.9996095285360059, 0.0, 0.0, 0.0, 0.6760683557861433], "samples": [1.1498325757799703, 1.2470122081961565, 1.710211927127615, 1.7211195028905093, 0.0, 0.0, 1.7716969262301647, 1.897637216264952, 0.0, 1.8890405342657925, 0.7627644725900512, 1.0089477545628365, 0.13952754814004675, 1.4015263832107638, 0.0, 0.0, 1.1451617432065706, 0.5370514885960991, 0.9415250490589124, 0.7592239009390112, 1.7342106519310327, 0.587745878827992, 1.9106737587639337, 1.1766925646003836, 0.0, 1.2644360666557557, 0.680158099396145, 2.1088618998471147, 0.7773166696887576, 1.5839332432451891, 1.4545798488282575, 2.1181245863150613, 0.4768235562535395, 0.0, 0.0, 0.0, 1.4177602137232288, 0.0, 0.0, 1.7403397662699707, 1.9312623532438111, 1.0809546476883072, 2.038817907239369, 0.9153779227804999, 1.6809730053787064, 1.6288523909179673, 0.18267567823596967, 2.3590868157651874, 0.0, 0.5373288684077887, 0.7211309937206943, 0.0, 1.406457468414056, 1.6003981407153514, 1.9007549609055245, 0.6538108677306086, 3.146988148350167, 1.9065913019058986, 1.178844983292667, 3.2033236059883095, 1.9635388938658294, 2.9413508435403046, 1.0962947107475305, 1.8312021696038703, 3.205259578809324, 1.5299109604012906, 0.8025998344770018, 1.9827287106404754, 1.7469930407362786, 2.8851812694776697, 1.0562269760558265, 1.170248529502749, 1.1798404258216642, 2.0230618618893823, 2.3696611493731052, 0.5269647368168597, 0.9283145146678591, 0.0, 0.22734502863548425, 3.5284137503510125, 1.4403081537703948, 0.0, 0.0, 0.0, 0.5926591490801718, -0.12283502732156729, 0.0, 1.2111596007152918, 3.0554542578841914, 2.0142421393065044, 0.0, 0.0, 2.0101470609277974, 1.0731311366481802, 0.9465301201110473, 0.0, 2.1318725458353236, 2.735056878456763, 0.8577716601490732, 1.6681212662141491, 0.7704476189328465, 1.1531546047416452, 1.937048465838299, 0.0, 0.7981429145855293, 1.9180760849134015, 1.2472269230633275, 1.3312994036640282, 0.9479959934474003, 1.8717937092743258, 0.9738710065767071, 0.0, 1.202797691706336, 0.0, 1.5262421792910479, 0.9715164177877592, 0.0, 0.0, 0.0, 0.0, 0.23902547606129074, 1.4220827313870732, 0.6014733728376498, 2.0348917810615057, 0.7744595296377911, 2.1464794261934577, 0.0, 1.6426794917733647, 1.329272663812746, 1.6760639858792938, 1.6114971400368416, 0.39884839474761036, 1.6661382694427376, 2.5593701974064476, 1.5405187974300623, 0.0, 1.3343742354238837, 1.3689919222828628, 1.0852783106014596, 0.6023795155237786, 0.8289434223033557, 2.7827115037358143, 2.4086848847444435, 2.512744382127646, 1.4117646258375118, 1.4319627155093502, 0.0, 0.0, 0.0, 1.391271743727052]}, "info": {"pct_words_masked": 0.3, "span_length": 10, "n_perturbations": 10, "n_samples": 150}, "raw_results": [{"original": "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "sampled": "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "perturbed_sampled": ["the problem of palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an effective solution Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an answer an answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in the US? A model for the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes assessment of long-term and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of medical care for acute and acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented . Answer: Yes. We should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies that can be considered by experts should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning ? The adoption of a strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for reduced care need to be implemented to reduce access to preventive care services. Health care providers should consider"], "perturbed_original": ["Question: Is an advance care planning Model feasible? Advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of an advance care planning model, as well as an important outcome measure.", "Question: Is it possible? The Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit s are necessary to measure the quality of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is largely an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible in community palliative care. Answer: Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible for community palliative care services? This model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are key for a progress care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model and an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the quality audit process and provide good outcomes in the evaluation process. Quality audit processes serve the value factor as an important outcome measure."], "original_ll": -3.686828136444092, "sampled_ll": -3.1857428550720215, "all_perturbed_sampled_ll": [-2.975879669189453, -3.3999667167663574, -3.4268245697021484, -3.4489965438842773, -3.224862813949585, -3.330549716949463, -3.4869778156280518, -3.354368209838867, -3.587303638458252, -3.4858901500701904], "all_perturbed_original_ll": [-4.516111850738525, -2.9307429790496826, -4.483269214630127, -3.6165952682495117, -3.9865517616271973, -3.675853967666626, -4.006080150604248, -3.9108822345733643, -3.451833963394165, -3.3553731441497803], "perturbed_sampled_ll": -3.3721619844436646, "perturbed_original_ll": -3.793329453468323, "perturbed_sampled_ll_std": 0.1621271942527708, "perturbed_original_ll_std": 0.4682268072350677}, {"original": "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "sampled": "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "perturbed_sampled": ["Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not unlike other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Coeliac disease screening is not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that coeliac disease screening be directed to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians carry out coeliac disease screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other risks, the main difference is not that that; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the doubt it does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended to provide an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening should be treated fairly. 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening"], "perturbed_original": ["Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients seems comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral management are not the problems that were a concern for the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening good? The quality of life and bone mineral density in coeliac patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality checked screening in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was consistent with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects . Diagnostic screening in risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and nutrition - quality of life and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and dietary compliance in those subjects seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening was much more expensive than harmful.", "Question: Is coeliac disease screening in risk groups justified? In vivo subjects of different stages of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful."], "original_ll": -3.3509790897369385, "sampled_ll": -2.4468579292297363, "all_perturbed_sampled_ll": [-2.794528007507324, -2.8654110431671143, -2.5011861324310303, -2.5487923622131348, -2.539862871170044, -3.048387050628662, -2.794528007507324, -3.3759522438049316, -2.798790216445923, -2.5026605129241943], "all_perturbed_original_ll": [-3.5256850719451904, -3.78271484375, -2.823810577392578, -3.768723487854004, -3.5070886611938477, -3.5812366008758545, -3.8712315559387207, -3.5986721515655518, -3.6065354347229004, -3.6028380393981934], "perturbed_sampled_ll": -2.7770098447799683, "perturbed_original_ll": -3.566853642463684, "perturbed_sampled_ll_std": 0.2647543571588664, "perturbed_original_ll_std": 0.2722979831212269}, {"original": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "sampled": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "perturbed_sampled": ["Question: Does blood pressure change in treated hypertensive patients depending on whether it is controlled or controlled? Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive hypertension patients with an infant or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients treated by a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a clinician? The difference, in many way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take up safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by medication or not? The blood pressure is taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take to the proper safety.", "Question: Does blood pressure change with treatment by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured correctly or not? Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure treatment, so there is no need for her own comfort and safety."], "perturbed_original": ["Question: Does blood pressure change the reading by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether /when? Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, as BP readings determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by the nurse or not? Blood pressure determined by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a BP sensor? Blood pressure determined by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure determined is a blood pressure measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by a physician is progressively more robust than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is an individual? Blood pressure measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost comparable to the readings obtained by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a blood pressure measurement system? Blood pressure levels expressed by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis"], "original_ll": -3.0541651248931885, "sampled_ll": -2.5679197311401367, "all_perturbed_sampled_ll": [-2.7854535579681396, -2.9266610145568848, -2.6713154315948486, -3.006596326828003, -2.7850444316864014, -2.853533983230591, -2.817411184310913, -2.5017688274383545, -2.829976797103882, -2.741255760192871], "all_perturbed_original_ll": [-3.4334945678710938, -3.5608112812042236, -3.222886800765991, -3.1354053020477295, -3.3032748699188232, -3.345527172088623, -3.3716728687286377, -3.4207279682159424, -3.028203248977661, -3.3396244049072266], "perturbed_sampled_ll": -2.791901731491089, "perturbed_original_ll": -3.316162848472595, "perturbed_sampled_ll_std": 0.1309673946240925, "perturbed_original_ll_std": 0.1461191518454602}, {"original": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "sampled": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "perturbed_sampled": ["Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so the next few studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. Neck dissection is not as commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate why, although most patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for clinical examinations? We have previously identified that many patients experience the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need to be investigated in the future? We are aware of many patients experiencing the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary diagnosis. This is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many health conditions and complications arise. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. How could metastatic cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an emergency solution for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions available should be considered. The question for future studies"], "perturbed_original": ["Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the cervical nodes of unknown cancer, whether that need to be removed from the unknown primary tumor: Is there any need for neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy , whether by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the head and neck? Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown . The use of neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local quality of life from head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the neck. The primary indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown cancer of the head and neck with neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, have become the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the neck, for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the correct diagnosis of neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial."], "original_ll": -3.847614049911499, "sampled_ll": -3.0388824939727783, "all_perturbed_sampled_ll": [-3.1307361125946045, -3.0996689796447754, -3.4587182998657227, -3.364159345626831, -3.2274508476257324, -3.3693721294403076, -3.3422787189483643, -3.339765787124634, -3.175462245941162, -3.0707192420959473], "all_perturbed_original_ll": [-3.795220136642456, -3.8574323654174805, -3.548207998275757, -3.999215602874756, -3.7942874431610107, -3.9423766136169434, -3.7330918312072754, -3.792177677154541, -4.23470401763916, -3.914551019668579], "perturbed_sampled_ll": -3.257833170890808, "perturbed_original_ll": -3.8611264705657957, "perturbed_sampled_ll_std": 0.1272141048604214, "perturbed_original_ll_std": 0.17203897304657637}, {"original": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "sampled": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "perturbed_sampled": ["Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved."], "perturbed_original": ["Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable"], "original_ll": -4.212801933288574, "sampled_ll": -2.8638219833374023, "all_perturbed_sampled_ll": [-2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023, -2.8638219833374023], "all_perturbed_original_ll": [-4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574, -4.212801933288574], "perturbed_sampled_ll": -2.8638219833374023, "perturbed_original_ll": -4.212801933288574, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "sampled": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "perturbed_sampled": ["Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement"], "perturbed_original": ["Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures."], "original_ll": -3.9180994033813477, "sampled_ll": -3.142951250076294, "all_perturbed_sampled_ll": [-3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294, -3.142951250076294], "all_perturbed_original_ll": [-3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477, -3.9180994033813477], "perturbed_sampled_ll": -3.142951250076294, "perturbed_original_ll": -3.9180994033813477, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "sampled": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "perturbed_sampled": ["Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that involve aneurysm replacement and repair within the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in aneurysm replacement) but those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the second. Will it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "is removing the cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that require surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "why are the spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. It is a long procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm s over time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop and they will grow). So how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Many of these kinds of aneurysms result in an aneurysm, and those that result in aneurysms, including bone lining, are benign. (For this case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal surgery take longer of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, the first cases are after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm is responsible for future life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Is your arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger age than at the core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur before the procedure, will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it ? The two types are caused by a rupture of a vertebral core"], "perturbed_original": ["Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste ? Usually, reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is safe, or is a waste. As with the perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. There is not indicated, and that, with evolving the risks of thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is there a reliable way to locate a cause of paraplegia? With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving surgical intervention in aorta, thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Reimplantation of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving understanding of spinal cord injury, reimplantation should be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar fibroids may reduce the rates of immediate and delayed paraplegia. This experience suggests that it is possible that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during invasive implantation is an immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not necessary to be surgical. Such endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal repair occurs in certain areas of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine , functional, permanent repair of the entire thoracic aorta is important. This provides insights into the practice. However, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as -a-self is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with monitoring of MEP and MEP, the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm are lost at the same time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as sailation is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of the arteries of spinal cord will ultimately be possible without spinal cord injury."], "original_ll": -3.9618704319000244, "sampled_ll": -2.465787649154663, "all_perturbed_sampled_ll": [-2.6726956367492676, -2.982626438140869, -2.7374727725982666, -2.504286766052246, -2.775988817214966, -2.8535678386688232, -2.9603841304779053, -2.8120663166046143, -2.462454319000244, -2.9418482780456543], "all_perturbed_original_ll": [-3.9282066822052, -4.314429759979248, -4.184841156005859, -3.7033681869506836, -3.7487270832061768, -3.9361703395843506, -4.166834354400635, -4.056177616119385, -4.300782680511475, -4.122532844543457], "perturbed_sampled_ll": -2.7703391313552856, "perturbed_original_ll": -4.046207070350647, "perturbed_sampled_ll_std": 0.1718981828616988, "perturbed_original_ll_std": 0.202116935439554}, {"original": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "sampled": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "perturbed_sampled": ["Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Sport medicine journals did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of that article do not take into account this analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in that post that sports medicine practitioners and athletes should be", "sports medicine practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. sports medicine journals can use this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? We do not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current journals discuss the current and current sports medicine journals. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Sport medicine journals did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine practitioners and athletes currently involved? However, the authors of the current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant ? The authors of the current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be"], "perturbed_original": ["Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base is limited to volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of evidence base for sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable ? The sports medicine literature should provide studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to sports medicine? Sport medicine journals are addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence and the evidence is out of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The sports medicine literature provides research on diagnostic interventions in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to the current field of medicine? It is not just the journal addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base consists of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There are many journals related to sports medicine and athletes in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment of medical issues that make sure sports medicine must continue to increase in terms of volume and quality."], "original_ll": -3.3213512897491455, "sampled_ll": -2.687255859375, "all_perturbed_sampled_ll": [-3.4083092212677, -3.1499075889587402, -3.4489593505859375, -2.6997318267822266, -3.3051912784576416, -3.363330364227295, -3.213447332382202, -3.4083092212677, -2.7299442291259766, -3.069483757019043], "all_perturbed_original_ll": [-3.5448012351989746, -3.250112295150757, -3.774547576904297, -3.5533928871154785, -3.8246545791625977, -3.465644598007202, -3.453244686126709, -3.6228601932525635, -3.0847597122192383, -3.877488851547241], "perturbed_sampled_ll": -3.179661417007446, "perturbed_original_ll": -3.5451506614685058, "perturbed_sampled_ll_std": 0.2594835058102568, "perturbed_original_ll_std": 0.23687048598248145}, {"original": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "sampled": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "perturbed_sampled": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia"], "perturbed_original": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN."], "original_ll": -3.904130220413208, "sampled_ll": -2.479994297027588, "all_perturbed_sampled_ll": [-2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588, -2.479994297027588], "all_perturbed_original_ll": [-3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208, -3.904130220413208], "perturbed_sampled_ll": -2.479994297027588, "perturbed_original_ll": -3.904130220413208, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "sampled": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "perturbed_sampled": ["Question: Hepatorenal syndrome: are we really biased towards it? When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: 1. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it 's a lot simpler. I don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very optimistic that it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. I think the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When I get much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to its knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, though, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very confident that much of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't understand it. I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a"], "perturbed_original": ["Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed ) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary activity of urine are likely to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be the best for survival.", "Question: Hepatorenal syndrome: are we missing some prognostic prognosis? The renal function used as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at times may increase survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal studies presented for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD s (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time that renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: this is the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival."], "original_ll": -3.3490052223205566, "sampled_ll": -2.819157123565674, "all_perturbed_sampled_ll": [-2.919037342071533, -2.9720067977905273, -3.0870401859283447, -2.9168896675109863, -3.0560550689697266, -3.2960219383239746, -3.177816867828369, -3.1196417808532715, -2.920217514038086, -2.993330955505371], "all_perturbed_original_ll": [-3.7561094760894775, -3.5665578842163086, -3.6034460067749023, -3.4666004180908203, -3.4694700241088867, -3.740096092224121, -3.4529051780700684, -3.588017463684082, -3.258293390274048, -3.4944350719451904], "perturbed_sampled_ll": -3.045805811882019, "perturbed_original_ll": -3.5395931005477905, "perturbed_sampled_ll_std": 0.11998084964568326, "perturbed_original_ll_std": 0.13898156376956983}, {"original": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "sampled": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "perturbed_sampled": ["Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: It\u2019s of paramount importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more kidney disease? It is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and possibly even causes. Suppose an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in clement envelop the kidneys of a kidney? I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a dditional or vitamin supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this is not the case. Questions: Any woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Is it possible to treat women with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in renal kidney systems in renal kidney syndrome persist? I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, not! Women who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation."], "perturbed_original": ["Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration can damage the kidney on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have the kidney damage caused by pregnancy? Answer: We suggest that glomerular hyperfiltration may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities? Question: Does pregnancy have adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration in pregnancy damage the kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, pregnancy may have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage kidney? According to our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy affects the kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration pose an adverse effect on kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy affects the kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy harms the kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration."], "original_ll": -2.9906833171844482, "sampled_ll": -2.960944890975952, "all_perturbed_sampled_ll": [-3.2416915893554688, -2.759039878845215, -3.4207077026367188, -3.2341251373291016, -4.089524745941162, -3.0633835792541504, -2.8768932819366455, -3.030515670776367, -3.203888416290283, -3.3322548866271973], "all_perturbed_original_ll": [-3.1484928131103516, -3.0351123809814453, -3.0729057788848877, -2.8645427227020264, -3.3030457496643066, -3.2996668815612793, -3.011563777923584, -2.8351125717163086, -3.011563777923584, -3.041029214859009], "perturbed_sampled_ll": -3.225202488899231, "perturbed_original_ll": -3.062303566932678, "perturbed_sampled_ll_std": 0.3464471765785875, "perturbed_original_ll_std": 0.1479544678534611}, {"original": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "sampled": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "perturbed_sampled": ["s for a healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in Koreans? (1) The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? (1) The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: I am currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? (1) Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "tiatrophic atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? (1) Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is working to produce a high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is it also possible to answer one question or another? (1) What is the Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon"], "perturbed_original": ["Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT levels were associated when there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both health and cardiovascular risk factors were conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were associated, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no correlation with hsCRP levels in Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk . Question: Both hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT levels in healthy Korean adults. There was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity high-sensitivity low-sensitivity lower? Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were linked to, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The expression of high-sensitivity protein involved high-sensitivity C-reactive protein was associated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was similar correlation between the level of hsCRP and the IMT in healthy Korean adults."], "original_ll": -2.42130184173584, "sampled_ll": -1.8374992609024048, "all_perturbed_sampled_ll": [-2.859513759613037, -1.9765080213546753, -1.847823143005371, -1.9495608806610107, -1.9775193929672241, -1.8975428342819214, -2.725508451461792, -2.0515356063842773, -2.1565072536468506, -2.805340051651001], "all_perturbed_original_ll": [-2.51617431640625, -2.8730244636535645, -2.363682985305786, -2.6893742084503174, -2.9277069568634033, -2.3440046310424805, -2.845973014831543, -2.4475009441375732, -2.576369285583496, -2.628344774246216], "perturbed_sampled_ll": -2.224735939502716, "perturbed_original_ll": -2.621215558052063, "perturbed_sampled_ll_std": 0.38380250795849746, "perturbed_original_ll_std": 0.19973672320790184}, {"original": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "sampled": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "perturbed_sampled": ["Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will increase osteoporotic acetabular fractures. This study will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic osteoporotic acetabular fractures. A cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Does cup-cage reconstruction with large cups provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cups also resulted in multiple anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. This study showed that excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. This study also demonstrated that cup-cage reconstruction with large cup size and excessive padding will prevent anterior extensor injuries during knee joint reconstruction..220 in anterior extension of injured knees.", "Question: Can cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that replacing oversized cups for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability ? Cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size can cause injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees."], "perturbed_original": ["Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved in the first THA with relatively large cups. This observation was in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The size is the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA ? Three of the 10 in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the acetabular core to bone. It remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable from the pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. We did not predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between these two cohorts in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups on the acetabular part? The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small influx of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of 30 years of age, but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We"], "original_ll": -4.39340353012085, "sampled_ll": -2.899731159210205, "all_perturbed_sampled_ll": [-2.7772231101989746, -2.912379264831543, -3.0365633964538574, -2.8046839237213135, -2.3863229751586914, -3.2285518646240234, -3.05157208442688, -3.487884521484375, -2.8832621574401855, -2.817437171936035], "all_perturbed_original_ll": [-4.084132671356201, -4.660865306854248, -4.739927291870117, -4.2732834815979, -4.2849202156066895, -4.279219150543213, -4.369343280792236, -4.7180609703063965, -4.433380603790283, -4.2300238609313965], "perturbed_sampled_ll": -2.938588047027588, "perturbed_original_ll": -4.407315683364868, "perturbed_sampled_ll_std": 0.2784890033212742, "perturbed_original_ll_std": 0.21420444985720982}, {"original": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "sampled": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "perturbed_sampled": ["Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the alternatives. Question: Are drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the literature? Answer: For certain drugs, please have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are you using heroin or methadone on your medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug interactions? We also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes ! The history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone maintenance, do not support your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs listed below? We recommend our Guide to opioid dependence as a \"safe, effective\" treatment. Read our Guide", "? Do you have any other drugs available in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP for assistance. Are there drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most people are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide"], "perturbed_original": ["Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among many other diseases of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Do patients receive MMT and medical care at different sites use documented documentation in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different stages, the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among the most patients in these populations, the lack of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of medical records that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of MMT varies in the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for most of these patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are opioid dependence and MMT. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different time, the record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. These patients should have maintained a proper coordination of treatment with methadone. This study highlights opportunities for improved coordination between medical care and MMT."], "original_ll": -3.0324795246124268, "sampled_ll": -2.585069179534912, "all_perturbed_sampled_ll": [-2.7507553100585938, -2.7262063026428223, -2.4851510524749756, -2.686169147491455, -2.850559949874878, -2.729109525680542, -2.710092306137085, -2.664520502090454, -2.785487413406372, -2.843930959701538], "all_perturbed_original_ll": [-3.3873138427734375, -3.1622793674468994, -3.2552924156188965, -3.2039191722869873, -3.2255845069885254, -3.200472831726074, -3.0570273399353027, -3.0160162448883057, -3.375544786453247, -3.1319704055786133], "perturbed_sampled_ll": -2.7231982469558718, "perturbed_original_ll": -3.201542091369629, "perturbed_sampled_ll_std": 0.09855616638804834, "perturbed_original_ll_std": 0.11399480010068008}, {"original": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "sampled": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "perturbed_sampled": ["Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to"], "perturbed_original": ["Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment."], "original_ll": -4.9236741065979, "sampled_ll": -3.131972074508667, "all_perturbed_sampled_ll": [-3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667, -3.131972074508667], "all_perturbed_original_ll": [-4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979, -4.9236741065979], "perturbed_sampled_ll": -3.131972074508667, "perturbed_original_ll": -4.9236741065979, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "sampled": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "perturbed_sampled": ["Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is"], "perturbed_original": ["Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS."], "original_ll": -3.7497522830963135, "sampled_ll": -3.078169822692871, "all_perturbed_sampled_ll": [-3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871, -3.078169822692871], "all_perturbed_original_ll": [-3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135, -3.7497522830963135], "perturbed_sampled_ll": -3.078169822692871, "perturbed_original_ll": -3.7497522830963135, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "sampled": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "perturbed_sampled": ["Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms . The first paper of endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to understand how the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to clinical trial and treatment by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it 's not associated with increased risk for vascular disease. The present study to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth ? This trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is more effective than before and therefore it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial examines vascular disease\u2019s high risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is increasing growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation transforming growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is associated with increased expression of vascular endothelial growth factor, and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and"], "perturbed_original": ["Question: Is endometrial polyp formation associated with increased expression of vascular endothelial polyps? The study looked at increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation transforming growth factor-beta1 and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. These cytokines showed increased TGF-<unk>1 expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there is increased TGF-<unk>1 and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation, supporting steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines bind to growth factor-beta1 in a polyp. Indeed, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor , TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, increase TGF-<unk>1 and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of TGF-<unk>1 and VEGF in polyps? There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF -<unk>1, suggesting that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression."], "original_ll": -2.4146218299865723, "sampled_ll": -2.402770757675171, "all_perturbed_sampled_ll": [-2.7038278579711914, -2.5711209774017334, -2.7912163734436035, -2.488168716430664, -2.678022623062134, -2.625537395477295, -3.2008888721466064, -3.199209690093994, -2.740316152572632, -2.238259792327881], "all_perturbed_original_ll": [-2.525733232498169, -2.644144058227539, -2.7193734645843506, -2.7180774211883545, -2.64479923248291, -2.6587255001068115, -2.7845981121063232, -2.845324754714966, -2.681241035461426, -2.5886294841766357], "perturbed_sampled_ll": -2.7236568450927736, "perturbed_original_ll": -2.6810646295547484, "perturbed_sampled_ll_std": 0.2802102753791693, "perturbed_original_ll_std": 0.08739997640778191}, {"original": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "sampled": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "perturbed_sampled": ["Question: Preparing patients at high risk of falls for discharge home after rehabilitation: If you know what you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place if they have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: If you know that your patient might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, you may not have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that does not include any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a special case that might be in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do you know you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at home? Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance"], "perturbed_original": ["Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Studies have shown that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls? Can we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we think in this case? Patients at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls were susceptible to falls. When the risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, many of these risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls may not perform falls early during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little knowledge of the potential for falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally that factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might result in falls post-discharge. Failure to assess risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing fall rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576."], "original_ll": -3.9579806327819824, "sampled_ll": -2.9387502670288086, "all_perturbed_sampled_ll": [-2.960301160812378, -3.045772075653076, -2.9911110401153564, -3.0870532989501953, -3.09009051322937, -3.050830364227295, -3.199791431427002, -2.964884042739868, -3.1148428916931152, -2.644010066986084], "all_perturbed_original_ll": [-4.054556369781494, -3.867145299911499, -4.127497673034668, -3.7908430099487305, -4.010674953460693, -3.92842960357666, -3.987497568130493, -4.203691005706787, -3.676257848739624, -4.133185386657715], "perturbed_sampled_ll": -3.014868688583374, "perturbed_original_ll": -3.9779778718948364, "perturbed_sampled_ll_std": 0.14173393644908425, "perturbed_original_ll_std": 0.15659159341389867}, {"original": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "sampled": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "perturbed_sampled": ["Question: Could the use of cancer drugs for treating cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy ? Besides the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the rare condition, effective treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Because these are severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy for cervical cancer? Given the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In addition, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe , chemotherapy in cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of cancer drugs is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with chemotherapy, the use of cancer drugs for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer"], "perturbed_original": ["Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified . Question: A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Difference in chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed no surgery performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified? A systemic or extensive lymphadenectomy, where the frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and frequency of lymphadenectomy in clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM s involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified . However, systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cervical cancer. LNs did not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in patients treated with NACT? The LNs are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and systematic diagnostic model has been developed to accommodate all LNM treatments plus surgery regardless of the response to NACT."], "original_ll": -3.9893767833709717, "sampled_ll": -2.56767201423645, "all_perturbed_sampled_ll": [-2.3355824947357178, -2.9109981060028076, -2.7819530963897705, -2.8183400630950928, -2.7426300048828125, -2.710714340209961, -2.965144157409668, -2.783414840698242, -2.488755941390991, -2.8450162410736084], "all_perturbed_original_ll": [-4.062936782836914, -4.572429180145264, -4.0368194580078125, -4.044450759887695, -3.7790091037750244, -4.182117938995361, -3.9054296016693115, -4.097597599029541, -3.5876121520996094, -4.3453240394592285], "perturbed_sampled_ll": -2.738254928588867, "perturbed_original_ll": -4.0613726615905765, "perturbed_sampled_ll_std": 0.18117724485707581, "perturbed_original_ll_std": 0.262123427486071}, {"original": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "sampled": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "perturbed_sampled": ["Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary disease? No necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: A few studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that cytokines have different health and immune responses, so these may have prevented colon cancer, including breast cancer. cited by colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that ligand bezafibrate may help patients with colon cancer, as shown by colleagues and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated bacteria control colon artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have been carried out by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in humans? This might not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors inhibit colon disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not be able to control colon cancer. A small study by Yost and colleagues"], "perturbed_original": ["Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from data on a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, have demonstrated a significant effect on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, can be found on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from the results, show a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, show the effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support for the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, have shown their effect on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent ligand bezafibrate? The following data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our aims are to establish an effective hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery arterial disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer."], "original_ll": -2.843569755554199, "sampled_ll": -2.9766039848327637, "all_perturbed_sampled_ll": [-3.515972137451172, -3.051800012588501, -3.3377389907836914, -3.049161911010742, -3.0668842792510986, -3.1108524799346924, -3.161674737930298, -3.2990944385528564, -2.726271390914917, -2.99994158744812], "all_perturbed_original_ll": [-3.24190616607666, -2.972289800643921, -3.1264681816101074, -3.13326358795166, -2.8118836879730225, -3.2455122470855713, -3.0635833740234375, -3.065347194671631, -3.0701544284820557, -3.3897080421447754], "perturbed_sampled_ll": -3.131939196586609, "perturbed_original_ll": -3.112011671066284, "perturbed_sampled_ll_std": 0.20459736786700988, "perturbed_original_ll_std": 0.15111082098526793}, {"original": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "sampled": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "perturbed_sampled": ["Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth does not affect long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the head. The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the chest. The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is about twice as wide at base of the nose and has long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about"], "perturbed_original": ["Question: Did I Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens ing results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does This make lens mobile? In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in the lens being in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might be evident in this context, such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber? According to apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the lens looks more mobile in the affected eye and this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower head position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to a head wound shut down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber depth. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study."], "original_ll": -4.250141620635986, "sampled_ll": -2.3694233894348145, "all_perturbed_sampled_ll": [-3.0317018032073975, -2.6760010719299316, -2.550825595855713, -2.689983606338501, -2.670555353164673, -2.8252921104431152, -2.4663429260253906, -2.629079818725586, -2.9762182235717773, -2.4387576580047607], "all_perturbed_original_ll": [-4.700063705444336, -4.579479694366455, -4.641660213470459, -4.391117572784424, -4.084256172180176, -4.565083026885986, -4.289484977722168, -4.526303768157959, -4.153373718261719, -4.468515396118164], "perturbed_sampled_ll": -2.6954758167266846, "perturbed_original_ll": -4.439933824539184, "perturbed_sampled_ll_std": 0.1880120081887473, "perturbed_original_ll_std": 0.19631971520986566}, {"original": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "sampled": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "perturbed_sampled": ["Question: Are more resources available to help with care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care . Question: I have asked them about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not affect your health. The answer is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not the outcomes will be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources and should continue to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources , and I have a great idea to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix e services work? I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers know how to be involved in the development of care delivery and delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can deliver care in the best interest of patients and providers, and is", "Question: Does case-mix -in-class care can help? I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is"], "perturbed_original": ["Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of processes in hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of a case-mix based reimbursement stimulates the development of care programmes by fostering a process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital hospitals can promote the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research indicates that the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care delivery processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to indicate that this finding may indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study may enable hospital budgeting for care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the cases-mix based reimbursement should be appropriate for a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the end of the year. No more research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care-oriented reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals."], "original_ll": -3.8974390029907227, "sampled_ll": -3.027855396270752, "all_perturbed_sampled_ll": [-2.479757308959961, -3.371950149536133, -3.351381301879883, -3.274587869644165, -3.2383785247802734, -3.3748843669891357, -3.1187994480133057, -3.019369602203369, -3.286781072616577, -3.2673988342285156], "all_perturbed_original_ll": [-4.011187553405762, -3.5213520526885986, -4.034483432769775, -4.032616138458252, -3.9247844219207764, -3.903207778930664, -4.134190559387207, -3.7881274223327637, -3.9936349391937256, -4.052083969116211], "perturbed_sampled_ll": -3.178328847885132, "perturbed_original_ll": -3.9395668268203736, "perturbed_sampled_ll_std": 0.25601787615156907, "perturbed_original_ll_std": 0.1660231070405131}, {"original": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "sampled": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "perturbed_sampled": ["Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that some of stroke risk factors increase mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? There is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of tumours cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. At no known risk of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is a different risk of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the outcome? Yes or no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no negative reaction to intravenous thrombolysis in a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a stroke is a common condition in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) in stroke patients. For a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke patients? Often times, there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke."], "perturbed_original": ["Question: What ischemic strokes are not known about an ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis ? An article in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of the ischemic stroke research suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Research conducted in the Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "life of men in the natural course of an ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex and gender affect women? Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage of ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in ischemic stroke reveal the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in ischemic stroke may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, even compared with men."], "original_ll": -3.3666269779205322, "sampled_ll": -2.1815600395202637, "all_perturbed_sampled_ll": [-2.53104567527771, -2.2634499073028564, -2.462275981903076, -2.373363733291626, -2.4367589950561523, -2.516340970993042, -2.259161949157715, -2.4024531841278076, -2.269360303878784, -2.264800786972046], "all_perturbed_original_ll": [-3.844252586364746, -3.5686275959014893, -3.3380701541900635, -3.203873634338379, -3.743056058883667, -4.188673496246338, -3.246767520904541, -3.570739507675171, -3.564936637878418, -3.4440276622772217], "perturbed_sampled_ll": -2.3779011487960817, "perturbed_original_ll": -3.5713024854660036, "perturbed_sampled_ll_std": 0.10276014331344373, "perturbed_original_ll_std": 0.28215582810603207}, {"original": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "sampled": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "perturbed_sampled": ["Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: time from first laparotomies to last laparotomies, duration of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies can be reduced based on hospitalization, and that this may occur as a result of hospitalization. Question: Here is an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day hospitalization is of concern and need for improvement? Answer: The general view is that the majority of the risk of death from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of death from the laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death : from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based patients; time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The first question indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur after 30 days of hospitalization. This article gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available mortality in the heart is decreased after 30 days of hospitalization, and that this may occur at the least after an early diagnosis. This page gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of death during emergency general surgery laparotomies may be approximately 7 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of the laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery . The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is relatively high and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart disease may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in mortality in emergency general surgery laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,"], "perturbed_original": ["Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols , bringing emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of patients for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring acute surgery rehabilitation or perhaps even considering centralisation by the community and organizations involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done that can involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency services and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for more patient care. We need to increase mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of training for the emergency surgeons and centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality rates have no need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over 30. This is being done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 24-Day treatment is an ongoing concern and need for quality care, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done, whether it involve increasing acute surgical care manpower, early recognition of patients requiring urgent medical care, or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an emergency general surgery group carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps starting with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of eight, and high mortality outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early delivery protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be met. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such a serious care problem, transportation to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care."], "original_ll": -3.5579025745391846, "sampled_ll": -2.3208224773406982, "all_perturbed_sampled_ll": [-2.23701548576355, -2.5841495990753174, -2.280444383621216, -2.6321680545806885, -2.482729911804199, -2.4681060314178467, -2.834821939468384, -2.6716601848602295, -2.4520468711853027, -2.5560004711151123], "all_perturbed_original_ll": [-3.523280382156372, -3.758288860321045, -3.7321434020996094, -3.593559980392456, -3.9379351139068604, -3.7193381786346436, -3.6787357330322266, -3.772679567337036, -3.936692237854004, -3.7286672592163086], "perturbed_sampled_ll": -2.5199142932891845, "perturbed_original_ll": -3.7381320714950563, "perturbed_sampled_ll_std": 0.1691961196475307, "perturbed_original_ll_std": 0.12329482601793874}, {"original": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "sampled": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "perturbed_sampled": ["Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will"], "perturbed_original": ["Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed."], "original_ll": -3.9390928745269775, "sampled_ll": -2.90850567817688, "all_perturbed_sampled_ll": [-2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688, -2.90850567817688], "all_perturbed_original_ll": [-3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775, -3.9390928745269775], "perturbed_sampled_ll": -2.90850567817688, "perturbed_original_ll": -3.9390928745269775, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "sampled": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "perturbed_sampled": ["Question: Diffusion-weighted echo-planar imaging of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumor: Where is the current research using imaging technique? A: It is the most recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest generation of UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of the end result based using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? A: diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: This review is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: There is a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: are a prediction of different histologic subtypes possible? Q: Where is the prediction from? Answer: It is the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? Q: The existing research is still using imaging technique and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Yes, this technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: MR imaging of primary parotid gland tumors: is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of"], "perturbed_original": ["Question: Diffusion-weighted echo-planar MR imaging techniques are possible? Are there any histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed . Not combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a new technique and has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions , but also on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of a predating model to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on their own. DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging results in different types of pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the tendency to overlap with other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of many individual MR imaging criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary structures are possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, special imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging is possible with all histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant adenoma, but also on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate from the epiDWI model. Due to an overlap not only in individual groups but between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the effect that other examined , not just on the basis of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: It is possible to treat different tumor adenomas from all other examined entities. Due to an imbalance not only in lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted."], "original_ll": -4.091708660125732, "sampled_ll": -2.577810287475586, "all_perturbed_sampled_ll": [-2.8617546558380127, -3.0971953868865967, -2.6882848739624023, -3.1510753631591797, -2.7168591022491455, -2.578240156173706, -2.693777084350586, -2.77838134765625, -2.6651289463043213, -2.788034200668335], "all_perturbed_original_ll": [-4.365045547485352, -4.099071502685547, -4.265383243560791, -4.105594635009766, -4.2826128005981445, -4.365865230560303, -4.136569023132324, -4.247273921966553, -4.626656532287598, -4.301673412322998], "perturbed_sampled_ll": -2.8018731117248534, "perturbed_original_ll": -4.279574584960938, "perturbed_sampled_ll_std": 0.1772037591761204, "perturbed_original_ll_std": 0.1484117688892516}, {"original": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "sampled": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "perturbed_sampled": ["Question: Is cholecystectomy really an indication for concomitant splenectomy in mild mild cases? What should I do when it is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that you have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an diagnosing diagnostic diagnostic diagnostic? There is some misconception, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but it is not necessarily diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant diagnosis? Cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is there cholecystectomy associated with hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, not cholecystectomy is. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that you have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Yes, not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is true that your family will know you"], "perturbed_original": ["Question: Is cholecystectomy really an indication for concomitant splenectomy ? The need for concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild HS? The need for splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the short term, the merits of such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS EP surgery is not the case. In the absence of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access , our evaluation must be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant gallstones? Therefore, a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: What is hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the meantime, such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in children with mild HS? To consider, the need for splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits."], "original_ll": -3.5392746925354004, "sampled_ll": -2.482008695602417, "all_perturbed_sampled_ll": [-2.9142909049987793, -2.6337077617645264, -2.5099687576293945, -2.8215558528900146, -2.306313991546631, -2.2890331745147705, -2.638963222503662, -2.6337077617645264, -2.6093807220458984, -2.7737314701080322], "all_perturbed_original_ll": [-3.4540059566497803, -3.433957099914551, -3.5445444583892822, -3.664743185043335, -3.808978796005249, -3.6143643856048584, -3.488528251647949, -3.904141664505005, -3.5786144733428955, -3.3317205905914307], "perturbed_sampled_ll": -2.6130653619766235, "perturbed_original_ll": -3.5823598861694337, "perturbed_sampled_ll_std": 0.19268559249762768, "perturbed_original_ll_std": 0.16561326157437736}, {"original": "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "sampled": "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "perturbed_sampled": ["Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition happen? Not at least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not . Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. The number of menopause cycles increases over time,", "Question: Does menopausal transition change? At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of this experience? In the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition . Menopausal transition cycles increases over time,", "Question: Does menopausal transition 'not very much'? At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the new age. It is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a journey over time,"], "perturbed_original": ["Question: Does menopausal transition affect the quality of life? Answer: Menopausal transition was reported on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life , but all linked to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the trend was due to all these symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the women\u2019s lifespan was a mixed symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This episode of menopausal transition impacted the quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The effect was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study examined the quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found significant decreases in the role limitations, particularly among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life. A manopause due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect quality of life? China is having a significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms."], "original_ll": -3.4842090606689453, "sampled_ll": -2.532646417617798, "all_perturbed_sampled_ll": [-2.6426451206207275, -3.0325679779052734, -2.784015417098999, -2.672807216644287, -3.1693742275238037, -3.0534141063690186, -3.169502019882202, -2.976362943649292, -2.831937313079834, -2.8283345699310303], "all_perturbed_original_ll": [-3.905564785003662, -3.429271936416626, -3.300309181213379, -3.77931547164917, -4.110496997833252, -3.0635244846343994, -3.910001516342163, -3.828376054763794, -3.114082098007202, -3.833573818206787], "perturbed_sampled_ll": -2.9160960912704468, "perturbed_original_ll": -3.6274516344070435, "perturbed_sampled_ll_std": 0.18182777813969123, "perturbed_original_ll_std": 0.34989902463240563}, {"original": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "sampled": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "perturbed_sampled": ["Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for aneurysm subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage? Answer: Subarachnoid hemorrhage is not aneurysm repair in the treatment and treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It \u2019s reasonable to use aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: What is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not possible for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is repair for subarachnoid hemorrhage repair after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for aneurysm subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older ? This chapter explains the definition for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid"], "perturbed_original": ["Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured more conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should have aSAH with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we have improved the risk factor for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results , it was possible to make definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of the surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not get enough aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm repair was obtained. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: There was less of anemia for the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained and the op was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH."], "original_ll": -3.4250407218933105, "sampled_ll": -1.5792100429534912, "all_perturbed_sampled_ll": [-1.5635273456573486, -1.5685302019119263, -2.0370941162109375, -1.8270025253295898, -1.6216315031051636, -1.8772295713424683, -1.6031312942504883, -1.421035647392273, -1.7841006517410278, -1.9580711126327515], "all_perturbed_original_ll": [-3.6507370471954346, -3.5785326957702637, -3.414774179458618, -3.624405860900879, -3.6115336418151855, -4.000723361968994, -3.630392551422119, -3.43154239654541, -3.532994031906128, -3.672696590423584], "perturbed_sampled_ll": -1.7261353969573974, "perturbed_original_ll": -3.6148332357406616, "perturbed_sampled_ll_std": 0.18901608537835163, "perturbed_original_ll_std": 0.15346908418617752}, {"original": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "sampled": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "perturbed_sampled": ["Question: Sternal goids or a fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages of normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth , and can cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The fracture can cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The fracture can cause an", "Question: Sternal fracture in growing children : A rare and often fatal incident in many or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to occur during growth. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can be caused by structural imbalances in the development of a large child, including other fractures and fractures that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children , can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an"], "perturbed_original": ["Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a highly detailed and reliable method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in kids : Radiography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related fractures. Risk detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is also the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and diagnosis of fractures and the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the preferred tool to detect dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful tool of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is used to detect the dislocation.", "Question: Sternal fracture in growing children : A rare and often fatal fracture in child care : A rare and often fatal condition due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: In age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation."], "original_ll": -3.8446812629699707, "sampled_ll": -3.4450199604034424, "all_perturbed_sampled_ll": [-3.718339204788208, -3.6363117694854736, -3.700770854949951, -3.6468544006347656, -3.6468544006347656, -3.922224998474121, -3.7732903957366943, -3.581578254699707, -3.3674511909484863, -3.93749737739563], "all_perturbed_original_ll": [-4.0632524490356445, -4.133566379547119, -4.210216999053955, -4.024767875671387, -3.9842584133148193, -4.045614719390869, -4.062156677246094, -4.018373012542725, -3.8896100521087646, -4.1015753746032715], "perturbed_sampled_ll": -3.69311728477478, "perturbed_original_ll": -4.053339195251465, "perturbed_sampled_ll_std": 0.15663369995507628, "perturbed_original_ll_std": 0.08199256339692422}, {"original": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "sampled": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "perturbed_sampled": ["Question: Emergency double-balloon enteroscopy combined with real-time and overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure d phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early stages and continues to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively in the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal conditions. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat bleeding-induced oedema. \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced bleeding-induced complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. Our focus is in using the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approach. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: A single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy"], "perturbed_original": ["Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and hypert-obscure gastrointestinal bleeding? Answer: Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Is Emergency DBE a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular and non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to patients that can be easily misdiagnosed by non-emergency DBE.", "Question: What is a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, but in-depth viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions for Emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, with many patients undergoing surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a DBE in DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing can identify gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE."], "original_ll": -4.674497127532959, "sampled_ll": -3.15360426902771, "all_perturbed_sampled_ll": [-3.0593976974487305, -3.3947184085845947, -3.4716882705688477, -3.264238119125366, -3.2828359603881836, -3.531486988067627, -3.3190953731536865, -3.56358003616333, -3.4185996055603027, -3.2886126041412354], "all_perturbed_original_ll": [-4.6529951095581055, -4.4221906661987305, -4.888533115386963, -4.601086139678955, -4.602459907531738, -4.757219314575195, -4.91795015335083, -4.671605110168457, -4.765699863433838, -4.765739917755127], "perturbed_sampled_ll": -3.3594253063201904, "perturbed_original_ll": -4.704547929763794, "perturbed_sampled_ll_std": 0.14149861725245294, "perturbed_original_ll_std": 0.13937151930626449}, {"original": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "sampled": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "perturbed_sampled": ["Question: Are physicians meeting the needs of family caregivers ? Health families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to have a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe majority of families seek comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to care for themselves with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for their elderly relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers ? Because many families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for someone who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a specialized treatment. Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of Americans are able to take care of someone who needs care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help . The Department for Medicare and Medicaid Services is working on a comprehensive health care"], "perturbed_original": ["Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for the elder or demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail ? Does doctors do be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested by their caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are that if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians discontentful about helping caregivers? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of most different backgrounds? Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of caregivers? An acoustic discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and the group itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even physicians may be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: The physicians are very good at managing issues in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself."], "original_ll": -3.9701955318450928, "sampled_ll": -2.3526010513305664, "all_perturbed_sampled_ll": [-2.7198023796081543, -2.5773274898529053, -2.511547327041626, -2.483811378479004, -2.5977940559387207, -2.5995757579803467, -2.611786127090454, -2.8808693885803223, -2.4430108070373535, -2.727881908416748], "all_perturbed_original_ll": [-4.262656211853027, -4.421097278594971, -4.120945930480957, -4.161449432373047, -4.093568325042725, -4.0583577156066895, -4.343686103820801, -4.186428070068359, -3.973287343978882, -4.073482990264893], "perturbed_sampled_ll": -2.6153406620025637, "perturbed_original_ll": -4.169495940208435, "perturbed_sampled_ll_std": 0.12404351111805466, "perturbed_original_ll_std": 0.13071565975359756}, {"original": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "sampled": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "perturbed_sampled": ["detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are a form of neuropathological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears have glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears are designed to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical disease that has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with the patient (and to prevent the reactions associated with the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by prescreening. A PDS is a condition associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient is allergic", "Question: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent development of non-pharmacological reactions associated with a PDS. Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the immune system becomes an allergic"], "perturbed_original": ["Question: Pap smears with glandular cell abnormalities: Are you a patient? Most glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are treated in that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% . No one are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% . Only those abnormalities are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Yes, Pap smears are detected by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as a QA of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid -cancell detection? Pap smears are flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC typically demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: these glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected by rapid prescreening. RPS is a valuable QA method."], "original_ll": -3.6503050327301025, "sampled_ll": -2.938793182373047, "all_perturbed_sampled_ll": [-3.349457263946533, -3.1415698528289795, -2.8444507122039795, -3.1129088401794434, -3.263617992401123, -3.3715200424194336, -3.0678951740264893, -2.97090744972229, -2.445927381515503, -3.0478217601776123], "all_perturbed_original_ll": [-4.021098613739014, -4.012397289276123, -3.776925802230835, -3.7205374240875244, -3.1269280910491943, -3.902312755584717, -4.094405174255371, -4.1367316246032715, -3.937124729156494, -3.7536191940307617], "perturbed_sampled_ll": -3.0616076469421385, "perturbed_original_ll": -3.8482080698013306, "perturbed_sampled_ll_std": 0.2575679472173308, "perturbed_original_ll_std": 0.2760641961286735}, {"original": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "sampled": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "perturbed_sampled": ["Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]"], "perturbed_original": ["Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a"], "original_ll": -3.3090710639953613, "sampled_ll": -2.7743232250213623, "all_perturbed_sampled_ll": [-2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623, -2.7743232250213623], "all_perturbed_original_ll": [-3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613, -3.3090710639953613], "perturbed_sampled_ll": -2.7743232250213623, "perturbed_original_ll": -3.3090710639953613, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "sampled": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "perturbed_sampled": ["Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you"], "perturbed_original": ["Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state."], "original_ll": -4.212550163269043, "sampled_ll": -3.0407514572143555, "all_perturbed_sampled_ll": [-3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555, -3.0407514572143555], "all_perturbed_original_ll": [-4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043, -4.212550163269043], "perturbed_sampled_ll": -3.0407514572143555, "perturbed_original_ll": -4.212550163269043, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "sampled": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "perturbed_sampled": ["Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and"], "perturbed_original": ["Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque."], "original_ll": -3.731715440750122, "sampled_ll": -2.950165271759033, "all_perturbed_sampled_ll": [-2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033, -2.950165271759033], "all_perturbed_original_ll": [-3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122, -3.731715440750122], "perturbed_sampled_ll": -2.950165271759033, "perturbed_original_ll": -3.731715440750122, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "sampled": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "perturbed_sampled": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis preventing osteoporosis? While some believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, or any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe they have no medical history in these areas, they can only find out if they can take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? There are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may include a weakness and dizziness. Also, if you have an emergency, take an exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal problems, consult a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel the pain of pain, always talk to your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still plenty of musculoskeletal symptoms in your life, take prescription. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? There are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a look at the article. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. During your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, go to an online or online doctor\u2019s office before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing musculoskeletal symptoms? If people believe musculoskeletal problems exist, you know that you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with musculoskeletal symptoms. Also, make sure you take a physical exam with your doctor before you"], "perturbed_original": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who have bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis : and is less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to receive tamoxifen. Patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and do not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients on AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered medical medical assistance, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to rely on other patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to preventing osteoporosis? AIs are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis : patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to preventing osteoporosis? We are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received AIs should be given Ca/Bis to prevent musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to prevention of osteoporosis? Those in the region are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were treated differently. Clinics in patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis : Patients who received tamoxifen before AIs understand that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key part? Patient with osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. It is important to comedication with Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related disease symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop osteoporosis. Patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs."], "original_ll": -2.5729708671569824, "sampled_ll": -2.267977237701416, "all_perturbed_sampled_ll": [-2.4345107078552246, -2.6039352416992188, -2.4688034057617188, -2.414015769958496, -2.4283065795898438, -2.6012024879455566, -2.5456366539001465, -2.833242177963257, -2.438520669937134, -2.182211399078369], "all_perturbed_original_ll": [-3.225024938583374, -2.5338993072509766, -3.0469350814819336, -2.7133336067199707, -2.789590835571289, -2.614553451538086, -2.8818609714508057, -3.0119569301605225, -2.7548060417175293, -2.6378819942474365], "perturbed_sampled_ll": -2.4950385093688965, "perturbed_original_ll": -2.8209843158721926, "perturbed_sampled_ll_std": 0.16015491863125927, "perturbed_original_ll_std": 0.20736220334203592}, {"original": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "sampled": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "perturbed_sampled": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased"], "perturbed_original": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis."], "original_ll": -3.1155216693878174, "sampled_ll": -3.0485403537750244, "all_perturbed_sampled_ll": [-3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244, -3.0485403537750244], "all_perturbed_original_ll": [-3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174, -3.1155216693878174], "perturbed_sampled_ll": -3.0485403537750244, "perturbed_original_ll": -3.1155216693878174, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "sampled": "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "perturbed_sampled": ["Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle"], "perturbed_original": ["Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility."], "original_ll": -3.491124391555786, "sampled_ll": -1.7649333477020264, "all_perturbed_sampled_ll": [-1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264, -1.7649333477020264], "all_perturbed_original_ll": [-3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786, -3.491124391555786], "perturbed_sampled_ll": -1.7649333477020264, "perturbed_original_ll": -3.491124391555786, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "sampled": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "perturbed_sampled": ["Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion? We compared fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be treated with fluoxetine? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "patients using gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent clinical ischaemia? SPECT has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Our previous studies were conducted for HIV-infected patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? We tested patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of a virus using quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using SPECT? We tested the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients use SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific blood in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients"], "perturbed_original": ["Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Of at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Is screening for SMI using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial SPECT? For a few years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was an important factor in the general population and the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients undergo myocardial SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened using the myocardial and perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients with small or other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: For at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for SMI? For the male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique."], "original_ll": -3.2096824645996094, "sampled_ll": -2.2999463081359863, "all_perturbed_sampled_ll": [-2.4594085216522217, -2.4185431003570557, -2.5302789211273193, -2.5448031425476074, -2.4156599044799805, -2.384056329727173, -2.466106414794922, -2.255335807800293, -2.5139200687408447, -2.5836243629455566], "all_perturbed_original_ll": [-3.3921866416931152, -3.33434796333313, -3.3478710651397705, -3.3119845390319824, -3.150904417037964, -3.1337950229644775, -3.3050076961517334, -3.3344287872314453, -3.340519666671753, -3.1609268188476562], "perturbed_sampled_ll": -2.4571736574172975, "perturbed_original_ll": -3.281197261810303, "perturbed_sampled_ll_std": 0.09034290448829592, "perturbed_original_ll_std": 0.0897915344980126}, {"original": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "sampled": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "perturbed_sampled": ["Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity? Answer: Is there one as important as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or alcohol misuse? Two factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve the assessment of common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any other health condition, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program prevent a diagnosis of obesity and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most common causes of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of factors often influence the severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity ? Question: What is the key risk factors? Answer: It is important to know the characteristics of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most common cause of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors ? The key is the number of potential factors, such as:\n\nthe severity of the condition and severity of"], "perturbed_original": ["Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to medically supervised weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard -keeping weight loss program. MSWM improves the most behavioral outcomes after LAGB in our patient population.", "Question: Does MSWM confer additional benefit than most behavioral outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss procedure seem to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program claim to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of the number of participants in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to normal weight loss and most behavioral outcomes after LAGB in our patient population."], "original_ll": -3.8269500732421875, "sampled_ll": -2.5426278114318848, "all_perturbed_sampled_ll": [-2.9540953636169434, -3.0851402282714844, -2.8708198070526123, -2.785201072692871, -2.8832595348358154, -2.628448009490967, -2.78471040725708, -2.805608034133911, -2.588644504547119, -3.0781710147857666], "all_perturbed_original_ll": [-4.115779876708984, -4.171684265136719, -4.146066665649414, -4.250749588012695, -3.8708436489105225, -4.168349742889404, -4.2524003982543945, -4.212713718414307, -3.4837939739227295, -4.225814342498779], "perturbed_sampled_ll": -2.846409797668457, "perturbed_original_ll": -4.089819622039795, "perturbed_sampled_ll_std": 0.15729710969943062, "perturbed_original_ll_std": 0.22756373020540405}, {"original": "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "sampled": "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "perturbed_sampled": ["Question: Native men and women are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? What are they supposed to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live longer. While the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years , while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live on the same site as women. The survey suggests that Aboriginal women are more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to age born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, the Indigenous population is younger than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe answer: Yes, it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live longer in urban centres as the \"overweight\" Indigenous population is growing, while it's not"], "perturbed_original": ["Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study . Considering this, the type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians face serious disability? This study is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and approach should not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous Australians age prematurely is the reality of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the Aboriginal government respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: Age is supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of aged care. Answer: These two types of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be considered for the issue of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and analysis suggests that ageing Indigenous people will not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea of aging is in this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people."], "original_ll": -3.4855172634124756, "sampled_ll": -2.4269142150878906, "all_perturbed_sampled_ll": [-2.4969985485076904, -2.5018057823181152, -2.57662296295166, -2.5635793209075928, -2.600372076034546, -2.959786891937256, -2.5305607318878174, -2.692296028137207, -2.388197898864746, -2.532336950302124], "all_perturbed_original_ll": [-3.278268814086914, -3.7964112758636475, -3.6268575191497803, -3.4897196292877197, -3.7063045501708984, -3.903353214263916, -3.402252674102783, -3.761435031890869, -3.6701090335845947, -3.817580461502075], "perturbed_sampled_ll": -2.5842557191848754, "perturbed_original_ll": -3.64522922039032, "perturbed_sampled_ll_std": 0.1455579144171034, "perturbed_original_ll_std": 0.18848348634127032}, {"original": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "sampled": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "perturbed_sampled": ["Question: Do French lay people and health professionals find it acceptable to breach a disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and physicians prevent a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or medical professional is not appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family is not only an acceptable solution, but necessary to", "Question: Do French lay people and health professionals support a wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach a legal disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health care professionals protect one patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect health? As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually abusive marriage? Ultimately, Canadians agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect their health? No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to"], "perturbed_original": ["Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's spouse? Both in France and France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted STD? Are there other factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife ? These factors are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: We are deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people violate confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: It may also be necessary to consider deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? What will be considered when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most physicians can ask if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by the confidentiality of his personal information to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are allowed to breach confidentiality to protect the spouse of a patient infected with STD."], "original_ll": -3.5996556282043457, "sampled_ll": -3.305102825164795, "all_perturbed_sampled_ll": [-3.6592471599578857, -3.4997076988220215, -3.6216111183166504, -3.458407163619995, -3.594993829727173, -3.7431070804595947, -3.3505735397338867, -3.7863523960113525, -3.8818719387054443, -3.5533933639526367], "all_perturbed_original_ll": [-4.004552841186523, -3.6556358337402344, -4.217499732971191, -3.6442785263061523, -3.7276878356933594, -3.6091694831848145, -3.6261422634124756, -3.689741849899292, -3.748319149017334, -3.486642599105835], "perturbed_sampled_ll": -3.6149265289306642, "perturbed_original_ll": -3.7409670114517213, "perturbed_sampled_ll_std": 0.15196242031510382, "perturbed_original_ll_std": 0.20280079460184858}, {"original": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "sampled": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "perturbed_sampled": ["Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Question: Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign? Answer: Deafin B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" 2. Bekker H"], "perturbed_original": ["Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? This sign is the marker that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a disease that occurs when esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma compared with endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms of a eosinophilic mucosa that readily tears in response", "Question: What is primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are exhibiting some morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the signs and is particularly effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients without loss of calcium in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the severity of the pain during surgery. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are affecting morbidity, despite development of disquieting lesions in response"], "original_ll": -3.4177308082580566, "sampled_ll": -1.72190523147583, "all_perturbed_sampled_ll": [-1.847084641456604, -1.710698127746582, -1.8800381422042847, -1.8980110883712769, -1.72190523147583, -1.710698127746582, -2.0440783500671387, -1.7932640314102173, -1.72190523147583, -1.8262951374053955], "all_perturbed_original_ll": [-4.017038822174072, -3.878549575805664, -3.3955705165863037, -3.121302366256714, -3.563234567642212, -3.4004271030426025, -3.33675217628479, -3.335073709487915, -3.3580477237701416, -3.371511697769165], "perturbed_sampled_ll": -1.815397810935974, "perturbed_original_ll": -3.477750825881958, "perturbed_sampled_ll_std": 0.10213549740871646, "perturbed_original_ll_std": 0.2577633954690777}, {"original": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "sampled": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "perturbed_sampled": ["Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P. S. G. Johns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Medicine Cleveland, Ohio 44119-201 PubMed Crossref Doctor of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201 PubMed Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' own stroke cases affected? Google Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health University of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health Indianapolis, Ohio 44114-0201 | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed CrossRef Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 40220-0201 PubMed Abstract | Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201 Karen W.K. Michele P. S. G. John D. Johns Hopkins Bloomberg School of Public Health Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n"], "perturbed_original": ["Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home and not only at home in front of them but also accurately affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of patients had always seemed to have bias at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' BPs accurate? In recent years, 65% of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings incorrect? The objective was to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to detect BP symptoms and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since there was no indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in the median home were the most reliable readings of any BP in any BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was detected. Blood pressure readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record and record blood pressure readings in their homes. Their records of BP readings would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Was the numbers reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,"], "original_ll": -4.0465497970581055, "sampled_ll": -1.5633275508880615, "all_perturbed_sampled_ll": [-1.8835499286651611, -2.4215943813323975, -2.1159164905548096, -1.7291808128356934, -1.626662015914917, -2.047917127609253, -1.7742376327514648, -2.020082950592041, -2.1776461601257324, -1.7538559436798096], "all_perturbed_original_ll": [-4.160883903503418, -4.149477958679199, -3.899836301803589, -4.347311973571777, -4.221196174621582, -4.031296730041504, -4.077475070953369, -4.097311496734619, -3.760852098464966, -4.27779483795166], "perturbed_sampled_ll": -1.955064344406128, "perturbed_original_ll": -4.102343654632568, "perturbed_sampled_ll_std": 0.2330416920822664, "perturbed_original_ll_std": 0.1654944909416235}, {"original": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "sampled": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "perturbed_sampled": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) was associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Evidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to have proof that their success has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that urinary albumin/creatinine ratio (ACR) is well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of urinary albin/creatinine ratios (ACR) on women with a capacity of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? The analysis of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio a maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in the pregnancy can produce a neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Are those with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and maternal blood flow? It appears that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%"], "perturbed_original": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for male adverse outcomes? ACR may be a prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent indicator of preeclampsia and preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? No prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcome. It is useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcome. This results in predicting risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcome. There is no ambiguity about gender risk predictions within a prognostic model.", "Question: Is the first hypothesis, is ACR an independent prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in the environment within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model."], "original_ll": -2.757969856262207, "sampled_ll": -2.6757867336273193, "all_perturbed_sampled_ll": [-2.8645694255828857, -2.9676759243011475, -3.1233761310577393, -2.5012354850769043, -3.0025079250335693, -3.0088162422180176, -3.054212808609009, -2.875727891921997, -3.0164523124694824, -3.063189744949341], "all_perturbed_original_ll": [-2.9989163875579834, -3.052827835083008, -2.9358017444610596, -3.0901782512664795, -2.8642613887786865, -2.999678611755371, -2.966360092163086, -3.046200752258301, -2.8492865562438965, -3.214406728744507], "perturbed_sampled_ll": -2.9477763891220095, "perturbed_original_ll": -3.001791834831238, "perturbed_sampled_ll_std": 0.166982384046111, "perturbed_original_ll_std": 0.10265933708412954}, {"original": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "sampled": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "perturbed_sampled": ["Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine that is less acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an adequate cure? It all depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of consuming urine? A significant factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A good question is because it is easy to", "Question: A model for removing acid oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be recommended, or whether 80-90 is considered an ideal level, because it is easy to", "Question: A reflux oesophagitis: Is there a time in the same with reflux oesophagitis? Answer: D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of water? One factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, as urine pH is acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of an acid suppression regime is considered a perfect treatment. So is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to"], "perturbed_original": ["Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a higher rate with an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an early treatment? After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements must be done for a minimum of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which the number of hours with intragastric pH>4.", "Question: A model of healing of therapy at an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of natural acid suppression during an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are made in a matter of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C or D oesophagitis? Question: Can a cure be applied in therapy of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 or 4 hours of successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux \u2013 is the same maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4."], "original_ll": -3.8805081844329834, "sampled_ll": -3.3675506114959717, "all_perturbed_sampled_ll": [-3.616535186767578, -3.3034982681274414, -3.4801082611083984, -3.679391860961914, -3.0786802768707275, -3.934786081314087, -2.900705099105835, -3.526578903198242, -3.5785903930664062, -3.1241297721862793], "all_perturbed_original_ll": [-3.852634906768799, -4.00810432434082, -4.0269012451171875, -3.9212353229522705, -4.315238952636719, -4.382926940917969, -3.923666000366211, -4.013025760650635, -4.38863468170166, -4.330470561981201], "perturbed_sampled_ll": -3.422300410270691, "perturbed_original_ll": -4.116283869743347, "perturbed_sampled_ll_std": 0.29971039003888, "perturbed_original_ll_std": 0.2014306868202812}, {"original": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "sampled": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "perturbed_sampled": ["Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience. 2. Patients who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have received surgery, may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and any other surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate cancer diagnosis a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery. Previous past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer or have taken a new path to health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who know that they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have a good medical experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with cancer and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is"], "perturbed_original": ["Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or multiple cancers. Each was the same between the three groups.", "Question: Is the ability to perform transurethral resection of tissue? A senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist would choose to have more experience within a prostate unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is this followed by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of tissues? The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the number of adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or infected patients. The average TURP was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced urologist. This raised the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more . A previous experience of a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to several distinct groups, the fact that the incidence of complications was the same between the three groups."], "original_ll": -3.2850184440612793, "sampled_ll": -2.2950735092163086, "all_perturbed_sampled_ll": [-2.5252437591552734, -2.563685655593872, -2.5347235202789307, -2.624908447265625, -2.445080041885376, -2.3048787117004395, -2.5178518295288086, -2.497218608856201, -2.582310676574707, -2.41762638092041], "all_perturbed_original_ll": [-3.576453685760498, -3.4835457801818848, -3.370570182800293, -3.601304769515991, -3.5068304538726807, -3.103651523590088, -3.470689296722412, -3.2913665771484375, -3.4568769931793213, -3.5609185695648193], "perturbed_sampled_ll": -2.5013527631759644, "perturbed_original_ll": -3.4422207832336427, "perturbed_sampled_ll_std": 0.08744029790728479, "perturbed_original_ll_std": 0.1438202769316342}, {"original": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "sampled": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "perturbed_sampled": ["Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the"], "perturbed_original": ["Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism."], "original_ll": -3.374971628189087, "sampled_ll": -3.453695297241211, "all_perturbed_sampled_ll": [-3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211, -3.453695297241211], "all_perturbed_original_ll": [-3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087, -3.374971628189087], "perturbed_sampled_ll": -3.453695297241211, "perturbed_original_ll": -3.374971628189087, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "sampled": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "perturbed_sampled": ["Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on the research literature, there are two approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions ? Based on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation analysis. One approach is to perform a simple but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article, there are two approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a molecular cross-sectional analysis of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation be a drug? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous families? In the literature, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the other is to perform a molecular cross-sectional (MHC) analysis.", "Question: Why are this adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis."], "perturbed_original": ["Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to give the fetal intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Because mutation analysis may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can we choose polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC deteriorate the age? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of disease. Question: In some cases, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even on the site of mutation, it may be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions may be made on the site of mutation, rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, it is not advisable to postpone elective colectomy because desmoids may arise through surgical intervention."], "original_ll": -3.8901426792144775, "sampled_ll": -2.7781283855438232, "all_perturbed_sampled_ll": [-2.7707571983337402, -2.8659064769744873, -3.0242319107055664, -2.783210277557373, -2.7696444988250732, -2.7422091960906982, -2.663170099258423, -2.8401501178741455, -2.9578170776367188, -2.9262242317199707], "all_perturbed_original_ll": [-3.898385763168335, -3.889843225479126, -4.137211322784424, -3.9049072265625, -4.209395885467529, -3.7935004234313965, -3.9417006969451904, -3.9027585983276367, -3.7727608680725098, -3.8828070163726807], "perturbed_sampled_ll": -2.8343321084976196, "perturbed_original_ll": -3.9333271026611327, "perturbed_sampled_ll_std": 0.104598368444895, "perturbed_original_ll_std": 0.13061088307054597}, {"original": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "sampled": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "perturbed_sampled": ["Treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. An geriatric oncology consultation can be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of this study is the availability of the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different ways that people think about their treatment plans. These specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the cancer treatment plan. Also, their specificities will be supported by", "Question: Does a geriatric oncology consultation help? Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation provide any more guidance? One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation work for patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about cancer patients and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This is governed by"], "perturbed_original": ["Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed for older patients.", "Question: Does a geriatric oncology consultation benefit a geriatric oncology consultation? The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan for older patients. The results are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation changes more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan? Yes, new patients have been subjected to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan? The results compare to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan? This has led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan for elderly patients. Several studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. This article provides a guide to the outcome of these older patients."], "original_ll": -2.701833486557007, "sampled_ll": -2.851677417755127, "all_perturbed_sampled_ll": [-3.247262954711914, -2.7334723472595215, -3.456657886505127, -3.034869909286499, -2.9173412322998047, -2.87964129447937, -2.9162862300872803, -2.8406829833984375, -3.1096694469451904, -2.8677890300750732], "all_perturbed_original_ll": [-2.726999044418335, -2.954662561416626, -2.766759157180786, -2.7198545932769775, -3.0514447689056396, -3.1679885387420654, -3.3388640880584717, -3.123471975326538, -2.703918933868408, -3.0574309825897217], "perturbed_sampled_ll": -3.0003673315048216, "perturbed_original_ll": -2.961139464378357, "perturbed_sampled_ll_std": 0.20618988095702992, "perturbed_original_ll_std": 0.21125093140879767}, {"original": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "sampled": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "perturbed_sampled": ["Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there"], "perturbed_original": ["Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens."], "original_ll": -3.880807638168335, "sampled_ll": -2.5348548889160156, "all_perturbed_sampled_ll": [-2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156, -2.5348548889160156], "all_perturbed_original_ll": [-3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335, -3.880807638168335], "perturbed_sampled_ll": -2.5348548889160156, "perturbed_original_ll": -3.880807638168335, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "sampled": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "perturbed_sampled": ["Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Exercise Association (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in looking at the eyes. The majority of the people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea be known? The general population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not training to look at the eyes. The Coalition recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American people in our group of women with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, reducing the hormones their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are motivated to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic physique, more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: A person who tries to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem to get active than their body can produce."], "perturbed_original": ["Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in this study, patients report a statistically significant decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients also have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater and higher apnea compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, OSA does not predict a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the other cohort of patients with elevated aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. Currently, Americans with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by oxygen. Populations greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the association between both these two testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a difference. Overall, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with OSA don\u2019t predict a significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with"], "original_ll": -2.9211440086364746, "sampled_ll": -2.350245952606201, "all_perturbed_sampled_ll": [-3.0975747108459473, -2.4024529457092285, -2.7426605224609375, -2.5154600143432617, -2.7815921306610107, -2.4911530017852783, -2.504931926727295, -2.6354238986968994, -2.555722951889038, -2.5014939308166504], "all_perturbed_original_ll": [-2.7788946628570557, -3.051642417907715, -3.3854708671569824, -2.814016342163086, -3.1184000968933105, -3.0659632682800293, -3.215139865875244, -3.0886709690093994, -3.207756996154785, -3.2065515518188477], "perturbed_sampled_ll": -2.6228466033935547, "perturbed_original_ll": -3.0932507038116457, "perturbed_sampled_ll_std": 0.19382075669500506, "perturbed_original_ll_std": 0.17496263417838048}, {"original": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "sampled": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "perturbed_sampled": ["Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the primary ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological abnormalities? Your loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological limitations? The loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special updates to Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special promotions on Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "The Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness hurt? It depends on who is nervous and how anxious you feel? Unconsciously, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. They're those that're anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological signs of depression? Depression, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with emotional distress. There are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps"], "perturbed_original": ["Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in a large number of cases. Difference between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. The literature examined the potential of measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. The results of this study are helpful for measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC on the developmental phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring neuropsychological decrements. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC in the early phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. We believe that LOC has a role in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) using neuropsychological testing procedures. This results suggest an important relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to predict neuropsychological decrement after mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study determine the predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large"], "original_ll": -2.8434038162231445, "sampled_ll": -1.8941656351089478, "all_perturbed_sampled_ll": [-1.925766110420227, -1.9595149755477905, -1.9602924585342407, -2.0618577003479004, -2.0354878902435303, -1.9040166139602661, -2.0662598609924316, -1.9996814727783203, -1.9508464336395264, -1.9438964128494263], "all_perturbed_original_ll": [-2.986534357070923, -2.985910415649414, -2.8264031410217285, -3.058056354522705, -2.7940783500671387, -2.9842872619628906, -2.8370413780212402, -2.895261526107788, -2.726224660873413, -3.043095588684082], "perturbed_sampled_ll": -1.980761992931366, "perturbed_original_ll": -2.913689303398132, "perturbed_sampled_ll_std": 0.054109259202032765, "perturbed_original_ll_std": 0.10787832438045324}, {"original": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "sampled": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief is limited to periods of less than three months, when they", "perturbed_sampled": ["Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with a headache of less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding that migraine patients will receive their headache and their relief is limited to periods of less than three months, when they", "Question: Does early migraine treatment shorten time to cope? This is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief is limited to periods of less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief system are more difficult than they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and migraine for months and even months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache s for less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with a headache within less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the patients seeking to get the right treatment for their migraines is limited to cope with their headache and their relief is limited to periods of less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak ? This may seem a difficult and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief is limited to periods of less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are often limited to periods of less than three months, when they"], "perturbed_original": ["Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not reduce the migraine burden by reducing total migraine headache duration.", "Question: Can triptans help reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to headache peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate the headache onset burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This may lead to shorter headache duration.", "migraine headache severity at peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of the term headache had its severity at peak and the headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten duration? Early migraine treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache s at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early treatment alleviate headache severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration."], "original_ll": -3.747938394546509, "sampled_ll": -3.192521095275879, "all_perturbed_sampled_ll": [-3.329455852508545, -3.6862950325012207, -3.254178047180176, -3.5496764183044434, -3.453366279602051, -3.4669432640075684, -3.3937087059020996, -3.641507863998413, -3.5306127071380615, -3.2751452922821045], "all_perturbed_original_ll": [-3.738861083984375, -3.863492727279663, -3.5582797527313232, -3.7913930416107178, -3.707817554473877, -3.8382136821746826, -4.241903781890869, -3.891541004180908, -3.95430588722229, -3.710783004760742], "perturbed_sampled_ll": -3.4580889463424684, "perturbed_original_ll": -3.8296591520309446, "perturbed_sampled_ll_std": 0.13971703692940637, "perturbed_original_ll_std": 0.17402930037346567}, {"original": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "sampled": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "perturbed_sampled": ["Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing programs from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing healthcare needs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the leading initiatives in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health program and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing come with an efficient public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing numbers in Thailand is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health policy programs. Question: National Institutes of Health and Welfare (NINTHW),", "Question: Living in an urban environment . One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns is that it is necessary to develop a number of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of public health programs. A traditional health care approach has been the National Institute for Health and Welfare (NINTHW),"], "perturbed_original": ["Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may be associated with higher physiological and behavioral risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these biological risk factors were not natural factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Generally, it is a combination of biological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in the city was a long timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors and reductions in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment , living in an urban environment is not a good experience. Question: Living in an urban environment. Question: Living in an urban environment. Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in behavioral and physiological risk factors. Many factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in urban areas may be affected by increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity associations may not reflect biological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures."], "original_ll": -3.3854615688323975, "sampled_ll": -2.8257205486297607, "all_perturbed_sampled_ll": [-2.9693644046783447, -2.8318753242492676, -3.0585315227508545, -2.876716375350952, -3.582050085067749, -2.8300108909606934, -3.2793235778808594, -2.6917190551757812, -2.797577381134033, -2.979644298553467], "all_perturbed_original_ll": [-3.4579925537109375, -3.4688432216644287, -3.4758543968200684, -3.60722017288208, -3.524010419845581, -2.857696771621704, -3.5419440269470215, -3.5279078483581543, -3.1964986324310303, -3.6233959197998047], "perturbed_sampled_ll": -2.9896812915802, "perturbed_original_ll": -3.428136396408081, "perturbed_sampled_ll_std": 0.25077702290197545, "perturbed_original_ll_std": 0.2204945556642914}, {"original": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "sampled": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "perturbed_sampled": ["Question: Marital status, living not quite. It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether this is in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not an expert in the manner or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in how we interpret the results.\n\nMarital status, living", "Question: Marital status, living in the house or by the gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect of the association is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It seems like I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the size of the results.\n\nMarital status, living", "Question: Marital status, living . It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living"], "perturbed_original": ["Question: Marital status, living arrangements, mortality risks in the marriage, etc. Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for determining marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in women and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality rates. As a result, living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: There are several gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: There are different gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of the difference in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living arrangements will be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living alone on both adults and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in men and women. It helps to gauge and explain differences between different models in life and living with a partner seems to be different in men and women."], "original_ll": -3.377171277999878, "sampled_ll": -2.6305131912231445, "all_perturbed_sampled_ll": [-3.060800790786743, -2.8716633319854736, -3.043581962585449, -2.8275907039642334, -2.7920305728912354, -2.9053757190704346, -2.9521305561065674, -2.953761339187622, -2.7967498302459717, -2.9043126106262207], "all_perturbed_original_ll": [-3.349360466003418, -3.4127509593963623, -3.9040331840515137, -3.453418254852295, -3.0960071086883545, -3.1212005615234375, -3.3742685317993164, -3.411518096923828, -3.897958993911743, -3.7071480751037598], "perturbed_sampled_ll": -2.910799741744995, "perturbed_original_ll": -3.4727664232254027, "perturbed_sampled_ll_std": 0.08906501623426608, "perturbed_original_ll_std": 0.2683130757134688}, {"original": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "sampled": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "perturbed_sampled": ["Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This association of major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report looks at the association of major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to depression? This study indicates that drinking in adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of depression than alcohol use disorders, with evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is no apparent association. The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults has reduced cognitive functions and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and behaviors. Some research also shows that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased symptoms of depression. Major depression is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: What does major depression and alcohol use disorders affect? Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with poor mental functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with"], "perturbed_original": ["Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group are seen from adults to those members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses of severe childhood experiences amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of up to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to influence the subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses reported amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst those comorbid group are likely to lead to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age should lead to longer adolescence exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: What can lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these figures on the Table 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of depression and alcohol use disorder at age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD."], "original_ll": -3.3694863319396973, "sampled_ll": -2.2745962142944336, "all_perturbed_sampled_ll": [-2.4057302474975586, -2.455317497253418, -2.4293887615203857, -2.3002612590789795, -2.3705906867980957, -2.489213705062866, -2.4192774295806885, -2.423800468444824, -2.3113820552825928, -2.315863609313965], "all_perturbed_original_ll": [-3.393848419189453, -3.454775810241699, -3.4897913932800293, -3.539165496826172, -3.450993299484253, -3.485767126083374, -3.674290657043457, -3.4447216987609863, -3.638561964035034, -3.327511787414551], "perturbed_sampled_ll": -2.3920825719833374, "perturbed_original_ll": -3.489942765235901, "perturbed_sampled_ll_std": 0.06162115476529245, "perturbed_original_ll_std": 0.09946296496873686}, {"original": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "sampled": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "perturbed_sampled": ["Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is the process of blood loss (clotting, blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In other words, there is some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: There's a kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and thus there's an increased risk of coronary artery disease, including some rare disease associated with this type of disease. A high degree of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a pathogenesis atrial fibrillation and an increased risk of coronary heart disease and coronary heart disease. It is now known that the presence of this mutation may result in", "important factors in the pathogenesis of atrial fibrillation? Answer: A small mutation is usually preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the process of inflamation. It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is possible that you get involved in", "Question: Stretch-sensitive KCNQ1 mutation A link to atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary artery disease. Q: Taking on this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by a mutation that can lead to atrial fibrillation . In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of coronary heart disease. Treatment of atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, inflammation, splinters) that occurs in the plasma level of glucose. In addition, there's an increased risk of coronary heart disease. It is now known that the presence of this mutation may result in"], "perturbed_original": ["Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C model would suggest a model in which a \"second hit\", such as an initial hit that unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? AF is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion , should be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic factors. These models did not have the idea to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel , which is manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors . We believe that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a model, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited role for AF to cause an age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 AF model, a model in which a \"second hit\", which disintegrates the stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation is a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and gives a \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutations are causing AF. Question: Do you think the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an R14C KCNQ1 mutation, unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model that, like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF development and for the age-related increase in AF development."], "original_ll": -3.5673489570617676, "sampled_ll": -2.5983331203460693, "all_perturbed_sampled_ll": [-2.754838705062866, -2.685310125350952, -2.7808444499969482, -2.6208479404449463, -2.4938483238220215, -3.010270833969116, -2.78537917137146, -2.794421434402466, -2.7469797134399414, -2.9191060066223145], "all_perturbed_original_ll": [-3.764082670211792, -4.142402648925781, -4.217282772064209, -4.067353248596191, -3.922790288925171, -3.855292558670044, -3.9002041816711426, -3.7960596084594727, -3.34961199760437, -3.7982277870178223], "perturbed_sampled_ll": -2.7591846704483034, "perturbed_original_ll": -3.8813307762145994, "perturbed_sampled_ll_std": 0.13644843247579067, "perturbed_original_ll_std": 0.2300062974397885}, {"original": "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "sampled": "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "perturbed_sampled": ["Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the visual aid. The diagnosis, under the treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose the child? This is under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during the day, does not require the visual aid (if the", "Question: No. No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do you need it? The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during the day, does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis , at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time , a child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be used for the treatment of the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, does not require the visual aid (if the"], "perturbed_original": ["Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, ultrasound is recommended as an imaging method for diagnosing unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis? It is important to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, further steps should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to diagnose appendicitis. The key to this be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key . A selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented . The second should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented . The most important should be ultrasonography.", "Question: Why? Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in all her patients? Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older , ultrasound should be a way to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography."], "original_ll": -3.559323310852051, "sampled_ll": -2.726213216781616, "all_perturbed_sampled_ll": [-2.959536075592041, -3.1291964054107666, -3.0494279861450195, -2.8932931423187256, -2.947011947631836, -3.0494279861450195, -3.134739398956299, -3.2589173316955566, -3.0113630294799805, -3.097217321395874], "all_perturbed_original_ll": [-3.3149139881134033, -3.656761407852173, -3.6742169857025146, -3.297400712966919, -4.020790100097656, -3.607869863510132, -3.4834086894989014, -4.104196071624756, -3.977161407470703, -3.8199336528778076], "perturbed_sampled_ll": -3.053013062477112, "perturbed_original_ll": -3.6956652879714964, "perturbed_sampled_ll_std": 0.10201899211324587, "perturbed_original_ll_std": 0.2693709156941946}, {"original": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "sampled": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "perturbed_sampled": ["Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, most of those students who teach this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize other residents who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Technical skills are not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to consider graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school have outstanding performance in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need to recognize the many ratings of resident's leadership skills in the technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do I know that I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings for leadership skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skills? It is the actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of people who aspire to be leaders. Thousands of graduates at this school are graduates who know how to make their own decisions in their field. I know"], "perturbed_original": ["Question: Do resident's leadership skills correlate with their directional instructions? Recent research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their ability to manage repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to skill decay or task difficulty during bowel repair? Residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a particular individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their initial repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical leadership skills? resident resident has significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and proficiency decay. These may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay . Following instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their internal repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's symptoms indicate no. During surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted."], "original_ll": -5.075577735900879, "sampled_ll": -3.227374792098999, "all_perturbed_sampled_ll": [-3.472592830657959, -3.372426748275757, -3.4921820163726807, -3.3687868118286133, -3.4017529487609863, -3.303328037261963, -3.258920907974243, -3.6253862380981445, -3.4690096378326416, -3.4726157188415527], "all_perturbed_original_ll": [-5.0169453620910645, -4.940983295440674, -4.8160552978515625, -5.127896785736084, -5.079179286956787, -5.479186058044434, -5.072737693786621, -5.306102752685547, -5.060543537139893, -5.438248634338379], "perturbed_sampled_ll": -3.423700189590454, "perturbed_original_ll": -5.1337878704071045, "perturbed_sampled_ll_std": 0.09998548951833, "perturbed_original_ll_std": 0.201389449991288}, {"original": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "sampled": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "perturbed_sampled": ["Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression in women is the cause, we know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is more acute, we know which is the greater symptom. As", "Question: Why is it possible for differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "are all the main symptoms caused by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression occurring? Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is an insignificant factor in woman deaths, we cannot know which is the greater symptom. As", "Question: Are there proofs of greater symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: As the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher -risk reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As"], "perturbed_original": ["Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women should have similar symptoms? Answer: No evidence that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community were diagnosed with depressive symptoms before the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in this community sample? Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this case have remained more than dependent on gender or gender. The study concluded that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community were not single and the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported less than four times. A differential reporting of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive depression by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depression in each province and region, but no significant differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depression, while male symptoms differs by gender was found.", "is there an indication of patterns caused by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found."], "original_ll": -3.2227110862731934, "sampled_ll": -2.9022057056427, "all_perturbed_sampled_ll": [-3.322659730911255, -3.278576135635376, -3.5004191398620605, -3.3240017890930176, -3.4021711349487305, -2.999814987182617, -3.411932945251465, -3.3024394512176514, -3.3868601322174072, -3.625208854675293], "all_perturbed_original_ll": [-3.3384480476379395, -3.834325075149536, -3.316957473754883, -4.090264320373535, -4.025611877441406, -3.9795401096343994, -4.14185905456543, -3.835219621658325, -4.1314568519592285, -3.7092363834381104], "perturbed_sampled_ll": -3.3554084300994873, "perturbed_original_ll": -3.840291881561279, "perturbed_sampled_ll_std": 0.15407979141695918, "perturbed_original_ll_std": 0.2889468117334665}, {"original": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "sampled": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "perturbed_sampled": ["Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse effects. Hypotension is an underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe adverse effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat . Common causes to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? A common condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: Why do we need to treat hypotension for more than 25 years? Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the heart problems with increased risk for hypertension, heart"], "perturbed_original": ["Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease were out of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with ischaemic heart disease and hypotension may be sensitive to ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred in a combination of hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly that of symptomatic cardiac, resulting in that patients seemed to be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events occur in patients with coronary disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events result in increased blood pressure? In patients with coronary disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may have been given much as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension or myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment."], "original_ll": -3.251067876815796, "sampled_ll": -2.180661678314209, "all_perturbed_sampled_ll": [-2.10145902633667, -2.2275288105010986, -2.2591261863708496, -2.180661678314209, -2.4795587062835693, -2.6594324111938477, -2.6975202560424805, -2.668429374694824, -2.4655044078826904, -2.3372323513031006], "all_perturbed_original_ll": [-3.536475419998169, -3.0290403366088867, -3.322070837020874, -3.468571186065674, -3.3920743465423584, -3.344209909439087, -3.6612496376037598, -3.462709665298462, -3.4619252681732178, -3.272462844848633], "perturbed_sampled_ll": -2.407645320892334, "perturbed_original_ll": -3.395078945159912, "perturbed_sampled_ll_std": 0.20704618963577026, "perturbed_original_ll_std": 0.16193489326285082}, {"original": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "sampled": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "perturbed_sampled": ["Question: Are laboratories reporting serum quantitative and hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are you doing this? Health care does not report serum hCG results. The FDA will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the lab if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the laboratory if you can help.\n\n", "Question: Are laboratories reporting serum quantitative ly hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum hCG results? Answer: Tests also serum hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the Health Center to see if you can help.\n\n", "Question: Are laboratories reporting serum or serum hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report the results correctly on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n"], "perturbed_original": ["Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) erroneous reporting of the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum hCG results? Are laboratories reporting serum hCG results erroneously, but are it erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting ; (a) dread and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG ; (c) the high resolution of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion over the personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the confusion of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum serum? Are hCG lab personnel making false and erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the imbalance of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting errors, confusion and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? hCG serum results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of"], "original_ll": -3.4359638690948486, "sampled_ll": -2.655153512954712, "all_perturbed_sampled_ll": [-3.001865863800049, -2.634408712387085, -3.32364559173584, -3.342000961303711, -3.2700202465057373, -2.889277696609497, -3.2415554523468018, -2.806199312210083, -3.048379421234131, -3.1177642345428467], "all_perturbed_original_ll": [-3.498650074005127, -3.5960750579833984, -4.18887186050415, -3.6806724071502686, -4.1699371337890625, -4.2751994132995605, -3.949298620223999, -4.284731864929199, -4.2521257400512695, -3.970954179763794], "perturbed_sampled_ll": -3.0675117492675783, "perturbed_original_ll": -3.986651635169983, "perturbed_sampled_ll_std": 0.22518444066832263, "perturbed_original_ll_std": 0.28337876944030915}, {"original": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "sampled": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "perturbed_sampled": ["Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it in my opinion? In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or even 3 weeks. We did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Patients with 2, 3, and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a pre-treatment technique, the results found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than more patients at the 3-week levels? Previously, more patients responded to an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 6-week levels of IVF had more success than patients at the baseline or 2, 3, or 4. Since we did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for infection and diagnosis of acute and chronic illness and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 6-week levels received more Antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Children at 6, 6 and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 2, 6 weeks. While we did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor ? In this study, patients at the 3-week and 6-week levels were evaluated in the assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: IVF--is the diagnosis of IVF--is it a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 6-week levels of FSH were assessed at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a more predictor or predictor than age and FSH? Answer: Patients at baseline and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a diagnosis for VF? According to a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4. Although IVF did not use a follow-up of a single patient with any given condition, we found that the"], "perturbed_original": ["Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both antral and antral follicle assessment. Unlike age and FSH, there were significantly more indications for bacterial fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle is a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone. Interestingly this may be a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicles differ slightly from outcome than were age or follicle in ovarian age that is distinct from chronological age or hormonal markers.", "effect in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone in children at an age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than IVF--It could be correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, or better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, and the reproductive and gender pathology. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or age. Question: We would recommend antral follicle assessment for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: We studied all gender and hormonal markers (ovarian ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or FSH) for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both antral and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than a predictive factor? Antral follicle assessment was correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was correlated with maternal age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: What is IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome was a better predictor than age, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers."], "original_ll": -3.370368242263794, "sampled_ll": -2.6468863487243652, "all_perturbed_sampled_ll": [-3.0962507724761963, -2.9522125720977783, -3.0730018615722656, -3.0740973949432373, -2.9671027660369873, -3.2064268589019775, -3.0859506130218506, -2.7846248149871826, -2.883406639099121, -3.027073383331299], "all_perturbed_original_ll": [-3.5694541931152344, -3.7665860652923584, -4.144867420196533, -3.8348891735076904, -3.979382276535034, -3.634411573410034, -3.623920202255249, -3.3209898471832275, -3.3986763954162598, -3.292858362197876], "perturbed_sampled_ll": -3.0150147676467896, "perturbed_original_ll": -3.65660355091095, "perturbed_sampled_ll_std": 0.11485135910869818, "perturbed_original_ll_std": 0.26591330582576894}, {"original": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "sampled": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "perturbed_sampled": ["Question: Is pain a clinically relevant problem in general? The best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general? Probably the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant cause in general? One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and to avoid physical", "Question: Is pain clinically relevant in general? Does it not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult ? The best way to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general adult psychiatry is to diagnose some symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain or not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not . Question: A best strategy to measure pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical"], "perturbed_original": ["Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are in other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical ly relevant aspect in general adult psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain in psychiatry seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical ly relevant problem in general adult psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We have studied these outcomes in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a serious clinical problem in adult psychiatry? We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? A clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Pain is a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry consist of other disciplines.", "Question: Is pain a common clinical problem in psychiatric patients? There is no evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines."], "original_ll": -3.8248400688171387, "sampled_ll": -2.522655487060547, "all_perturbed_sampled_ll": [-2.6636853218078613, -2.7606663703918457, -2.664724826812744, -2.790874481201172, -2.875663995742798, -2.777323007583618, -2.5820980072021484, -3.146512985229492, -2.9972546100616455, -3.307234764099121], "all_perturbed_original_ll": [-3.8268306255340576, -4.166689395904541, -4.085358142852783, -3.991644859313965, -4.1954474449157715, -3.856982707977295, -4.212802410125732, -4.072421073913574, -3.9697787761688232, -3.676344156265259], "perturbed_sampled_ll": -2.8566038370132447, "perturbed_original_ll": -4.00542995929718, "perturbed_sampled_ll_std": 0.21827959835329522, "perturbed_original_ll_std": 0.16723747131090094}, {"original": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "sampled": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "perturbed_sampled": ["Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course, inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic with Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage al Affection Pathological to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Chronic inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic ? Or Is Alveolar Macrophage Phagocytic in Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation is in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that B. bronchitis, on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar The Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic To Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in bronchitis, although cl. B. bronchitis affects the immune system"], "perturbed_original": ["Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Diseases? Any macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction Unavoidable? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this is the case remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children ? A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children ? The reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children ? The reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this has been confirmed remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in children with protracted Bacterial Bronchitis. Nevertheless, the path to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A rhizomysterine NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is PBB a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown."], "original_ll": -3.3009274005889893, "sampled_ll": -2.679349422454834, "all_perturbed_sampled_ll": [-2.90378999710083, -2.694885730743408, -3.0053298473358154, -2.9410696029663086, -2.47717547416687, -2.812443494796753, -2.598632335662842, -3.07344913482666, -2.760660409927368, -3.1424717903137207], "all_perturbed_original_ll": [-3.656747341156006, -3.3508472442626953, -3.4814059734344482, -3.453202486038208, -3.4882800579071045, -3.4882800579071045, -3.5605921745300293, -3.430072069168091, -3.6934814453125, -3.692922353744507], "perturbed_sampled_ll": -2.8409907817840576, "perturbed_original_ll": -3.5295831203460692, "perturbed_sampled_ll_std": 0.20139719993158733, "perturbed_original_ll_std": 0.111395939787274}, {"original": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "sampled": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "perturbed_sampled": ["Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed . What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, prefer patients to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including Winnipeg, might have to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? The practice may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: This process, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be removed or to wait longer for medical appointments to be removed.s?d=272-818-5526.::.::.:::::::Impled care:.::.:It's been good! ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, such as Winnipeg, can wait longer to be removed or to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? "], "perturbed_original": ["Question: Discharging patients earlier from hospital is a challenge. Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in less treatment than 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of patients waiting. A quick and concise route to the hospital is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after the length of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in a loss of patient care 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to impact outcomes of hospital visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital occupancy and quality of care can result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect patients earlier? Time of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does not the treatment improve? Failure to address the delay by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay"], "original_ll": -3.7183687686920166, "sampled_ll": -3.0462779998779297, "all_perturbed_sampled_ll": [-3.4074740409851074, -3.417146921157837, -3.2155075073242188, -3.344874858856201, -3.2155075073242188, -3.409627676010132, -3.472221612930298, -3.8235208988189697, -3.2155075073242188, -3.3327887058258057], "all_perturbed_original_ll": [-3.5673410892486572, -3.789959192276001, -4.117634296417236, -3.9825034141540527, -3.9495363235473633, -3.578723192214966, -3.6730780601501465, -3.7179038524627686, -4.223098278045654, -4.213773727416992], "perturbed_sampled_ll": -3.3854177236557006, "perturbed_original_ll": -3.881355142593384, "perturbed_sampled_ll_std": 0.17104696268216116, "perturbed_original_ll_std": 0.23804154702724953}, {"original": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "sampled": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "perturbed_sampled": ["Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured \" tab to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at age 50? Perhaps you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 or 60\" option to be realistic without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the age of 3 to 5 years older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you \"want the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use Optimism and survival. You are not going to achieve it without getting older.", "How is survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at all? Suppose you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict survival and survival? If you get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to achieve it: \"Well measured from age 50 to the 50s\". You are not going to achieve it without getting older."], "perturbed_original": ["Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor for men. An optimistic outlook seems to be a significant predictor for men but the sample size is small.", "Question: Optimism and survival are predictors of the young ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival ? An optimistic outlook may also be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Optimism is predictive of improved survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and hope is a significant predictor of survival among the oldest-old women of all ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be an important predictor and may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old adults, but the sample size is small.", "Question: Optimism and survival in the older ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival ? Optimism and survival: does an optimistic outlook predict better survival? It may also be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Optimism predicts better survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small."], "original_ll": -3.298966884613037, "sampled_ll": -3.4336202144622803, "all_perturbed_sampled_ll": [-4.002419471740723, -3.6751253604888916, -3.856117010116577, -3.7321648597717285, -3.865004539489746, -3.5180766582489014, -3.405334234237671, -3.937505006790161, -3.678518772125244, -3.9901344776153564], "all_perturbed_original_ll": [-3.155000925064087, -3.4633564949035645, -3.4673283100128174, -3.644704818725586, -2.896470546722412, -3.465231418609619, -3.370025634765625, -3.35691237449646, -3.0209004878997803, -3.57611346244812], "perturbed_sampled_ll": -3.7660400390625, "perturbed_original_ll": -3.341604447364807, "perturbed_sampled_ll_std": 0.19028113841834193, "perturbed_original_ll_std": 0.23013825892093728}, {"original": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "sampled": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "perturbed_sampled": ["Question: Is grandmultiparity an ongoing risk factor? There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor ? Research papers indicate risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity high linked to mortality? There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many factors to consider, like death, in men. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Studies have found that women are highly associated with mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent role? There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for mortality, which indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. Many studies have found that mortality is highly associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many research papers to be published. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. We cannot determine the risks associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For"], "perturbed_original": ["Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous patients are not even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling the occurrence of breast cancer in multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had a tendency of not controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Question: Question: Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? It was a significant effect on neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality in young women increased by increased observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent diagnosis? Grandmultiparity is an increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a stronger risk factor for perinatal outcomes and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling grand multiparous patients during labor and delivery.", "Question: Is grandmultiparity an indicator of maternal mortality in neonatal mortality? He had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery."], "original_ll": -3.4482922554016113, "sampled_ll": -2.5642006397247314, "all_perturbed_sampled_ll": [-2.82094669342041, -3.150893211364746, -2.864166736602783, -3.162721633911133, -3.0597171783447266, -2.9400153160095215, -3.0980231761932373, -2.777902841567993, -3.1301987171173096, -2.8246917724609375], "all_perturbed_original_ll": [-3.8417985439300537, -3.4539034366607666, -3.879910945892334, -3.6553728580474854, -3.922417402267456, -3.8386223316192627, -3.883349657058716, -3.1332509517669678, -3.659785747528076, -3.985637903213501], "perturbed_sampled_ll": -2.9829277276992796, "perturbed_original_ll": -3.725404977798462, "perturbed_sampled_ll_std": 0.14513025313323002, "perturbed_original_ll_std": 0.24805023216175937}, {"original": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "sampled": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "perturbed_sampled": ["Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? This sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, the sample is representative of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. This is an interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I s bipolar disorder generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. We have found an interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available . A highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the children have bipolar I disorder? The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are"], "perturbed_original": ["Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects were more severely ill. While all subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT sample, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects are also present, the generalization of the sample from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more aggressive, RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% were worse. Answer: On the other hand, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because these were not the criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because of different criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of the subjects were splintered. As such, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: a good fit to diagnosis, but a very good solution. Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania."], "original_ll": -3.7058684825897217, "sampled_ll": -2.992370128631592, "all_perturbed_sampled_ll": [-3.495126724243164, -2.8825087547302246, -3.0784432888031006, -3.7724363803863525, -3.1920366287231445, -3.156384229660034, -3.2616987228393555, -3.2618677616119385, -3.005995512008667, -3.368372917175293], "all_perturbed_original_ll": [-3.9157276153564453, -3.9413135051727295, -3.712719202041626, -3.9080848693847656, -3.727675199508667, -3.830857992172241, -3.837655544281006, -3.804567813873291, -3.727121353149414, -3.617114782333374], "perturbed_sampled_ll": -3.2474870920181274, "perturbed_original_ll": -3.802283787727356, "perturbed_sampled_ll_std": 0.24153611787041826, "perturbed_original_ll_std": 0.09949407264358172}, {"original": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "sampled": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "perturbed_sampled": ["Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid ? Learn more about the relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Is it to me that the relationship between providers services and the expenditures for HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid programs? The relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case ? Answer: no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There are multiple provider service networks for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, providers are primarily responsible for their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not many providers service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do providers provide HMO or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures . For the better information on providers services, please click here.", "Question: Do provider service networks result in lower expenditures for a Medicare or Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here."], "perturbed_original": ["Question: Do provider service networks result in lower expenditures compared with Medicaid Demonstration? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenses compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary -service networks? Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly higher PMPMs. The Demonstration seems to be a promising", "Question: Do provider service networks result in lower expenditures compared with providers network networks? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared to Demonstration HMOs. Are providers a promising program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration Department's PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in the PMPM expenditures, a promising", "Question: Do provider service networks result in slower maintenance and management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising"], "original_ll": -4.253201484680176, "sampled_ll": -2.908825397491455, "all_perturbed_sampled_ll": [-3.2786593437194824, -2.9071309566497803, -3.304718255996704, -3.0983338356018066, -3.176495313644409, -3.2468066215515137, -3.4474294185638428, -2.9569191932678223, -3.599055528640747, -2.807811975479126], "all_perturbed_original_ll": [-4.387151718139648, -4.532703876495361, -4.5819621086120605, -4.490074157714844, -4.472168445587158, -4.1827073097229, -4.449833393096924, -4.276345729827881, -4.680998802185059, -4.588048934936523], "perturbed_sampled_ll": -3.1823360443115236, "perturbed_original_ll": -4.464199447631836, "perturbed_sampled_ll_std": 0.23372013715435827, "perturbed_original_ll_std": 0.14223366037116292}, {"original": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "sampled": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "perturbed_sampled": ["Question: Is cancer screening required? I have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and GF tend to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We ask: Most tumor cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor s? Patients with cancer, diabetes, and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are high, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer hypoxia has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other triglycerides express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a different type of tracer in cancer? It is possible that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with GluC1. This has been shown to", "Question: Is (18)F-FDG a question that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to"], "perturbed_original": ["Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions for tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for measuring tumor hypoxia. For example, specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either way used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: Is a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG ? Evidence showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good tracer for the treatment of specific hypoxia conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a good tracer? In the short-term that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. It is not good surrogate tracer for tumor hypoxia.", "Question: Is (18)F-FDG a good surrogate tracer? Is (18)F-FDG a good surrogate tracer? Is the answer that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to be used? The answer is: Do you think it is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia."], "original_ll": -3.1576170921325684, "sampled_ll": -3.532965898513794, "all_perturbed_sampled_ll": [-3.4242238998413086, -3.9661970138549805, -3.925812244415283, -4.037646770477295, -4.094832420349121, -3.7542426586151123, -3.724083423614502, -3.358982563018799, -3.908095598220825, -3.910672664642334], "all_perturbed_original_ll": [-3.442887544631958, -2.964817762374878, -3.451115846633911, -3.2577624320983887, -3.823462963104248, -3.1748087406158447, -3.7011187076568604, -3.17793607711792, -3.0373849868774414, -3.58152437210083], "perturbed_sampled_ll": -3.810478925704956, "perturbed_original_ll": -3.361281943321228, "perturbed_sampled_ll_std": 0.23521233983646267, "perturbed_original_ll_std": 0.27083832623505655}, {"original": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "sampled": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are many possible and specific risks. For the patient's best benefit, it is", "perturbed_sampled": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are many risks to viral infections in this case. Question is", "Question: Do viral infections have a role in benign paroxysmal disease? One might consider viral infections a virulent factor in several cases, and this should not be taken as a given. However, one is cautioned that there are many possible and specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? There are several cases, and this should not be taken as a given. However, one is cautioned that there are many possible and specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are some pitfalls that may arise in this case. As it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. We can identify patients' specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that to provide the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there has not been a benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a risk factor because of both simple and specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. The patient may face specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this is an advantage. The patient is cautioned that there are many possible and specific risks. For the patient's best benefit, it is"], "perturbed_original": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in cases which lead to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, causing virus attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral attacks between spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to its infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year when viral infections initiate secondary BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year. People can trigger BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign infections? Viral infections often produce a more prominent role in benign infection serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and summer. Such infections can lead to a development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring , in which bacteria develop the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with BPPV attacks mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis."], "original_ll": -3.7278993129730225, "sampled_ll": -2.9772040843963623, "all_perturbed_sampled_ll": [-3.0894863605499268, -3.1442153453826904, -3.2385292053222656, -2.9858040809631348, -3.269029140472412, -3.1130857467651367, -3.119966983795166, -3.211348056793213, -3.149010181427002, -3.318544626235962], "all_perturbed_original_ll": [-3.884732723236084, -4.074646949768066, -3.906967878341675, -3.8119051456451416, -3.7823781967163086, -3.8155579566955566, -3.948234796524048, -3.772792339324951, -4.161045074462891, -3.6346678733825684], "perturbed_sampled_ll": -3.1639019727706907, "perturbed_original_ll": -3.879292893409729, "perturbed_sampled_ll_std": 0.09228481436547231, "perturbed_original_ll_std": 0.14569676008545682}, {"original": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "sampled": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "perturbed_sampled": ["Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous specimen varies. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the radiographic transition zone correlates with Hirschsprung's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? This is stronger in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The cell is closer in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than the normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in the aganglionous tissue with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the radiographic transition zone? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Question: Does the radiographic transition zone correlate with the signal of more aggressive aganglionosis in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous condition is consistent with its normal position. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the radiographic transition zone in Hirschsprung's disease. This is consistent with its normal position in the aganglionous"], "perturbed_original": ["Question: Does the radiographic transition zone correlate with the intensity of radiographic transition? Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast specimen by laser cfz by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate to age or disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone vary between the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate s with disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with contrast enema? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone decrease in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis on the specimen, is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast ing specimens is critical but the treatment that is performed either by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with other radiographic transition zones? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory."], "original_ll": -4.1569504737854, "sampled_ll": -2.8820645809173584, "all_perturbed_sampled_ll": [-3.3198299407958984, -3.1644303798675537, -3.4551339149475098, -3.494035243988037, -2.994821548461914, -3.1126208305358887, -3.2575817108154297, -3.1293740272521973, -3.188502788543701, -3.188483715057373], "all_perturbed_original_ll": [-4.61202335357666, -4.83322811126709, -4.71516752243042, -4.719914436340332, -4.984166622161865, -4.585691928863525, -4.6055707931518555, -3.8053362369537354, -4.483757019042969, -4.531017303466797], "perturbed_sampled_ll": -3.23048141002655, "perturbed_original_ll": -4.5875873327255245, "perturbed_sampled_ll_std": 0.14703234224073158, "perturbed_original_ll_std": 0.2963483571161175}, {"original": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "sampled": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "perturbed_sampled": ["Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at all \u2013 both a benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity , but we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is no hormonal differences at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the difference in severity, or what are those differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not a guarantee of growth of the female from birth to the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "brain shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic injury, the difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the severity of these injuries and whether these differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism that precedes the injury. There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries after a trauma as if it were performed with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician."], "perturbed_original": ["Question: What are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization and hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Clinical failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of hormonal differences and are the hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: Comparison of gender with a male male or female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates is in relation with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic activity of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of hormone differences rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and menopausal levels. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences correlated with multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to"], "original_ll": -3.728212594985962, "sampled_ll": -2.8390607833862305, "all_perturbed_sampled_ll": [-3.2022624015808105, -3.2195374965667725, -2.9605605602264404, -2.7503182888031006, -3.0823135375976562, -2.755802869796753, -2.9180710315704346, -2.746410369873047, -2.648735284805298, -3.1885321140289307], "all_perturbed_original_ll": [-3.867131471633911, -4.091664791107178, -3.750114679336548, -3.842845916748047, -3.9000797271728516, -4.258631706237793, -4.07509708404541, -3.7157225608825684, -4.086817741394043, -3.87416410446167], "perturbed_sampled_ll": -2.9472543954849244, "perturbed_original_ll": -3.946226978302002, "perturbed_sampled_ll_std": 0.20531470995998605, "perturbed_original_ll_std": 0.1646149531915937}, {"original": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "sampled": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "perturbed_sampled": ["Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: The risk of a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with the severity in the psychotic episode symptom or it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with transition. If the person has transition to psychosis, the risk of psychosis severity may be associated with that person's transition. It may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. Ultra high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity is also described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "What is the difference between different levels of risk for transition to psychosis? Answer: Yes. If a person has transition to psychosis, the risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for psychotic episodes? As with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a diagnostic person is diagnosed, a high risk for psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of psychosis severity in a person ? The risk of psychosis severity is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) is associated with transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, a high risk is associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Do individuals have levels of risk for transition to psychosis? Answer: If a person has transition to psychosis, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for a person committing to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the high risk is associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra large dose of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk is associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and"], "perturbed_original": ["Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over the short time, suggesting that BLIPS patients are at the highest risk of transition over the short term. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) clinical transition to psychosis? Answer: Our data suggest that BLIPS patients are in the lowest order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the group. We conclude that the patients are at the highest risk of transition over the first 8 months with the best potential model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for BLIPS patients at high risk of transition to psychosis? Answer: High Risk (USHR) for transition to psychosis? Answer: Our data suggest that we are in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that UHR intake criteria predict transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be given to treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait . However, a risk of transition over the short term is consistent with the \"early\" versus \"late\" studies that need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of psychological stress? The fact that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at high risk is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? BLIPS patients receive their highest risk for transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. Generally, the lowest risk is to be paid to BLIPS patients, especially early in the course of treatment.", "Could we predict different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of exposure for UHR intake criteria ? There are four parameters::<unk>APS alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment."], "original_ll": -3.72223162651062, "sampled_ll": -2.554813861846924, "all_perturbed_sampled_ll": [-3.1130707263946533, -2.846234083175659, -3.028909683227539, -2.5035600662231445, -2.8454391956329346, -2.897618055343628, -2.413917303085327, -2.552677869796753, -2.6432108879089355, -2.7245144844055176], "all_perturbed_original_ll": [-3.426787853240967, -3.691837787628174, -3.6520233154296875, -3.5243418216705322, -3.8956449031829834, -3.92903470993042, -4.010546684265137, -3.834726333618164, -3.544095754623413, -4.108035564422607], "perturbed_sampled_ll": -2.756915235519409, "perturbed_original_ll": -3.7617074728012083, "perturbed_sampled_ll_std": 0.21770786783916113, "perturbed_original_ll_std": 0.21585049104913395}, {"original": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "sampled": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "perturbed_sampled": ["Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme"], "perturbed_original": ["Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients."], "original_ll": -2.8141767978668213, "sampled_ll": -2.374695062637329, "all_perturbed_sampled_ll": [-2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329, -2.374695062637329], "all_perturbed_original_ll": [-2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213, -2.8141767978668213], "perturbed_sampled_ll": -2.374695062637329, "perturbed_original_ll": -2.8141767978668213, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "sampled": "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "perturbed_sampled": ["Question: Is there a first night effect on sleep bruxism? Answer: A first night effect affects sleep bruxism. The question is not that simple as it sounds. Is there a first night effect on sleep bruxism? Answer: The question is not as simple as it sounds and it doesn't appear to be specific in the meaning of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer : Typically a first night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep ? How does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is a phenomenon we all live in life, but it's a general perception", "Question: Is there a first night effect on first night effect and what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not just about life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a problem, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that usually has a specific effect, it varies as we go along in life, but it's a general perception", "Question: What's on the effect of a first night effect? A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception"], "perturbed_original": ["Question: Is there a first night effect on the severity of RMMA frequency? The overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young SB patients. Such recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and aging SB patients. The results showed no overall first night effect on bruxism may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency cases which could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, this bruxism was confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for any sleep recovery but the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results indicated a higher RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. Bruxism is confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency is not a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a dental history."], "original_ll": -3.796168088912964, "sampled_ll": -2.8125813007354736, "all_perturbed_sampled_ll": [-2.425236701965332, -3.1111271381378174, -2.8053643703460693, -3.10211181640625, -2.7192935943603516, -2.8156237602233887, -3.0226566791534424, -2.924293041229248, -3.025747060775757, -2.649958372116089], "all_perturbed_original_ll": [-3.561326026916504, -3.951643228530884, -3.6372780799865723, -4.037233829498291, -3.978407382965088, -4.029077053070068, -3.708200216293335, -3.996138334274292, -4.003514766693115, -3.9859066009521484], "perturbed_sampled_ll": -2.8601412534713746, "perturbed_original_ll": -3.8888725519180296, "perturbed_sampled_ll_std": 0.20919724095729691, "perturbed_original_ll_std": 0.17056330320257057}, {"original": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "sampled": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "perturbed_sampled": ["Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Orthopaedic Surgery Area, 30 orthopaedic surgery clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the study. Patients had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary patients of the age of 28 years and a mean life expectancy of 78.5 years were compared for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Center, the death rate was measured on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were treated for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in particular. In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had an overall average age of 28 years and the heart rate was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the results were not revealed, given the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was different for patients who had already a median age of 28 years. The rate of death was different for patients", "Question: Does Residency Selection Criteria Predict the outcome of the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures and increased the rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in the study. 28 orthopaedic surgery patients enrolled from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Be Tested in the study are not in line with the results found in randomized controlled trials ? In a study in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes were found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average lifespan of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 patients from six different clinics at the prestigious Orthopaedic Surgery Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. The following mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients"], "perturbed_original": ["Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step s\u2019s group membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in terms of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. This role does not lend increasing confidence to our pool of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of clinical trials are based on the continually emerging complexities of the competition based on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance ? No. 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Some studies demonstrate in programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2 membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of the field, with continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to determine whether residents may be \"high ly high\" in their own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies demonstrate the applicability of our findings. The continually emerging complexities of the field of orthopedic surgery provides appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA steps 2 are correlated with performance. Our aim in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in terms of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict residency performance? Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing these data, but responses to requests across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and residency criteria for the residency program had \"high yield\" in applying. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of residency criteria, while orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents."], "original_ll": -3.87711763381958, "sampled_ll": -2.2956619262695312, "all_perturbed_sampled_ll": [-2.5059502124786377, -2.733632802963257, -2.5241284370422363, -2.5898373126983643, -2.57440185546875, -2.576503038406372, -2.6648128032684326, -2.691594362258911, -2.4553723335266113, -2.6846225261688232], "all_perturbed_original_ll": [-3.9071919918060303, -4.0639142990112305, -4.243175983428955, -4.231606483459473, -4.023472785949707, -3.7271008491516113, -4.122061729431152, -3.8583216667175293, -4.280608177185059, -3.937128782272339], "perturbed_sampled_ll": -2.6000855684280397, "perturbed_original_ll": -4.039458274841309, "perturbed_sampled_ll_std": 0.08627776210435183, "perturbed_original_ll_std": 0.17395269610291303}, {"original": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "sampled": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "perturbed_sampled": ["Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on primary care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the answer can vary based on the primary care specialty. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology? The characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation? When implementing IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation vary depending on the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary widely. If there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation in the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics vary in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. Depending on whether the primary care physician or primary care physician has specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician"], "perturbed_original": ["Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but with the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant field. Uptake use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that practice nurse use may influence uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at some point, initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was up to 10 percent in 2004 and there was sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system , a second diabetes system, with a focus beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics influence uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, diabetes would benefit some GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an IT facility? Tests show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Science and technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years."], "original_ll": -4.4012274742126465, "sampled_ll": -2.5890626907348633, "all_perturbed_sampled_ll": [-3.008230686187744, -2.645246982574463, -3.0737545490264893, -2.998619556427002, -2.753840446472168, -2.7462077140808105, -2.7183403968811035, -2.7097246646881104, -2.8086071014404297, -2.6229538917541504], "all_perturbed_original_ll": [-4.618958950042725, -4.133410930633545, -4.364115238189697, -4.379037380218506, -3.9943952560424805, -4.389455318450928, -4.602143287658691, -4.292693614959717, -4.700876235961914, -4.63129997253418], "perturbed_sampled_ll": -2.808552598953247, "perturbed_original_ll": -4.410638618469238, "perturbed_sampled_ll_std": 0.1523909363727546, "perturbed_original_ll_std": 0.2192344073235418}, {"original": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "sampled": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "perturbed_sampled": ["Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually"], "perturbed_original": ["Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants."], "original_ll": -4.34203577041626, "sampled_ll": -3.6752936840057373, "all_perturbed_sampled_ll": [-3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373, -3.6752936840057373], "all_perturbed_original_ll": [-4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626, -4.34203577041626], "perturbed_sampled_ll": -3.6752936840057373, "perturbed_original_ll": -4.34203577041626, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "sampled": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "perturbed_sampled": ["Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n"], "perturbed_original": ["Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These"], "original_ll": -5.936349868774414, "sampled_ll": -5.597890853881836, "all_perturbed_sampled_ll": [-5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836, -5.597890853881836], "all_perturbed_original_ll": [-5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414, -5.936349868774414], "perturbed_sampled_ll": -5.597890853881836, "perturbed_original_ll": -5.936349868774414, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "sampled": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "perturbed_sampled": ["Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the"], "perturbed_original": ["Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling."], "original_ll": -3.6431052684783936, "sampled_ll": -2.4072155952453613, "all_perturbed_sampled_ll": [-2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613, -2.4072155952453613], "all_perturbed_original_ll": [-3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936, -3.6431052684783936], "perturbed_sampled_ll": -2.4072155952453613, "perturbed_original_ll": -3.6431052684783936, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "sampled": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "perturbed_sampled": ["Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, the fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical lumen, which results in inflammation of the spine. The cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present? It is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The tissue is the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin-aggrecan complex is not present in cervical fluid, not an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the cervical axis on the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, while this complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin-aggrecan complex is a disease that is an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical tract, which can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical fluid in the cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not"], "perturbed_original": ["Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation between the a diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals a correlation between structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in the cervical spine? Statistical analysis for the fibronectin-aggrecan complex in the two disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation in the target diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the cervical spine a health problem? The research of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural cells, and fibrillators. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a new potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further , a therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex ? Testification of cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical disk disease results in MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine."], "original_ll": -3.705162525177002, "sampled_ll": -2.235882043838501, "all_perturbed_sampled_ll": [-2.2544307708740234, -2.099661111831665, -2.4657676219940186, -2.6708855628967285, -2.1776885986328125, -2.6277005672454834, -2.545445680618286, -2.156435251235962, -2.1425704956054688, -2.432816982269287], "all_perturbed_original_ll": [-4.053595066070557, -3.7666454315185547, -3.509565830230713, -4.11880350112915, -3.8453516960144043, -3.666339874267578, -3.886590003967285, -4.026797771453857, -4.138204574584961, -3.98171329498291], "perturbed_sampled_ll": -2.3573402643203734, "perturbed_original_ll": -3.899360704421997, "perturbed_sampled_ll_std": 0.20493772967207186, "perturbed_original_ll_std": 0.19466486266215557}, {"original": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "sampled": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "perturbed_sampled": ["Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Prostate and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? RTOG consensus definitions and daily CT on rails volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "CT and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and superior portions? (e.g., inferior or inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails . (E.g., inferior or superior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions . Questions are the differences between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed movement on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed side movement on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Are Prostate and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus . (e.g., does the proton target area differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered"], "perturbed_original": ["Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the CTV? Does target motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Neither are INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion (PRD)? Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions ? Does apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and a definition of motion between the superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does it improve clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: In addition to INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Both CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ from INF-CTV? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the CTV? Do motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV."], "original_ll": -5.799015522003174, "sampled_ll": -4.189638137817383, "all_perturbed_sampled_ll": [-4.333712100982666, -4.555721759796143, -4.043639183044434, -4.559001922607422, -4.327246189117432, -4.056373596191406, -3.7254908084869385, -3.767160654067993, -4.399097442626953, -3.746638059616089], "all_perturbed_original_ll": [-5.839380264282227, -6.1082868576049805, -5.241174697875977, -6.34628963470459, -5.469513893127441, -6.1306471824646, -6.013392925262451, -5.960432529449463, -5.821798324584961, -5.993462085723877], "perturbed_sampled_ll": -4.151408171653747, "perturbed_original_ll": -5.892437839508057, "perturbed_sampled_ll_std": 0.31123016778881946, "perturbed_original_ll_std": 0.3081539618550962}, {"original": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "sampled": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "perturbed_sampled": ["Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n"], "perturbed_original": ["Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent"], "original_ll": -3.7832143306732178, "sampled_ll": -2.632730484008789, "all_perturbed_sampled_ll": [-2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789, -2.632730484008789], "all_perturbed_original_ll": [-3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178, -3.7832143306732178], "perturbed_sampled_ll": -2.632730484008789, "perturbed_original_ll": -3.7832143306732178, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "sampled": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "perturbed_sampled": ["Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first place. Furthermore, elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and smelted to, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can be on the blood vessels that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. Answer: No, if not a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. It should be a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is produced due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants . Low prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released in the first week of life. However, prolonged exposure to high levels of atmospheric carbon dioxide can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial pulmonary outcome in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the volume of air in the lungs. This is due to increased circulation, which can contribute to a"], "perturbed_original": ["Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in first week of life. Conclusion: These measures should be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending infants in the first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be used in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide measurements in first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in first week of life. This can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon monitoring help detect abnormal PaCO(2) values in ELBW birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in first week of life. These measurements might be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weights. There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low tidal CO(2)? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial carbon dioxide in extremely low birth weight infants in first week of life. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life."], "original_ll": -3.278958320617676, "sampled_ll": -2.8174610137939453, "all_perturbed_sampled_ll": [-3.136162281036377, -3.1908843517303467, -3.204099655151367, -3.0739333629608154, -2.9791417121887207, -2.9984302520751953, -3.245699167251587, -2.6498680114746094, -2.8828465938568115, -2.910686731338501], "all_perturbed_original_ll": [-3.3912618160247803, -3.1641833782196045, -3.05702543258667, -3.3463621139526367, -3.3358232975006104, -3.265899181365967, -3.3536248207092285, -3.5085816383361816, -3.526262044906616, -3.1624743938446045], "perturbed_sampled_ll": -3.027175211906433, "perturbed_original_ll": -3.31114981174469, "perturbed_sampled_ll_std": 0.17315157968333306, "perturbed_original_ll_std": 0.14340630315734917}, {"original": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "sampled": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "perturbed_sampled": ["Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not so sure that any number of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure which pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 20%. But that number is a lower number", "Question: Neck pain treatment is not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure that a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a difference. The number", "Question: Neck pain treatment with acupuncture: does this mean that that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the greater number is about 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a lower number is the average cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does your neck pain help? The total pain of that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number"], "perturbed_original": ["Question: Neck pain treatment with acupuncture: does the number of needles 1-2 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles decrease? If the number of needles is 11 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when compared to individual groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles is an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles increase between 9 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic activity of the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, treatment of the neck pain might be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an actual number. The effect of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles 4-5 or 10? The number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the dosage of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups."], "original_ll": -3.6063694953918457, "sampled_ll": -2.966541290283203, "all_perturbed_sampled_ll": [-3.384956121444702, -3.3972582817077637, -3.3382010459899902, -3.1077663898468018, -3.220069646835327, -3.349489212036133, -3.4728057384490967, -3.351803779602051, -3.589592218399048, -3.2786262035369873], "all_perturbed_original_ll": [-4.033106803894043, -3.654463768005371, -3.7348902225494385, -3.5527586936950684, -3.974047899246216, -3.7349300384521484, -3.8507773876190186, -3.656367778778076, -3.5536341667175293, -4.357636451721191], "perturbed_sampled_ll": -3.34905686378479, "perturbed_original_ll": -3.8102613210678102, "perturbed_sampled_ll_std": 0.12519106529399238, "perturbed_original_ll_std": 0.23858416579876718}, {"original": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "sampled": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "perturbed_sampled": ["Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by the use of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the study, and a novel version of the study. All of our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a fluoroprotein-induced immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we report on the emergence of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of a highly efficient and highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. Zero central line infection rate can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current day, we have demonstrated that these studies involve a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective CRISPR. Therefore, it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a single immune assay. In addition, our results provide evidence that it is feasible to"], "perturbed_original": ["Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough organizational planning may help us better understand the benefits of training. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful training is essential into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in risk. Question: Many individuals are unaware of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may be necessary to enhance the unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what can sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may help enhance the unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and collaborative organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, education, and collaboration may provide the unit with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Unsupervised training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. This goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term."], "original_ll": -4.608151912689209, "sampled_ll": -3.1907739639282227, "all_perturbed_sampled_ll": [-3.482233762741089, -3.2894999980926514, -3.7282814979553223, -3.6383447647094727, -3.386629104614258, -3.31135630607605, -3.5710527896881104, -3.64508056640625, -3.3207764625549316, -3.568150281906128], "all_perturbed_original_ll": [-4.184592247009277, -4.847183704376221, -4.361382961273193, -4.659484386444092, -4.627198219299316, -4.796455383300781, -4.362695217132568, -4.714504718780518, -4.206389427185059, -4.874514102935791], "perturbed_sampled_ll": -3.494140553474426, "perturbed_original_ll": -4.563440036773682, "perturbed_sampled_ll_std": 0.15061078488341592, "perturbed_original_ll_std": 0.24896188189003116}, {"original": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "sampled": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "perturbed_sampled": ["Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it"], "perturbed_original": ["Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP."], "original_ll": -3.855994939804077, "sampled_ll": -2.700441598892212, "all_perturbed_sampled_ll": [-2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212, -2.700441598892212], "all_perturbed_original_ll": [-3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077, -3.855994939804077], "perturbed_sampled_ll": -2.700441598892212, "perturbed_original_ll": -3.855994939804077, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "sampled": "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "perturbed_sampled": ["Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they"], "perturbed_original": ["Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified."], "original_ll": -3.576117992401123, "sampled_ll": -2.8370423316955566, "all_perturbed_sampled_ll": [-2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566, -2.8370423316955566], "all_perturbed_original_ll": [-3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123, -3.576117992401123], "perturbed_sampled_ll": -2.8370423316955566, "perturbed_original_ll": -3.576117992401123, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "sampled": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "perturbed_sampled": ["Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical instrument? Answer: Yes Yes. GERD surgery are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require surgery to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication for the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced diagnosis of GERD or GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes the advanced age provide you with an ortho- or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of the advanced age or the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do we look at the advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require a surgeon to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age of advanced surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced"], "perturbed_original": ["Question: Is the advanced age a contraindication to GERD laparoscopic therapy? A new age is one of the best treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the diagnosis effective? An antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is common among younger patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, but also in a crowded world with the highest number of symptoms comparable to younger patients.", "Question: Is the advanced age a good option to take a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Laparoscopic antireflux surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication for GERD? Early years can offer a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in cases of significant improvement of symptoms comparable to younger patients.", "Question: Is the diagnosis a concern? A multi-stage antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for higher mortality rates and a significant improvement of symptoms comparable to younger patients."], "original_ll": -3.197444438934326, "sampled_ll": -2.754941940307617, "all_perturbed_sampled_ll": [-2.8007524013519287, -2.877291440963745, -3.1704020500183105, -3.1088829040527344, -3.157809257507324, -2.9764959812164307, -3.1261210441589355, -3.0541141033172607, -2.900602340698242, -3.2825114727020264], "all_perturbed_original_ll": [-3.590548276901245, -3.5694546699523926, -3.486419677734375, -3.4159867763519287, -3.993258476257324, -3.153921604156494, -3.4698245525360107, -3.3107051849365234, -3.6280598640441895, -3.4602134227752686], "perturbed_sampled_ll": -3.0454982995986937, "perturbed_original_ll": -3.507839250564575, "perturbed_sampled_ll_std": 0.14454482706204, "perturbed_original_ll_std": 0.20915320118266723}, {"original": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "sampled": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "perturbed_sampled": ["Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect yourself from stress. Adults who live too long are at higher risk for complications and", "Question: Do people a higher risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence the outcome of Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Diabetes are some type of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood pressures. Adults who experience diabetes for too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, adults at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a very long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure , people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is an increased blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and"], "perturbed_original": ["Question: Does aerobic fitness influence microvascular function in the skin? In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in this group, aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, the 'at-risk' group showed skin microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared to baseline. Adults with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. Question: Does aerobic fitness influence microvascular function? Answer: Adults at risk of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness have serious adverse effects on the diagnosis of Type 2 diabetes? Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal ly increased. The problem is: And in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of skin skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of hypotension or in young people? In healthy skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group with better microvascular and endothelial responsiveness."], "original_ll": -2.895808696746826, "sampled_ll": -2.3497273921966553, "all_perturbed_sampled_ll": [-2.774766206741333, -2.2227416038513184, -2.4148340225219727, -2.3057637214660645, -2.9170384407043457, -2.7531180381774902, -2.620368480682373, -2.553323984146118, -2.6602630615234375, -2.493159294128418], "all_perturbed_original_ll": [-2.956261396408081, -3.1707229614257812, -2.9334537982940674, -3.1931545734405518, -2.9881579875946045, -3.191342830657959, -3.5170366764068604, -3.4022374153137207, -3.3145687580108643, -3.06182599067688], "perturbed_sampled_ll": -2.5715376853942873, "perturbed_original_ll": -3.172876238822937, "perturbed_sampled_ll_std": 0.20669449019104477, "perturbed_original_ll_std": 0.18509043018989305}, {"original": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "sampled": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "perturbed_sampled": ["Question: Estradiol and Antagonist In Vitro Fertilization as It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Liver Care? As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, there are several limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in 8 Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist: Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as A result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist, this study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As for IVF Outcomes in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, there are several important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in vitro Fertilization, there are several important and important limitations that have to be addressed. First, this study has several limitations"], "perturbed_original": ["Question: Estradiol and Antagonist Pretreatment Prior to Microdose and E2+antag Pretreatment in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior ity to Enhancing IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment in poor responders when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro types Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Oral Contraceptive Pill \u2013 Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol and trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF outcomes in AVF as a Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Does Not Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol (ML protocol) trials with adequate power to study the optimal method of steroid pretreatments appear justified."], "original_ll": -4.205254077911377, "sampled_ll": -2.92803692817688, "all_perturbed_sampled_ll": [-2.8925528526306152, -2.8620784282684326, -2.9843008518218994, -3.1911182403564453, -2.9934189319610596, -3.0489649772644043, -3.225255012512207, -3.1852381229400635, -2.974062204360962, -3.0490145683288574], "all_perturbed_original_ll": [-4.429199695587158, -4.610247611999512, -4.282115936279297, -4.681637763977051, -4.3031840324401855, -4.073504447937012, -4.480692386627197, -4.417899131774902, -4.288311004638672, -4.51932430267334], "perturbed_sampled_ll": -3.0406004190444946, "perturbed_original_ll": -4.408611631393432, "perturbed_sampled_ll_std": 0.11892224925120053, "perturbed_original_ll_std": 0.16942508650175295}, {"original": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "sampled": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "perturbed_sampled": ["Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n"], "perturbed_original": ["Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The"], "original_ll": -4.0360612869262695, "sampled_ll": -3.8673784732818604, "all_perturbed_sampled_ll": [-3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604, -3.8673784732818604], "all_perturbed_original_ll": [-4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695, -4.0360612869262695], "perturbed_sampled_ll": -3.8673784732818604, "perturbed_original_ll": -4.0360612869262695, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "sampled": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "perturbed_sampled": ["Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you lose, neck pain is the main factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to drop down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an expensive lifestyle. If you choose not to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount of neck pain down for years, you may be the greatest risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain weigh less than 1 kg per day and is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, though if you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's very important that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is why you will find that on whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say that neck pain can help make neck pain a better fit for you. Also, if neck"], "perturbed_original": ["Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of the work of communities, researchers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Neck pain is a result of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future of health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with quality of life and found that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life. Question: Our findings suggest that future neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be associated with a lower cost of health in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical health with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain was associated with illness in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with physical HRQoL? Our analysis found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain may be contributing to the future poor physical HRQoL in the population, depending on their mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations."], "original_ll": -2.7274506092071533, "sampled_ll": -2.558384895324707, "all_perturbed_sampled_ll": [-2.6405866146087646, -2.669625997543335, -2.703465461730957, -2.712764024734497, -2.83426833152771, -2.6281650066375732, -2.7822439670562744, -2.8807265758514404, -2.8259713649749756, -2.688025951385498], "all_perturbed_original_ll": [-3.1938462257385254, -2.8576111793518066, -3.134611129760742, -2.8814094066619873, -2.7984251976013184, -2.766669511795044, -3.0595226287841797, -2.830674886703491, -2.664179801940918, -2.7330846786499023], "perturbed_sampled_ll": -2.7365843296051025, "perturbed_original_ll": -2.8920034646987913, "perturbed_sampled_ll_std": 0.08358822136366141, "perturbed_original_ll_std": 0.16873374096661306}, {"original": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "sampled": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "perturbed_sampled": ["Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis was was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis? Studies have indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Then what did you think are improved with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis treatment was a significant complication in this study and was", "Question: Is decompressive surgery effective ? No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Nervosis and muscle structure can be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary Myelopathy was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be a complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not have a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be a significant complication in this study and was"], "perturbed_original": ["Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis was needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The first diagnosis of cervical myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective ? The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "sarcoidosis with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied by compressive myelopathy? The association of spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompressive surgery is not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive myelopathy? The treatment of sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis was needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not considered to be accurate. Either treatment or surgical therapy should be needed."], "original_ll": -3.4646880626678467, "sampled_ll": -2.7719671726226807, "all_perturbed_sampled_ll": [-3.346057176589966, -3.142608880996704, -3.2956833839416504, -3.351078748703003, -3.5819013118743896, -3.5004725456237793, -2.8523292541503906, -3.2525925636291504, -3.3731706142425537, -3.2270143032073975], "all_perturbed_original_ll": [-3.291520118713379, -3.9954819679260254, -4.145529270172119, -3.7568678855895996, -3.3766798973083496, -3.830033540725708, -3.64274263381958, -4.001594066619873, -3.291520118713379, -3.346444606781006], "perturbed_sampled_ll": -3.2922908782958986, "perturbed_original_ll": -3.667841410636902, "perturbed_sampled_ll_std": 0.19024237110813103, "perturbed_original_ll_std": 0.30872207113992717}, {"original": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "sampled": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "perturbed_sampled": ["Question: Can bedside assessment reliably exclude hypotension? As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient had to withdraw. Although with acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. The patient had to be able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient had very weak feet, indicating that as of the following clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain adequate head temperature. The patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated , if the patient had to withdraw or maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As piration was maintained to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical treatment options, the goal is very important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. In these circumstances, the patient had to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with acute stroke it is important"], "perturbed_original": ["Question: Can bedside assessment reliably exclude aspiration following acute stroke? Bedside assessment can be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, a gold standard, or not as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns over the relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard for predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and risk are also studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment is a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity needed to be measured, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard for predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment serves as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative adverse outcome needs to be studied."], "original_ll": -3.6945083141326904, "sampled_ll": -3.2333762645721436, "all_perturbed_sampled_ll": [-3.2370293140411377, -3.538972854614258, -3.440580129623413, -3.7154576778411865, -3.1594858169555664, -3.722623825073242, -4.114969253540039, -3.425311326980591, -3.181351900100708, -3.2609338760375977], "all_perturbed_original_ll": [-3.5596909523010254, -3.80763578414917, -3.839747190475464, -4.065899848937988, -3.9576072692871094, -3.6605124473571777, -4.012462615966797, -4.065899848937988, -3.664214849472046, -4.051990985870361], "perturbed_sampled_ll": -3.479671597480774, "perturbed_original_ll": -3.8685661792755126, "perturbed_sampled_ll_std": 0.2871339126147236, "perturbed_original_ll_std": 0.18032001791371363}, {"original": "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "sampled": "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "perturbed_sampled": ["Question: Does family practice at residency teaching sites reflect community practice? Residency teaching sites at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice: family practice at residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites reflect community practice. Many practice at residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites reflect community practice, but there are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are two reasons for community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Family practice does not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Residential teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does community practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? The reason why residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no"], "perturbed_original": ["Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern are compared to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Studies by the College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites offer family care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice training training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to fellowship referral practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the residency teaching sites are similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at the research sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency teaching sites provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice training training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the residency teaching sites of the site have programs similar to those found in a national survey of family and general practitioners."], "original_ll": -4.216692924499512, "sampled_ll": -2.658169984817505, "all_perturbed_sampled_ll": [-2.869539499282837, -2.7394814491271973, -3.0597574710845947, -2.8094239234924316, -2.7257940769195557, -3.0809500217437744, -3.212095022201538, -3.258258581161499, -2.8446810245513916, -2.992584466934204], "all_perturbed_original_ll": [-4.393548488616943, -4.538021564483643, -4.322136878967285, -4.739354133605957, -4.718966484069824, -4.040449619293213, -4.228820323944092, -4.198054790496826, -4.739354133605957, -4.208724021911621], "perturbed_sampled_ll": -2.9592565536499023, "perturbed_original_ll": -4.412743043899536, "perturbed_sampled_ll_std": 0.18049441304451583, "perturbed_original_ll_std": 0.24321590970720872}, {"original": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "sampled": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "perturbed_sampled": ["Question: Is duration of psychological treatment for Depression? Yes, there are many reasons that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to support people who seek help or psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of techniques that might help with post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have the option to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such treatment to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that depression develops over time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might be recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression can have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is it time to get a psychological treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression or depression worse? Ideally, a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is"], "perturbed_original": ["Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably , has shown that a tendency towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. We have analyzed whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Can someone return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, no causal inference can be drawn. A trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the recent decline in psychoactive recovery, they are not a significant risk factor. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into mental health care? Although this theory is considered, the length of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment in certain groups less efficient? The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the treatment, it is suggested that less duration, in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be made to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use."], "original_ll": -3.0138180255889893, "sampled_ll": -2.507321834564209, "all_perturbed_sampled_ll": [-2.5472309589385986, -2.825706958770752, -2.666025400161743, -2.5500540733337402, -2.6361093521118164, -2.6067371368408203, -2.5503594875335693, -2.5635550022125244, -2.3444316387176514, -2.6943349838256836], "all_perturbed_original_ll": [-3.252516269683838, -3.1883175373077393, -3.251718521118164, -3.091486692428589, -3.2177202701568604, -3.145050048828125, -3.208418607711792, -3.1444246768951416, -3.2207775115966797, -3.150123357772827], "perturbed_sampled_ll": -2.59845449924469, "perturbed_original_ll": -3.1870553493499756, "perturbed_sampled_ll_std": 0.11828534794709274, "perturbed_original_ll_std": 0.05008105538877262}, {"original": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "sampled": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "perturbed_sampled": ["Question: Are increased carotid artery pulsatility and resistance indexes early in the adulthood? The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young children was early. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: What early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that their presence might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it was revealed that obese young males might be an initial marker for early vascular abnormalities. The early indicators include: (i) reduced muscle mass, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young obese males was unclear. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities and resistance index in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young males? Examples of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young males might be better. Early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes important in adolescence? No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) reduced vascular mass, (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid plasma plasma in obese males significantly increased in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The evidence was presented in terms of (i) increased ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of this was in a very early age and it appeared that the vascular decline index appeared to be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in this study indicated that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other"], "perturbed_original": ["Question: Are increased carotid artery wall properties in young obese subjects and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that we could analyse the studies of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in the case, we could also determine whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of existing arterial wall properties. Although improvements in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether increased blood flow and increased vascular resistance can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? If increases in vascular resistance are features of young, obese, normotensive subjects independently of their lifestyle. Given that decreased arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are more important in addition to cardiovascular risk factors. As changes in arterial wall movement decrease and abnormalities, analysis will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results examine cardiovascular features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As with young and obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early intervention? These results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient , these results may demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Increased arterial pulsatility and resistance are also in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Carotid artery pulsatility and resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether the younger obese males population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are important factors in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, changes such as diet and exercise in this population can improve vascular functions."], "original_ll": -3.4877820014953613, "sampled_ll": -2.5414085388183594, "all_perturbed_sampled_ll": [-2.764911413192749, -2.535808563232422, -2.914329767227173, -2.5024502277374268, -2.751523494720459, -2.8254637718200684, -3.066237688064575, -2.968911647796631, -2.8314948081970215, -2.471848249435425], "all_perturbed_original_ll": [-3.4702022075653076, -3.6677842140197754, -3.508194923400879, -3.8270657062530518, -3.869765520095825, -3.5030157566070557, -3.927266836166382, -3.3662781715393066, -3.4426121711730957, -3.6369051933288574], "perturbed_sampled_ll": -2.763297963142395, "perturbed_original_ll": -3.6219090700149534, "perturbed_sampled_ll_std": 0.19241949293845811, "perturbed_original_ll_std": 0.18619099778385848}, {"original": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "sampled": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "perturbed_sampled": ["Question: Can mental diseases affect disorders of consciousness? Answer: Evidence from patients \u2019 responses. van der Kolk, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with a chronic bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, A. M. The Journal of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Research and Research, 2012. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging . 29. Leimer, S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia. Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. T. E. for a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: 481, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, J. The Functional Characteristics of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Fletcher, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in memory memory? For schizophrenia, schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (1999). 25. The effect of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Brown, A. M. The Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging be used? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives National Archives, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of functional magnetic resonance imaging in brain imaging, 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: The New Medicine and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl"], "perturbed_original": ["Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI predicts recovery and the clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs during the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients exhibited a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for this clinical course: In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed activation were detected after the end of the observation period. We therefore propose that they may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? In a VS, the method may be combined with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore can use this method. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic -mechanical? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases in which the fMRI system exhibits prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation occurred at the end of the observation period. We therefore propose the term \"functional minimally conscious brain imaging\" that is applied to treatment at the beginning of the observation period. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical outcome. The clinician of a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation is allowed in the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course . The method was referred to as the term \"functional minimally conscious state\" for these patients. They may benefit from more clinical support by using their cognitive capabilities, but the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The treatment was positive for the further clinical course of patients . Patients who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic imaging, for this purpose, function magnetic resonance? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a clinical setting. Patient activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the"], "original_ll": -3.9908230304718018, "sampled_ll": -2.2859673500061035, "all_perturbed_sampled_ll": [-2.636791706085205, -2.3751988410949707, -2.8191497325897217, -2.697695255279541, -2.6580429077148438, -2.554077625274658, -2.4785408973693848, -2.3181209564208984, -2.611936569213867, -2.4984583854675293], "all_perturbed_original_ll": [-3.9232897758483887, -4.1595563888549805, -4.003535270690918, -4.00748348236084, -4.232160568237305, -3.7824020385742188, -4.165304660797119, -4.171111106872559, -3.9694130420684814, -4.264983177185059], "perturbed_sampled_ll": -2.564801287651062, "perturbed_original_ll": -4.067923951148987, "perturbed_sampled_ll_std": 0.14394783742506276, "perturbed_original_ll_std": 0.14638246451947556}, {"original": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "sampled": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "perturbed_sampled": ["Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view"], "perturbed_original": ["Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection."], "original_ll": -3.280395746231079, "sampled_ll": -2.8754100799560547, "all_perturbed_sampled_ll": [-2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547, -2.8754100799560547], "all_perturbed_original_ll": [-3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079, -3.280395746231079], "perturbed_sampled_ll": -2.8754100799560547, "perturbed_original_ll": -3.280395746231079, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "sampled": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "perturbed_sampled": ["Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: 1. On a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood flow. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a needle. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Healthy Medical System Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using your radiologist. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The University of Pennsylvania, a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can I Increase Blood Pressure and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Novel Treat Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to a New Medicine Solution be developed because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? 2. Surgical methods using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses"], "perturbed_original": ["Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the tumor results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and a favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the VMPA. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can improve access and reduce complicacy of TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct , good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Physician Choose an Approach? The Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access ibility and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach Be Considered? The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular VMPA provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries."], "original_ll": -3.944814920425415, "sampled_ll": -2.649872303009033, "all_perturbed_sampled_ll": [-2.8980019092559814, -2.9354770183563232, -3.240603446960449, -2.450420379638672, -3.299679756164551, -3.3237857818603516, -2.2893612384796143, -2.7665629386901855, -2.8868348598480225, -3.006561756134033], "all_perturbed_original_ll": [-4.071378231048584, -4.7160820960998535, -3.9074671268463135, -3.91884446144104, -4.138556480407715, -4.350470066070557, -4.047759056091309, -4.941984176635742, -4.259696960449219, -4.486822605133057], "perturbed_sampled_ll": -2.9097289085388183, "perturbed_original_ll": -4.283906126022339, "perturbed_sampled_ll_std": 0.32557653620808874, "perturbed_original_ll_std": 0.32604771620509126}, {"original": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "sampled": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "perturbed_sampled": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a drug used to treat multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical therapy of bone-enhancing surgery that was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology for the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was administered by the National College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. Question: The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell proliferation? Researchers hope to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Health as a result of an interest in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was carried out by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Medicine and the Institute of Medicine in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing techniques. The research was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The"], "perturbed_original": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic cholecystectomy is not reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? HA cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA HA cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells and decreased serum and serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to Kupffer and endothelial cells and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage has more significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has become a probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the sole purpose of the procedure. Multiple other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes."], "original_ll": -3.562427520751953, "sampled_ll": -2.347944498062134, "all_perturbed_sampled_ll": [-2.422168016433716, -2.4845869541168213, -2.5391135215759277, -2.5605523586273193, -2.4722108840942383, -2.6882236003875732, -2.639732837677002, -2.4814629554748535, -2.580221652984619, -2.3728315830230713], "all_perturbed_original_ll": [-3.638502359390259, -4.079794406890869, -3.7075390815734863, -3.486618757247925, -3.3369979858398438, -3.683885097503662, -3.6095283031463623, -3.6713593006134033, -3.7698915004730225, -3.6925504207611084], "perturbed_sampled_ll": -2.524110436439514, "perturbed_original_ll": -3.667666721343994, "perturbed_sampled_ll_std": 0.09184512531229126, "perturbed_original_ll_std": 0.18142095324355675}, {"original": "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "sampled": "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "perturbed_sampled": ["Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people suffering from nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it 's not quite bad (as is in the condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but that's not the case! GABA is no longer an expression of killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy help us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of it can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people who would like to relieve nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can be a powerful source of stress (depending on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with nausea, vomiting, and", "Question: Do mossy fibers use mossy fibers? Do mossy fibers do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially when it's smelly). Fentanyl causes insomnia, nausea, vomiting, and"], "perturbed_original": ["Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated , and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Yes! Yes, it release a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory effect on its actual role.", "Question: There are several compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently of developmental importance. We are therefore using some of the empirical evidence to predict their therapeutic effect, and further work is needed to elucidate its actual role.", "Question: No compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. Both mossy fibers and GABA release are uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is having an disinhibitory effect, and further work is needed to elucidate its actual role.", "Molecular Study has provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The signal may release GABA but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role."], "original_ll": -3.0321710109710693, "sampled_ll": -2.7340645790100098, "all_perturbed_sampled_ll": [-2.7836384773254395, -3.0505502223968506, -3.1690452098846436, -2.8578104972839355, -2.9885730743408203, -2.8001413345336914, -2.9252238273620605, -2.7916126251220703, -2.8280186653137207, -2.7552151679992676], "all_perturbed_original_ll": [-3.166722297668457, -3.126021385192871, -3.3418257236480713, -2.941591262817383, -3.231900453567505, -2.986405849456787, -3.337061643600464, -3.0944719314575195, -2.9596447944641113, -3.4185760021209717], "perturbed_sampled_ll": -2.89498291015625, "perturbed_original_ll": -3.160422134399414, "perturbed_sampled_ll_std": 0.12902089280674528, "perturbed_original_ll_std": 0.16121849733176538}, {"original": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "sampled": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "perturbed_sampled": ["Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists regarding the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, also a sideeffect of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether it is the appropriate time for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient with high risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with the differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance in assessing and interpreting red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists ? In a patient with a known risk of cardiovascular disease, red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The association between clinicians and an individual, or a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, however, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of questions that might ask whether the difference in the way that an individual is treated for a"], "perturbed_original": ["Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments and RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M changes, depending on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about treatment practices between clinical pathologists and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about diagnosis and interpreting CBC reports should be examined critically to improve communication, transparency, and ultimately medical decisions. Question: Is there discordance between clinical pathologists and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports should be interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of RBC-M terms should ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are reviewed and examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that patient practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians ; the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms are required. Clearly reviewing and interpreting RBC-M terms in CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions."], "original_ll": -4.163998603820801, "sampled_ll": -2.8606038093566895, "all_perturbed_sampled_ll": [-2.874380350112915, -3.032526731491089, -2.9215505123138428, -3.057889223098755, -3.040921211242676, -3.3384039402008057, -2.9628615379333496, -3.262722969055176, -2.932725191116333, -3.053102970123291], "all_perturbed_original_ll": [-4.313143730163574, -4.426671981811523, -4.2730631828308105, -3.7003438472747803, -4.412217140197754, -3.994978904724121, -4.1834306716918945, -4.400691032409668, -4.504765510559082, -4.103150367736816], "perturbed_sampled_ll": -3.0477084636688234, "perturbed_original_ll": -4.231245636940002, "perturbed_sampled_ll_std": 0.14054288148644917, "perturbed_original_ll_std": 0.23222755161808203}, {"original": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "sampled": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "perturbed_sampled": ["Question: Colorectal cancer : The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients. The formation of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is cancer survival similar? Colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with the presence of a tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The morphology (along with the age of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical pattern? Colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a tumor in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical progression that (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a tumor-bearing tumor,"], "perturbed_original": ["Question: Colorectal cancer in young patients or younger patients and cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a therapeutic pathology? Colorectal cancer can constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it not necessarily a colorectal cancer that may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute the predominant factor in our understanding of our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute an active component in our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity to define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients: is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is that certain patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is aimed at finding treatment for colorectal cancer in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity or a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population."], "original_ll": -2.6658191680908203, "sampled_ll": -2.5326521396636963, "all_perturbed_sampled_ll": [-2.756730556488037, -2.6774373054504395, -2.992358446121216, -2.2911031246185303, -3.5368032455444336, -2.877169370651245, -3.3295705318450928, -3.4393351078033447, -2.8055081367492676, -2.3995306491851807], "all_perturbed_original_ll": [-3.3051278591156006, -3.134488344192505, -3.26090669631958, -3.286796808242798, -3.3034987449645996, -2.9615869522094727, -3.2180821895599365, -3.6709342002868652, -2.546947479248047, -3.09340500831604], "perturbed_sampled_ll": -2.9105546474456787, "perturbed_original_ll": -3.1781774282455446, "perturbed_sampled_ll_std": 0.3986330220740014, "perturbed_original_ll_std": 0.273737749363236}, {"original": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "sampled": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "perturbed_sampled": ["Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially affect their developmental stage. TEOAE and AABR are different in developmental stage, and", "Question: You can question AABR and TEOAE as a Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often ask. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. Discordance could potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects that TEOAE and AABR can be quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable ? Most research shows that TEOAE and AABR results are predictable, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes important? There are some challenges we encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often ask: In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and"], "perturbed_original": ["Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of the cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given that discordance in the TEOAE and AABR outcomes is inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable ? TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of newborns to receive prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some newborns that have received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received screening. Hence, the importance of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns . Consequently, avoiding morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR? Using some supplementary hearing loss technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities may require further consideration."], "original_ll": -4.206080436706543, "sampled_ll": -2.913886308670044, "all_perturbed_sampled_ll": [-3.0381593704223633, -3.4697508811950684, -3.169870376586914, -3.250509023666382, -3.26324725151062, -3.356412410736084, -3.3490684032440186, -2.9160592555999756, -3.060410499572754, -3.2493159770965576], "all_perturbed_original_ll": [-4.144337177276611, -4.073115825653076, -4.509758949279785, -4.112306594848633, -4.058917045593262, -4.238427639007568, -4.6561784744262695, -4.519206523895264, -4.195914268493652, -4.039275646209717], "perturbed_sampled_ll": -3.212280344963074, "perturbed_original_ll": -4.254743814468384, "perturbed_sampled_ll_std": 0.15941609100113607, "perturbed_original_ll_std": 0.21215360738577085}, {"original": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "sampled": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "perturbed_sampled": ["Question: May student examiners be reasonable substitute examiners for faculty in selecting some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least 10 percent of the credits] receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? ] [You may receive at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on boarding school? [The student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student be required to pay compensation to OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A ] Students should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be any question [A student should be authorized to receive the college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least 10 credits] to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be multiple degrees for any student [A student should be authorized to receive the degree after the college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE program? [The student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have"], "perturbed_original": ["Question: May student examiners be reasonable for medical students in emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite likely that student examiners may be substitute examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student advisor to OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in medical education to consider it admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in emergency medicine? It is admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to assess their medical emergencies but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE OSCE formative testing? The objective is to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It is incumbent that student examiners may officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage students to be good substitute examination examiners in an undergraduate OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical tests? Is there an opportunity for emergency medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations."], "original_ll": -4.896374702453613, "sampled_ll": -3.7494866847991943, "all_perturbed_sampled_ll": [-3.694814920425415, -4.257440090179443, -4.397321701049805, -4.212869644165039, -3.3829591274261475, -4.29541540145874, -4.123954772949219, -4.189228057861328, -3.953204393386841, -3.881418466567993], "all_perturbed_original_ll": [-5.034158229827881, -4.552096366882324, -5.175700664520264, -5.232783794403076, -4.841049671173096, -4.923640727996826, -4.501247882843018, -4.845788955688477, -4.6300554275512695, -4.943946361541748], "perturbed_sampled_ll": -4.038862657546997, "perturbed_original_ll": -4.868046808242798, "perturbed_sampled_ll_std": 0.2971399402935302, "perturbed_original_ll_std": 0.23587256784233201}, {"original": "Question: Amblyopia: is visual loss permanent? Answer: Older", "sampled": "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "perturbed_sampled": ["Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n"], "perturbed_original": ["Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older"], "original_ll": -5.546280384063721, "sampled_ll": -4.514839172363281, "all_perturbed_sampled_ll": [-4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281], "all_perturbed_original_ll": [-5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721], "perturbed_sampled_ll": -4.514839172363281, "perturbed_original_ll": -5.546280384063721, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "sampled": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "perturbed_sampled": ["Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Some studies have been related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Could surgery be related to men with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with the same cancer? The answer is those that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated ? Answer: Do you hear findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be possible at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict that? There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated ? Answer: Do any preliminary findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this: The patient can be assessed first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical cancer patients? The consequences may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does it work? Is it possible that radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery"], "perturbed_original": ["Question: Does prior benign prostate biopsy suggest a perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy predicts biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign biopsy predicts favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: These results predict more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients with prostate biopsy? The benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with surgery, but several studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable testing techniques used to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for prostate biopsy? This question: Winning benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy do the opposite thing after perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with other types of tumours. Additional studies are needed to confirm these findings."], "original_ll": -3.1973495483398438, "sampled_ll": -3.1437790393829346, "all_perturbed_sampled_ll": [-3.701430559158325, -2.954684257507324, -3.8428008556365967, -4.03956937789917, -3.511829137802124, -3.48187518119812, -4.067445755004883, -3.597031354904175, -4.0315680503845215, -2.935729742050171], "all_perturbed_original_ll": [-3.1171963214874268, -3.1802451610565186, -3.4131431579589844, -3.6776235103607178, -3.437582492828369, -3.4699766635894775, -3.879148006439209, -3.8755877017974854, -3.2249667644500732, -3.300269603729248], "perturbed_sampled_ll": -3.616396427154541, "perturbed_original_ll": -3.457573938369751, "perturbed_sampled_ll_std": 0.3929317382552779, "perturbed_original_ll_std": 0.25981310956316483}, {"original": "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "sampled": "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "perturbed_sampled": ["Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel"], "perturbed_original": ["Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses."], "original_ll": -4.199948787689209, "sampled_ll": -3.8350327014923096, "all_perturbed_sampled_ll": [-3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096, -3.8350327014923096], "all_perturbed_original_ll": [-4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209, -4.199948787689209], "perturbed_sampled_ll": -3.8350327014923096, "perturbed_original_ll": -4.199948787689209, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "sampled": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "perturbed_sampled": ["Question: the answer is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, they used external palliative radiotherapy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Probably, is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, respondents received external palliative radiotherapy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the most intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the first intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma is esp? In vivo patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn contrast, gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients took a diagnostic procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides a better treatment for gallbladder carcinoma. 27,000 patients received intraoperative therapy"], "perturbed_original": ["Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. External palliative radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be effective against gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, radiotherapy may be effective in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy and adjuvant chemotherapy considered to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of evaluation. Q: Does radiotherapy work to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management . Question: Is radiotherapy effective? Answer: It seems a safe and effective method of palliative management. Answer: Is radiotherapy effective in palliative or adjuvant treatment? Answer: Is radiotherapy effective for gallbladder carcinoma? Answer: Is radiotherapy effective? : I am interested in understanding of the role of radiotherapy in palliative management of gallbladder carcinoma.: This paper highlights the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative radiotherapy. Question: Does external radiotherapy work to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further treatment is available for palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for palliative treatment a safe, safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems effective in palliative or adjuvant treatment of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma."], "original_ll": -2.2156364917755127, "sampled_ll": -2.721501588821411, "all_perturbed_sampled_ll": [-2.9462201595306396, -2.9369728565216064, -3.0661118030548096, -2.9300289154052734, -2.895395278930664, -2.8611743450164795, -3.489772319793701, -3.1340322494506836, -3.2285075187683105, -2.776602029800415], "all_perturbed_original_ll": [-2.4105234146118164, -2.3260605335235596, -2.3674659729003906, -2.514592170715332, -2.925055980682373, -2.0866165161132812, -2.568197250366211, -2.4959874153137207, -2.5874345302581787, -2.1320862770080566], "perturbed_sampled_ll": -3.0264817476272583, "perturbed_original_ll": -2.441402006149292, "perturbed_sampled_ll_std": 0.1998242237988161, "perturbed_original_ll_std": 0.22823950363331033}, {"original": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "sampled": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "perturbed_sampled": ["Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Yes, we, as the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of the Internet is not just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, for many years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the rich? Not the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing more to demonstrate that our goal is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, this study takes over many years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just wrong? Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the poor and the poor? Of course the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just the result? Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case."], "perturbed_original": ["Question: The use of audit to identify maternal mortality in different settings: is n't it helpful? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference ? The number of factors that identify maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the need to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more important than the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of maternal mortality is more than just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between rich and poor? Both are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong learning from practitioners and doctors, there is no single, general", "Question: The rich is very weak; is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality between rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality is more than just differences between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general"], "original_ll": -3.2243471145629883, "sampled_ll": -2.799184560775757, "all_perturbed_sampled_ll": [-3.1378536224365234, -2.469954252243042, -3.143052339553833, -3.5051839351654053, -2.674560785293579, -3.1114771366119385, -3.2640933990478516, -3.0893476009368896, -3.130120038986206, -3.155871629714966], "all_perturbed_original_ll": [-3.680453300476074, -3.7030482292175293, -3.2239251136779785, -3.5958733558654785, -2.9277515411376953, -3.589463949203491, -3.5530014038085938, -3.1968302726745605, -3.452908754348755, -3.1456105709075928], "perturbed_sampled_ll": -3.0681514739990234, "perturbed_original_ll": -3.406886649131775, "perturbed_sampled_ll_std": 0.27685266898086125, "perturbed_original_ll_std": 0.2510981165368779}, {"original": "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "sampled": "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "perturbed_sampled": ["Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes."], "perturbed_original": ["Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned."], "original_ll": -3.3954811096191406, "sampled_ll": -3.0690927505493164, "all_perturbed_sampled_ll": [-3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164, -3.0690927505493164], "all_perturbed_original_ll": [-3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406, -3.3954811096191406], "perturbed_sampled_ll": -3.0690927505493164, "perturbed_original_ll": -3.3954811096191406, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "sampled": "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "perturbed_sampled": ["Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it"], "perturbed_original": ["Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy."], "original_ll": -3.712476968765259, "sampled_ll": -2.588107109069824, "all_perturbed_sampled_ll": [-2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824, -2.588107109069824], "all_perturbed_original_ll": [-3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259, -3.712476968765259], "perturbed_sampled_ll": -2.588107109069824, "perturbed_original_ll": -3.712476968765259, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "sampled": "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "perturbed_sampled": ["Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?"], "perturbed_original": ["Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned."], "original_ll": -3.337890386581421, "sampled_ll": -2.6662752628326416, "all_perturbed_sampled_ll": [-2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416, -2.6662752628326416], "all_perturbed_original_ll": [-3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421, -3.337890386581421], "perturbed_sampled_ll": -2.6662752628326416, "perturbed_original_ll": -3.337890386581421, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "sampled": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "perturbed_sampled": ["Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass"], "perturbed_original": ["Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG."], "original_ll": -3.099543571472168, "sampled_ll": -2.1120846271514893, "all_perturbed_sampled_ll": [-2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893, -2.1120846271514893], "all_perturbed_original_ll": [-3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168, -3.099543571472168], "perturbed_sampled_ll": -2.1120846271514893, "perturbed_original_ll": -3.099543571472168, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "sampled": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "perturbed_sampled": ["Question: Prognosis of low-tone sudden deafness - does it inevitably progress to indicate that low-tone sudden deafness might not occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably prevent the symptoms of sudden deafness which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. The answer is a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness . There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which may not impede Meniere's health. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of vision and they will often get the \"audible eye\"", "Question: Prognosis of a severe disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. This is a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "'s progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Is Meniere's disease a precursor to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\""], "perturbed_original": ["Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: Meniere suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness went into vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even though electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's diagnosis? The DT (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic s, and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? We'd like to ask the question: Many patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had not received either. This was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness patients, Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably a useful prognostic tool? Traditionally low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that low-tone sudden apparition has hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool."], "original_ll": -3.970932722091675, "sampled_ll": -3.5817577838897705, "all_perturbed_sampled_ll": [-3.735316038131714, -3.682886838912964, -3.6015751361846924, -3.741489887237549, -3.619643449783325, -4.014146327972412, -3.341392993927002, -3.6226463317871094, -3.611747980117798, -3.3034307956695557], "all_perturbed_original_ll": [-4.41357946395874, -4.1045145988464355, -4.0257110595703125, -4.628995895385742, -4.0054097175598145, -4.225029945373535, -3.9455549716949463, -3.9514880180358887, -4.197794437408447, -4.396482944488525], "perturbed_sampled_ll": -3.627427577972412, "perturbed_original_ll": -4.189456105232239, "perturbed_sampled_ll_std": 0.19106663789650183, "perturbed_original_ll_std": 0.2171724639265327}, {"original": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "sampled": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "perturbed_sampled": ["Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which can cause different disease disorders in the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty syndrome is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients try a primary angioplasty. The primary angioplasty is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients carry my angioplasty routine and have a treatment package that is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to represent a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed for people with arthritis and affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one of the most serious condition that affects a significant percentage of the population.\n\nMyths"], "perturbed_original": ["Question: Is primary angioplasty an acceptable alternative to secondary angioplasty? The service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Primary angioplasty was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care took place at home and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of the services given by patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were reasonable, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to all parents and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care for patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Angioplasty was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of the patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were acceptable with exception of discharge and aftercare."], "original_ll": -3.2886338233947754, "sampled_ll": -2.195575475692749, "all_perturbed_sampled_ll": [-2.632822036743164, -2.294837474822998, -2.294837474822998, -2.3311827182769775, -2.1743736267089844, -2.7959141731262207, -2.519940137863159, -2.4604344367980957, -2.5124006271362305, -2.4079346656799316], "all_perturbed_original_ll": [-3.27963924407959, -3.2296597957611084, -3.48713755607605, -3.325183153152466, -3.4211769104003906, -3.4859983921051025, -3.2982630729675293, -3.3306055068969727, -3.2980828285217285, -3.5704381465911865], "perturbed_sampled_ll": -2.442467737197876, "perturbed_original_ll": -3.3726184606552123, "perturbed_sampled_ll_std": 0.17361314926053045, "perturbed_original_ll_std": 0.10566076786464697}, {"original": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "sampled": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "perturbed_sampled": ["Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? This is a general practice of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after acquired choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic intervention of patients with certain types of cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile l? Use of a nasobiliary drainage tube or an infarction tube may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance ? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance ? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in order for patients to get a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a small bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this is a problem for people who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of a cholangitis? Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an"], "perturbed_original": ["Question: Is it necessary to insert a nasobiliary drainage tube routinely inserted to help with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure clinical treatment. The process may be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? The patient\u2019s clinical course is no longer a viable clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary ENBD duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of an underepiosis tube? A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not save much procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the tube? No, a routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely inserted in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the tube? A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Of course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary."], "original_ll": -4.165398597717285, "sampled_ll": -3.0467536449432373, "all_perturbed_sampled_ll": [-3.2642388343811035, -3.0515873432159424, -2.850494623184204, -3.1686131954193115, -3.140016794204712, -3.140016794204712, -3.2561535835266113, -3.1131632328033447, -3.212595224380493, -2.9935076236724854], "all_perturbed_original_ll": [-4.370930194854736, -4.267045021057129, -4.259677886962891, -4.340456962585449, -4.804348468780518, -4.201468467712402, -4.439034938812256, -4.270725250244141, -4.5034356117248535, -4.1398515701293945], "perturbed_sampled_ll": -3.119038724899292, "perturbed_original_ll": -4.359697437286377, "perturbed_sampled_ll_std": 0.12018001663984858, "perturbed_original_ll_std": 0.18028839544544759}, {"original": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "sampled": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "perturbed_sampled": ["Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception, birth contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have provided contraception during pregnancy? Does birth center care do not provide contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on how much she needs to receive contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of pregnancy, parents who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need for birth control, women without birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center provides contraception during pregnancy for her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because , the women who undergo birth control during pregnancy are not", "Question: Does her pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide birth contraception for the newborn, most women who undergo birth control during pregnancy are not"], "perturbed_original": ["Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model 's first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, is a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, is a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy. A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care during pregnancy, is a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, is a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be as accurate in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy, is a significant factor to affect subsequent reproduction in Sweden."], "original_ll": -3.149041175842285, "sampled_ll": -2.7892401218414307, "all_perturbed_sampled_ll": [-3.4095466136932373, -2.9835455417633057, -3.144322395324707, -3.1626787185668945, -2.836538076400757, -3.0680527687072754, -3.0599379539489746, -3.191309690475464, -2.9425528049468994, -3.2324600219726562], "all_perturbed_original_ll": [-3.5985145568847656, -3.4913504123687744, -3.337489366531372, -3.5135743618011475, -3.5135743618011475, -3.583878517150879, -3.417555093765259, -3.5135743618011475, -3.407486915588379, -3.319094657897949], "perturbed_sampled_ll": -3.103094458580017, "perturbed_original_ll": -3.469609260559082, "perturbed_sampled_ll_std": 0.15423637741308466, "perturbed_original_ll_std": 0.09089809707795411}, {"original": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "sampled": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "perturbed_sampled": ["Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The report is conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is required by medical institutions. Through an extensive and complete investigation of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation , a complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical and diagnostic team who provides full medical assistance provided to ensure a proper and proportionate outcome for", "Question: Are we aware of suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent independent radiologists. Data will be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, the UK Department of Health is satisfied with the assessment provided by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of their training and support from the Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis conducted by the UK radiologists is an expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "was received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for"], "perturbed_original": ["Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 2050: education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests a reduction in welfare care should be increased by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if effective and should be implemented.", "Question: Are UK radiologists satisfied with the training and support? There is a significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if the service should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by a few more. Such education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential consequences if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The health-service service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts is potential. Several service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented."], "original_ll": -3.8486931324005127, "sampled_ll": -2.779942274093628, "all_perturbed_sampled_ll": [-3.0604424476623535, -3.2371206283569336, -3.1060056686401367, -3.186444044113159, -2.5367071628570557, -3.043694496154785, -2.7638988494873047, -2.849362850189209, -3.1040656566619873, -2.6576340198516846], "all_perturbed_original_ll": [-4.083410263061523, -3.9401323795318604, -3.9623465538024902, -3.930697441101074, -3.884488821029663, -3.9843106269836426, -3.9481868743896484, -3.9727847576141357, -4.031412601470947, -3.926342248916626], "perturbed_sampled_ll": -2.954537582397461, "perturbed_original_ll": -3.966411256790161, "perturbed_sampled_ll_std": 0.22544148741444256, "perturbed_original_ll_std": 0.053764735713164716}, {"original": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "sampled": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "perturbed_sampled": ["Question: Does preoperative anemia adversely affect preoperative colitis? Few other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported three-fold adolescence of preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the presence of antigenic drugs has increased postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery ? Reviews have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, but no one has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have shown that patients in the U.S. have less incidence with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, and the incidence has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with CSC [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic anemia in a healthy control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery ? Research has shown that clinically ineffective patients have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has"], "perturbed_original": ["and outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and moderate colon complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon surgery? It suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? The incidence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: If severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This is because moderate and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and colon complications? It was suggested that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis shows that mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery."], "original_ll": -3.6812846660614014, "sampled_ll": -2.9066381454467773, "all_perturbed_sampled_ll": [-2.990936040878296, -3.520857572555542, -3.2802793979644775, -3.153193235397339, -3.0950801372528076, -3.1456682682037354, -3.124683141708374, -3.2882444858551025, -3.1559481620788574, -3.289964437484741], "all_perturbed_original_ll": [-4.330299377441406, -4.243362903594971, -3.7130990028381348, -3.539322853088379, -3.672684669494629, -3.7928884029388428, -3.6542162895202637, -3.6257669925689697, -3.539322853088379, -3.7116267681121826], "perturbed_sampled_ll": -3.2044854879379274, "perturbed_original_ll": -3.7822590112686156, "perturbed_sampled_ll_std": 0.13876086528318102, "perturbed_original_ll_std": 0.2633965124612281}, {"original": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "sampled": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "perturbed_sampled": ["Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus"], "perturbed_original": ["Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year."], "original_ll": -2.999654531478882, "sampled_ll": -3.4923973083496094, "all_perturbed_sampled_ll": [-3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094, -3.4923973083496094], "all_perturbed_original_ll": [-2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882, -2.999654531478882], "perturbed_sampled_ll": -3.4923973083496094, "perturbed_original_ll": -2.999654531478882, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "sampled": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "perturbed_sampled": ["Question: Upstream solutions: does the homeowner come up with a homeless person? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There are two sets of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: For elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but the benefits of supplemental security income will go up in the home program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the elderly for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person and their disability will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing and the benefit for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that will go up, and the cost will go up. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of RVs in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the elderly for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV"], "perturbed_original": ["Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to determine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to determine the different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even for elderly people, many have to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability ? Incomes are a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new study. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? These are critical principles for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their impact on income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of factors that contribute to how a range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should look into income support policy, such as whether a broader range of social and economic policies affect health."], "original_ll": -3.6616573333740234, "sampled_ll": -2.9117074012756348, "all_perturbed_sampled_ll": [-3.0093977451324463, -3.0676937103271484, -3.0978903770446777, -3.016486167907715, -2.9986822605133057, -2.9554429054260254, -3.0085301399230957, -2.9780797958374023, -3.2313125133514404, -2.9986822605133057], "all_perturbed_original_ll": [-3.8505303859710693, -3.900714159011841, -3.9828784465789795, -3.8883750438690186, -3.7958285808563232, -3.653399705886841, -3.7757363319396973, -3.8398494720458984, -3.7726309299468994, -3.8179099559783936], "perturbed_sampled_ll": -3.0362197875976564, "perturbed_original_ll": -3.827785301208496, "perturbed_sampled_ll_std": 0.07579834468354113, "perturbed_original_ll_std": 0.08425360063635536}, {"original": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "sampled": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "perturbed_sampled": ["Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic overview of the physiological and neurophysiology of acute respiratory distress syndrome (ASE) and the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major exposure to acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic framework of biological mechanisms. The study on biology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome and prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Many neurobiological mechanisms, particularly of the central nervous system, are unknown. Here, this review will examine neurophysiology and neurophysiology of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome: associated neurobiology and neurophysiology of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil s in the pathogenesis of acute respiratory distress syndrome (ASE) and prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure , and there are not yet a number of the related parameters. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of acute respiratory distress syndrome (ASE), by Peter Heel, and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory population? acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter P., revealed that neutrophil migration and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model . A study of the neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,"], "perturbed_original": ["Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may lead to downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early detection of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after blunt distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity contributed to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a retrospective review. These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration of the migratory capacity of circulating neutrophils. For people who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory capacity of acute respiratory distress syndrome? This is due to the increased migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: What is the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 weeks after receiving interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be a characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor s. Unlike ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with acute respiratory distress syndrome suggest establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of neutrophil proliferation after major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. Symptom counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within patients who later develop ARDS, especially in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be a characteristic of ARDS.", "Question: Increased neutrophil migratory activity after blunt distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary and other neutrophil counts imply the neutrophil infiltration that is characteristic of ARDS."], "original_ll": -3.2472386360168457, "sampled_ll": -2.3074817657470703, "all_perturbed_sampled_ll": [-2.323188304901123, -2.6149942874908447, -2.3337903022766113, -2.48939847946167, -2.370223045349121, -2.3068606853485107, -2.5809803009033203, -2.6868865489959717, -2.627668857574463, -2.5508410930633545], "all_perturbed_original_ll": [-3.4429354667663574, -3.6045517921447754, -3.2951836585998535, -3.212798833847046, -3.240053415298462, -3.345069169998169, -3.4758188724517822, -3.5077900886535645, -3.209242820739746, -3.645781993865967], "perturbed_sampled_ll": -2.488483190536499, "perturbed_original_ll": -3.3979226112365724, "perturbed_sampled_ll_std": 0.13616576171081654, "perturbed_original_ll_std": 0.15245887222169666}, {"original": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "sampled": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "perturbed_sampled": ["Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An individual may have the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to take a long break in that period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and therefore avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are in the process of recovery from myelomeningocele and may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune system degrades. The untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. Patients can experience the presence of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary for a diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require the detection or treatment of the condition for a period of time without being"], "perturbed_original": ["Question: A patient with myelomeningocele: is untethering necessary prior to surgery? MM untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: How does spinal cord untethering function include spinal cord correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to surgery? A cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients who are not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study is directed at patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that MM patients with myelomeningocele and MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cords are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cords are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: Is spinal cord correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with clinical symptoms present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated."], "original_ll": -3.8268306255340576, "sampled_ll": -3.31512713432312, "all_perturbed_sampled_ll": [-3.621279001235962, -3.470787763595581, -3.5077767372131348, -3.657630205154419, -3.2564167976379395, -3.4469804763793945, -3.591331720352173, -3.5234174728393555, -3.7887818813323975, -3.730060577392578], "all_perturbed_original_ll": [-4.187896251678467, -3.8467252254486084, -4.085630416870117, -3.947732448577881, -3.9994606971740723, -3.877563953399658, -4.142404079437256, -4.142404079437256, -4.087371349334717, -4.005490303039551], "perturbed_sampled_ll": -3.5594462633132933, "perturbed_original_ll": -4.0322678804397585, "perturbed_sampled_ll_std": 0.14576957147730782, "perturbed_original_ll_std": 0.11030098739372424}, {"original": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "sampled": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "perturbed_sampled": ["Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the age group but do not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way as their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, kids may not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive body image differently? Answer: Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Do parents and their kids' physicians perceive body image differently? Answer: Does parents and their children may not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their kids know about body perception? Children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body but are aware of the", "Question: Body perception: do parents, their children, and children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way. They recognize their body when they are younger, and they are not aware of the"], "perturbed_original": ["Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates children underestimated their degree of overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study found that some children underestimated their degree of overweight and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their family share their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate and counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body perception? Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their siblings and so doing physicians share this misperception? Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their study found that this study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's caregivers share an increased degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to assess the body image of their children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the difference between parents and their children, so that they can counsel children and their families."], "original_ll": -3.6529042720794678, "sampled_ll": -2.641486644744873, "all_perturbed_sampled_ll": [-2.9485654830932617, -2.7711806297302246, -2.9038331508636475, -2.8247618675231934, -2.7528645992279053, -2.760120391845703, -2.8017051219940186, -2.950507879257202, -3.1826963424682617, -2.6968164443969727], "all_perturbed_original_ll": [-3.831951856613159, -3.752474308013916, -3.913724899291992, -3.767413377761841, -3.9225451946258545, -4.052127361297607, -3.923492193222046, -3.8332459926605225, -3.4752519130706787, -3.645568370819092], "perturbed_sampled_ll": -2.859305191040039, "perturbed_original_ll": -3.8117795467376707, "perturbed_sampled_ll_std": 0.13516533221410876, "perturbed_original_ll_std": 0.15496414840390715}, {"original": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "sampled": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "perturbed_sampled": ["Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. An candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", ". A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n"], "perturbed_original": ["Question: The insertion allele of insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene may help us conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that the same number occurs through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance to DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for which the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased ACE genes may cause insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Answer: A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion of DD genotype for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: Can DD have a different candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for the polymorphism of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased"], "original_ll": -3.9086427688598633, "sampled_ll": -2.0651865005493164, "all_perturbed_sampled_ll": [-2.18554425239563, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.688206672668457, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164], "all_perturbed_original_ll": [-3.8783631324768066, -3.9849984645843506, -4.308810710906982, -4.277868747711182, -4.254456043243408, -3.9571008682250977, -3.9235119819641113, -3.540593147277832, -3.82948899269104, -3.9983890056610107], "perturbed_sampled_ll": -2.139524292945862, "perturbed_original_ll": -3.995358109474182, "perturbed_sampled_ll_std": 0.1863810745523653, "perturbed_original_ll_std": 0.22359563588141776}, {"original": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "sampled": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "perturbed_sampled": ["Question: The clinical significance of Bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? It may be more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of Bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Of course it is more difficult to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are not bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones are from an older", "duct stones are different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it an important indication? Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it is older", "Question: The clinical significance of bile duct sludge: is it different from those that were produced for bile duct stones? They are more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older"], "perturbed_original": ["Question: The clinical significance of bile duct stones may have an early stage of choledocholithiasis. The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of BDS is similar to that of CBD duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of CBD stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of the first stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is believed to be an early stage of choledocholithiasis.", "Question: The clinical significance of symptomatic BDS is similar to CBD duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct sludge? The value of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The clinical significance of bile duct sludge is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it symptomatic?? Asking: Does bile duct sludge have a health significance? Answer: Perhaps the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis."], "original_ll": -3.4409372806549072, "sampled_ll": -2.826911211013794, "all_perturbed_sampled_ll": [-3.0572762489318848, -3.232184648513794, -3.0572762489318848, -2.948153018951416, -2.9170989990234375, -3.2260828018188477, -2.88039231300354, -3.334794282913208, -3.042179822921753, -3.3958144187927246], "all_perturbed_original_ll": [-3.4280107021331787, -3.283538818359375, -3.905851125717163, -3.9151124954223633, -3.6971523761749268, -3.8880112171173096, -3.9277665615081787, -3.7383761405944824, -2.9966468811035156, -3.620062828063965], "perturbed_sampled_ll": -3.109125280380249, "perturbed_original_ll": -3.640052914619446, "perturbed_sampled_ll_std": 0.1693821422521225, "perturbed_original_ll_std": 0.29831725694423517}, {"original": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "sampled": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "perturbed_sampled": ["Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to CT, and the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not involve medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Many studies have shown that PET/CT could actually improve the outcomes of patients on PET, which is similar to our studies, which is the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study as long as our studies. I will look at the preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really work? So we did a small study of our patients on PET, which is similar to a standardized study, but not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients undergoing invasive resection on the CT. However, it is not the same as our studies. I will post some notes below: We used a single CT to require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a CT that would require an invasive biopsy and did and did not have to wait for the", "Question: Preoperative staging CT, can we really add something to multidetector CT? Answer: Yes, we are doing a small study of our patient on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which means it is not the same as our studies. I will post some notes below: We used a large sample of PET that didn\u2019t require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of a study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. We did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we used PET, which is similar to the study done on the CT. However, it is not the same as the test we used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the"], "perturbed_original": ["Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection , it can also be hampered by its accuracy in all the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic disease, as with detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and inaccurate. Therefore we support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add value to the results? It may seem that PET/CT contributes to reduction in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the staging and in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher PPV locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 9% of staging, with the most valuable data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic al trials, we have provided additional useful information in 8% of the staging than we did in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in the diagnosis of PPV. Although PET/CT also has a high PPV for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. The low PPV is used in some locations but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients is something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective selection of T cells with local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT provided additional useful information in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in the use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of patients with inherited extrahepatic disease and low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT play a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases involving the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence."], "original_ll": -3.6918342113494873, "sampled_ll": -2.9590978622436523, "all_perturbed_sampled_ll": [-3.2455551624298096, -3.1521730422973633, -3.31898832321167, -3.0247676372528076, -3.283332347869873, -3.245889663696289, -3.2447285652160645, -3.379503011703491, -3.2081542015075684, -3.0829408168792725], "all_perturbed_original_ll": [-3.9345204830169678, -3.8741989135742188, -3.6299073696136475, -3.7231664657592773, -3.8383002281188965, -3.6337521076202393, -4.283048152923584, -3.827359676361084, -3.688105344772339, -3.82322096824646], "perturbed_sampled_ll": -3.218603277206421, "perturbed_original_ll": -3.8255579710006713, "perturbed_sampled_ll_std": 0.10139424739169807, "perturbed_original_ll_std": 0.18114993832972492}, {"original": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "sampled": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "perturbed_sampled": ["Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an estimated number of health care applications. The data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis that says the United States health data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are incomplete, the results of the analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya comprises 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? An analysis of health care data based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in that they vary in the quality of health care in Kenya, the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of the Kenya Health Authority? The data on the distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: What are the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does this analysis influence the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health"], "perturbed_original": ["Question: Does the distribution of health care benefits ? The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all Kenyans benefit from health care when the health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. Health care benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: Does the distribution of benefits in Kenya meet the principles of universal coverage? No provision of benefits vary. Kenya cannot benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the streets. The provision of the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? How can Kenyans benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of the need. Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to enable all Kenyan health system to benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector should provide health care on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya in relation to the provision of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it."], "original_ll": -2.94423508644104, "sampled_ll": -2.310852527618408, "all_perturbed_sampled_ll": [-2.471054792404175, -2.5820486545562744, -2.3204870223999023, -2.367845296859741, -2.5691468715667725, -2.619945764541626, -2.391552209854126, -2.379854917526245, -2.5236072540283203, -2.685950756072998], "all_perturbed_original_ll": [-3.3081579208374023, -2.892609119415283, -2.909011125564575, -2.9604547023773193, -3.2357940673828125, -3.059262990951538, -3.103801965713501, -3.0228168964385986, -2.886518955230713, -3.172218084335327], "perturbed_sampled_ll": -2.491149353981018, "perturbed_original_ll": -3.055064582824707, "perturbed_sampled_ll_std": 0.11703643387109981, "perturbed_original_ll_std": 0.14105291477976664}, {"original": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "sampled": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "perturbed_sampled": ["Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n"], "perturbed_original": ["Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The"], "original_ll": -4.984091758728027, "sampled_ll": -4.731563568115234, "all_perturbed_sampled_ll": [-4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234, -4.731563568115234], "all_perturbed_original_ll": [-4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027, -4.984091758728027], "perturbed_sampled_ll": -4.731563568115234, "perturbed_original_ll": -4.984091758728027, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "sampled": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "perturbed_sampled": ["Question: Preoperative cancer is a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an early stage of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a part of predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. In fact, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor because it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic analysis? It is also about which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have \u2013 not so many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a good way of predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very"], "perturbed_original": ["Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a measure of platelet count? We therefore suggest it may be the best cutoff point for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival, as the 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor . We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Preoperative platelet count predicts survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that esophageal platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count : Preoperative platelet count. Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in ESCC patients? Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a good idea for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a good indicator of platelet count? Preoperative platelet count is a great indicator for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients."], "original_ll": -3.098870038986206, "sampled_ll": -2.343740701675415, "all_perturbed_sampled_ll": [-2.58207106590271, -2.459005355834961, -2.7717182636260986, -2.7176513671875, -2.675199031829834, -2.3862507343292236, -2.7457995414733887, -3.153453826904297, -2.6455321311950684, -2.3100719451904297], "all_perturbed_original_ll": [-3.4364705085754395, -3.209681987762451, -3.365997076034546, -3.4013290405273438, -2.6960012912750244, -3.5348610877990723, -3.456041097640991, -3.658231496810913, -3.183783769607544, -3.66269588470459], "perturbed_sampled_ll": -2.6446753263473513, "perturbed_original_ll": -3.3605093240737913, "perturbed_sampled_ll_std": 0.2255249064939716, "perturbed_original_ll_std": 0.26879327850567303}, {"original": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "sampled": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "perturbed_sampled": ["Question: What are the causes of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they associated with increased levels of risk of suicide? These episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be the same as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of high serotonin (5-HT), as well as changes in the", "Question: Long-term duration of those interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of infection in serotonin (5-HT), as well as changes in the", "Question: How many episodes of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes III? The increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes will be observed by interictal psychotic episodes. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some might also suggest that other causes may be involved in the clinical investigation of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the"], "perturbed_original": ["Question: Long-term significance of postictal significance is not the one that is not an independent predictor. The Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be more important than PIPE. The disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of interictal psychotic episodes has become an independent predictor.", "Question: A history of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they still likely that they may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic treatment: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history study of IPE has revealed no trace of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes and the history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the preictal psychotic episodes in the past, but the analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE : PIPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor."], "original_ll": -3.4959616661071777, "sampled_ll": -2.6270575523376465, "all_perturbed_sampled_ll": [-2.545889377593994, -2.625418186187744, -3.1410977840423584, -3.025181770324707, -2.9120852947235107, -3.109766721725464, -3.031658411026001, -3.3025619983673096, -2.699540853500366, -3.153604507446289], "all_perturbed_original_ll": [-3.613125801086426, -3.5890486240386963, -3.427894115447998, -3.715757369995117, -3.9942421913146973, -3.665501832962036, -3.8949177265167236, -3.61995530128479, -3.261812448501587, -3.8813271522521973], "perturbed_sampled_ll": -2.9546804904937742, "perturbed_original_ll": -3.6663582563400268, "perturbed_sampled_ll_std": 0.23931692570530297, "perturbed_original_ll_std": 0.20973461879964306}, {"original": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "sampled": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "perturbed_sampled": ["Question: Are Biochemical Markers of Bone Turnover ? There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Returns Important? There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Turnover?\u201d? We can answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? It seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is still doubt that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the gender of women appears slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is currently no doubt the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are there 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the responses may seem slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There are some studies suggest that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in"], "perturbed_original": ["Question: Are Biochemical Markers of Bone turnover markers? Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The same was true for bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Turnover? The biochemical Markers of neo-turnover are significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover markers may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in the last 15 years, and almost perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The following parameters involved bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover markers. Similarly, in this case, bone crest bone may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover markers in women who may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac women after the whole bone turnover.", "Question: Are Biochemical Studies of Women in Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover."], "original_ll": -4.224788665771484, "sampled_ll": -3.1788341999053955, "all_perturbed_sampled_ll": [-3.106182098388672, -2.867476463317871, -3.809579610824585, -3.6644043922424316, -3.7478394508361816, -3.6540541648864746, -3.7142364978790283, -3.270028591156006, -3.601915121078491, -3.5661253929138184], "all_perturbed_original_ll": [-4.437929153442383, -3.9339637756347656, -4.25572395324707, -4.4464006423950195, -4.203883647918701, -4.108841896057129, -4.350369453430176, -4.340378761291504, -4.338709831237793, -4.458419322967529], "perturbed_sampled_ll": -3.500184178352356, "perturbed_original_ll": -4.287462043762207, "perturbed_sampled_ll_std": 0.29609914370155316, "perturbed_original_ll_std": 0.15854681164473536}, {"original": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "sampled": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "perturbed_sampled": ["Question: Is lumbar hemorrhaging Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the number of patients with spine surgery. The results from the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The risk of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in accuracy. Results of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery indicated as a major decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar lumbar? Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Results of a study identify a role in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the brain's drainage. The results of the present study support a possible causal", "Question: Is this effective? Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal"], "perturbed_original": ["is spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of the lumbar drainage? Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in acute and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal drainage to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery an important factor both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective in treating large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine pain safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery necessary both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in the debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective in the cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks."], "original_ll": -3.729109048843384, "sampled_ll": -3.250746726989746, "all_perturbed_sampled_ll": [-3.178030252456665, -3.3076083660125732, -3.629969835281372, -3.7163503170013428, -3.7142577171325684, -3.8665056228637695, -2.8835010528564453, -3.923100709915161, -3.53763747215271, -2.9086732864379883], "all_perturbed_original_ll": [-4.375495910644531, -3.8384439945220947, -3.77847957611084, -4.34168815612793, -4.307131767272949, -3.9028608798980713, -4.594797134399414, -4.416665077209473, -3.754544973373413, -3.9302847385406494], "perturbed_sampled_ll": -3.4665634632110596, "perturbed_original_ll": -4.124039220809936, "perturbed_sampled_ll_std": 0.3582736973279335, "perturbed_original_ll_std": 0.29585977584292106}, {"original": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "sampled": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "perturbed_sampled": ["Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs is poor health care and health care as well as lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs to middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One of the major problems with quality care has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is providing health care is central to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income low-income country with high income inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country would have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening , but another issue with a lack of quality health care. What has plagued the field is that one of the greatest MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country does not have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in the low-income state is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than"], "perturbed_original": ["Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to have had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact at many levels was measured by the qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The national level had an influence on graduates as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at the global level; graduates contributed significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much was found to have potential educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- income levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact at different levels; a qualitative method study and qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was a growing need for graduates to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence aimed at strengthening health system in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute more, including those at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways."], "original_ll": -3.994440793991089, "sampled_ll": -2.9140422344207764, "all_perturbed_sampled_ll": [-2.854482889175415, -2.8647687435150146, -2.900181531906128, -3.179738998413086, -2.946758508682251, -3.1396031379699707, -3.359356164932251, -3.3344390392303467, -3.0334696769714355, -2.987720489501953], "all_perturbed_original_ll": [-4.0985870361328125, -3.9304511547088623, -3.9054481983184814, -4.104645729064941, -4.127261638641357, -4.498103618621826, -3.9891669750213623, -3.9944655895233154, -4.178645610809326, -4.000351428985596], "perturbed_sampled_ll": -3.060051918029785, "perturbed_original_ll": -4.082712697982788, "perturbed_sampled_ll_std": 0.17613950443481036, "perturbed_original_ll_std": 0.1619871645405094}, {"original": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "sampled": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "perturbed_sampled": ["Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials for paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of adjuvant glioma therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? In addition to adjuvant glioma therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, we are presented with three treatments by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG clinical trial, patients developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain and concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In rats with rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In many rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: In clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel -induced glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by"], "perturbed_original": ["Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of brain tumors of interest for the treatment of brain tumors.", "Question: Answer: Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "s using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The treatment of tumors is designed to be able to detect tumors in the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced chemotherapeutic agents LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier or potential use of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant transport agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept for releasing the receptor of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new study examining the locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced light in LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors."], "original_ll": -4.175081253051758, "sampled_ll": -3.2207107543945312, "all_perturbed_sampled_ll": [-3.8444035053253174, -3.563352108001709, -3.5116939544677734, -3.77126407623291, -3.7875401973724365, -3.9171547889709473, -3.808662176132202, -3.7587263584136963, -3.3168537616729736, -3.7296125888824463], "all_perturbed_original_ll": [-4.46303653717041, -4.246842384338379, -4.587182998657227, -3.9246792793273926, -4.037041664123535, -3.8636953830718994, -4.422401428222656, -4.236320972442627, -4.11330509185791, -4.312762260437012], "perturbed_sampled_ll": -3.700926351547241, "perturbed_original_ll": -4.220726799964905, "perturbed_sampled_ll_std": 0.17257110430169142, "perturbed_original_ll_std": 0.22438087208142485}, {"original": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "sampled": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "perturbed_sampled": ["Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on the headache, migraine is very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If it happens, you might notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work as an overall source of pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes that pose a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work really hard? It can cause severe pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating , these are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to your job? After concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice there is a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and sometimes have a physical effect. Question: Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine (mybrogenic) migraine is sometimes accompanied by some other physical or"], "perturbed_original": ["Question: Do episodic migraineurs selectively attend to headache-related facial stimuli? Using observational findings and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related facial stimuli? Given a significant difference in sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest the need to select attentional processing between chronic migraine samples and episodic headache stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given the large sample size and prior pilot testing of presented samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to visual stimuli. In chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest size, further experiments suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest significant differences in attentional processing between migraineurs to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs selectively attend to headache-related visual stimuli? True? Answer: Given evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In the presentation of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among both subjects, we are strongly referring to the difference in color processing between chronic and episodic headache subforms."], "original_ll": -3.521576404571533, "sampled_ll": -2.9697115421295166, "all_perturbed_sampled_ll": [-3.212812662124634, -3.016535997390747, -3.250185966491699, -3.4675967693328857, -3.263836145401001, -3.3890130519866943, -3.4580130577087402, -3.2421035766601562, -3.3331611156463623, -3.1823322772979736], "all_perturbed_original_ll": [-3.7296688556671143, -3.6127238273620605, -3.66570782661438, -3.185274839401245, -3.5574636459350586, -3.7309730052948, -3.6589744091033936, -3.5453073978424072, -3.515746593475342, -3.8054492473602295], "perturbed_sampled_ll": -3.2815590620040895, "perturbed_original_ll": -3.600728964805603, "perturbed_sampled_ll_std": 0.12946796064926497, "perturbed_original_ll_std": 0.1637148839515747}, {"original": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "sampled": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "perturbed_sampled": ["Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue area? Because your skin can become visceral adipose tissue, it is more than likely that it could become visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the contrary, it is more than likely that it would not be able to be divided into your visceral adipose tissue if this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue? If your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue if you questioned your skin. However, the number of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin is healthy, it is possible that it would not be able to be divided into your visceral adipose tissue if you were to measure the amount of tissue that is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin needs to measure it, it is often that it would not be able to be used or able to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area ? Question: How is a skin's tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your tissue size and then dividing it into your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can be removed, it would not be necessary if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Does it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your body and your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Does it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is likely to be divided into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin does not contain blood, you should know that it would not be able to be divided into your visceral adipose tissue region measurement. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it"], "perturbed_original": ["Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a CT slice 1cm with L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm with changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: As VAT area at a CT slice 1cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight on this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue area 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight location.", "Question: Visceral adipose tissue volume and visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of L3 can best reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. VAT area measurements at a single level 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight. In other words, the same should be performed at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level: can it represent visceral adipose tissue volume? Answer: This measurement at a single level of the vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in the conversion curve and the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level 3 cm above the lower margin of L3 vertebra is feasible. Visceral adipose tissue area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area at a CT slice 3cm above the lower margin of the L3 can best reflect interval changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra e body weight. Advances in knowledge: As VAT area at a single level may best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight. If VAT area measurement at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location."], "original_ll": -3.576467990875244, "sampled_ll": -2.426393985748291, "all_perturbed_sampled_ll": [-2.6309354305267334, -2.8367295265197754, -2.9479851722717285, -2.7223188877105713, -2.806969404220581, -2.8886232376098633, -2.705526828765869, -2.5578815937042236, -2.56355881690979, -2.7519783973693848], "all_perturbed_original_ll": [-3.767946243286133, -3.673675298690796, -4.048956394195557, -3.6277756690979004, -3.1028525829315186, -3.4560604095458984, -2.984891891479492, -3.2956066131591797, -3.8859291076660156, -3.165217638015747], "perturbed_sampled_ll": -2.741250729560852, "perturbed_original_ll": -3.500891184806824, "perturbed_sampled_ll_std": 0.12530392906339272, "perturbed_original_ll_std": 0.33873594221537995}, {"original": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "sampled": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "perturbed_sampled": ["Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a decrease in birthweight between 1973 and 1978 among both whites and males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine birthweights were increasing between 1970 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significantly increase between 1973 and 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: In comparison, pregnant women increased their birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational vested whites mean whites and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweight? The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine birthweight grew between 1967 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "True pregnancyweight for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census of 1978, 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a decrease in birthweight among males between 1970"], "perturbed_original": ["Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in birthweights, along with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification determines the difference in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Are the average birthweights differ between Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Some studies have found some interesting data for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is a good choice for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. Answer: No comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in birthweight. It can help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? This could explain the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights in comparison with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in birthweights, and it can help with the interpretation of other between-population comparisons."], "original_ll": -3.12014102935791, "sampled_ll": -2.7083327770233154, "all_perturbed_sampled_ll": [-2.7951819896698, -3.0206122398376465, -2.9806454181671143, -3.3738903999328613, -3.929107427597046, -3.091925859451294, -3.1234776973724365, -3.213270425796509, -3.2908694744110107, -2.7550437450408936], "all_perturbed_original_ll": [-3.2239813804626465, -3.162062883377075, -3.548611640930176, -3.5447638034820557, -3.2046165466308594, -3.2600386142730713, -3.212463617324829, -3.429691791534424, -3.488576889038086, -3.186567783355713], "perturbed_sampled_ll": -3.1574024677276613, "perturbed_original_ll": -3.3261374950408937, "perturbed_sampled_ll_std": 0.3180910489508411, "perturbed_original_ll_std": 0.14943107613568934}, {"original": "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "sampled": "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "perturbed_sampled": ["Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given stage and how testosterone levels affect women as affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that measure the level of", "Question: Is there a correlation between women's testosterone levels? If the answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was incorrect, you could make it at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking yourself this time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is Your Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and penis? If the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Yes, yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are. So, there is a wide range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of"], "perturbed_original": ["Question: Is there a study of sexual desire? In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a different significance? In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between FT and androstenedione? In the study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens. These results suggest measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androstenedione versus FT with androstenedione. Is it a different measurement technique? Answer: By measuring circulating androgens by mass spectrometry.", "Question: Is there a question? In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly with other sexual desire factors, superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not respond correctly and it is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire and is correlated significantly more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry."], "original_ll": -3.092439889907837, "sampled_ll": -2.3461618423461914, "all_perturbed_sampled_ll": [-2.882591485977173, -2.3699429035186768, -2.4592278003692627, -2.590322971343994, -2.6062393188476562, -2.791095495223999, -2.7725350856781006, -2.3699429035186768, -2.535522222518921, -2.499962568283081], "all_perturbed_original_ll": [-3.669796943664551, -3.8138861656188965, -3.2547967433929443, -3.204557418823242, -3.1611523628234863, -3.82763934135437, -3.3023252487182617, -3.1198220252990723, -3.3613269329071045, -3.0040082931518555], "perturbed_sampled_ll": -2.587738275527954, "perturbed_original_ll": -3.3719311475753786, "perturbed_sampled_ll_std": 0.16870301898596138, "perturbed_original_ll_std": 0.2796004336582056}, {"original": "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "sampled": "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "perturbed_sampled": ["Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n"], "perturbed_original": ["Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy"], "original_ll": -3.7739946842193604, "sampled_ll": -3.8494129180908203, "all_perturbed_sampled_ll": [-3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203, -3.8494129180908203], "all_perturbed_original_ll": [-3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604, -3.7739946842193604], "perturbed_sampled_ll": -3.8494129180908203, "perturbed_original_ll": -3.7739946842193604, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "sampled": "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "perturbed_sampled": ["Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to"], "perturbed_original": ["Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight."], "original_ll": -2.708817720413208, "sampled_ll": -2.585548162460327, "all_perturbed_sampled_ll": [-2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327, -2.585548162460327], "all_perturbed_original_ll": [-2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208, -2.708817720413208], "perturbed_sampled_ll": -2.585548162460327, "perturbed_original_ll": -2.708817720413208, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "sampled": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "perturbed_sampled": ["Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed"], "perturbed_original": ["Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008."], "original_ll": -3.2163238525390625, "sampled_ll": -2.229689598083496, "all_perturbed_sampled_ll": [-2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496, -2.229689598083496], "all_perturbed_original_ll": [-3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625, -3.2163238525390625], "perturbed_sampled_ll": -2.229689598083496, "perturbed_original_ll": -3.2163238525390625, "perturbed_sampled_ll_std": 1, "perturbed_original_ll_std": 1}, {"original": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "sampled": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "perturbed_sampled": ["Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better plasma glucose level is seen in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 patients, was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Is type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved plasma glucose levels? The fasting plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Question: Are lowering plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: The plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with diabetes? Some data indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the plasma glucose levels in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients . Question: Compared with regular fasting plasma glucose levels in the first 6"], "perturbed_original": ["Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite diagnosis. If you was presenting with type 2 diabetes at diagnosis, active case detection programs would be required to identify them.", "Is type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes; people with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who experience fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with lower glucose levels? People with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Are people presenting with type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Are people presenting with type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier diagnosed with type 2 diabetes may have improved outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are not well identified, it is often difficult to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes? People with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them."], "original_ll": -3.5304787158966064, "sampled_ll": -2.33132004737854, "all_perturbed_sampled_ll": [-2.4914135932922363, -2.511697292327881, -2.432542562484741, -2.399404287338257, -2.4061193466186523, -2.4171783924102783, -2.4661357402801514, -2.363867998123169, -2.5217015743255615, -2.7517614364624023], "all_perturbed_original_ll": [-3.5572023391723633, -3.6954612731933594, -3.849529266357422, -3.762852191925049, -3.784903049468994, -3.5859570503234863, -3.5859570503234863, -3.3559045791625977, -3.4222755432128906, -3.7360410690307617], "perturbed_sampled_ll": -2.476182222366333, "perturbed_original_ll": -3.633608341217041, "perturbed_sampled_ll_std": 0.10412212829085737, "perturbed_original_ll_std": 0.1525431924712905}], "metrics": {"roc_auc": 0.6371777777777778, "fpr": [0.0, 0.0, 0.013333333333333334, 0.013333333333333334, 0.02, 0.02, 0.02666666666666667, 0.02666666666666667, 0.03333333333333333, 0.03333333333333333, 0.04, 0.04, 0.04666666666666667, 0.04666666666666667, 0.05333333333333334, 0.05333333333333334, 0.06, 0.06, 0.06666666666666667, 0.06666666666666667, 0.08, 0.08, 0.09333333333333334, 0.09333333333333334, 0.13333333333333333, 0.13333333333333333, 0.14, 0.14, 0.15333333333333332, 0.15333333333333332, 0.16666666666666666, 0.16666666666666666, 0.18, 0.18, 0.19333333333333333, 0.19333333333333333, 0.2, 0.2, 0.21333333333333335, 0.21333333333333335, 0.22, 0.22, 0.22666666666666666, 0.22666666666666666, 0.23333333333333334, 0.23333333333333334, 0.24, 0.24, 0.26, 0.26, 0.28, 0.28, 0.34, 0.34, 0.3466666666666667, 0.3466666666666667, 0.36666666666666664, 0.36666666666666664, 0.37333333333333335, 0.37333333333333335, 0.38, 0.38, 0.38666666666666666, 0.38666666666666666, 0.4, 0.4, 0.41333333333333333, 0.41333333333333333, 0.44666666666666666, 0.44666666666666666, 0.47333333333333333, 0.47333333333333333, 0.5, 0.5, 0.52, 0.52, 0.5266666666666666, 0.5266666666666666, 0.5466666666666666, 0.5466666666666666, 0.5733333333333334, 0.5733333333333334, 0.5933333333333334, 0.5933333333333334, 0.6733333333333333, 0.6733333333333333, 0.6933333333333334, 0.6933333333333334, 0.7333333333333333, 0.7333333333333333, 0.76, 0.98, 0.9866666666666667, 0.9866666666666667, 1.0], "tpr": [0.0, 0.006666666666666667, 0.006666666666666667, 0.03333333333333333, 0.03333333333333333, 0.06666666666666667, 0.06666666666666667, 0.08, 0.08, 0.09333333333333334, 0.09333333333333334, 0.1, 0.1, 0.12, 0.12, 0.16, 0.16, 0.16666666666666666, 0.16666666666666666, 0.22666666666666666, 0.22666666666666666, 0.23333333333333334, 0.23333333333333334, 0.35333333333333333, 0.35333333333333333, 0.36, 0.36, 0.41333333333333333, 0.41333333333333333, 0.42, 0.42, 0.44, 0.44, 0.46, 0.46, 0.4666666666666667, 0.4666666666666667, 0.47333333333333333, 0.47333333333333333, 0.49333333333333335, 0.49333333333333335, 0.5, 0.5, 0.52, 0.52, 0.5266666666666666, 0.5266666666666666, 0.54, 0.54, 0.5533333333333333, 0.5533333333333333, 0.56, 0.56, 0.5666666666666667, 0.5666666666666667, 0.5733333333333334, 0.5733333333333334, 0.5866666666666667, 0.5866666666666667, 0.5933333333333334, 0.5933333333333334, 0.6066666666666667, 0.6066666666666667, 0.6133333333333333, 0.6133333333333333, 0.62, 0.62, 0.6333333333333333, 0.6333333333333333, 0.6666666666666666, 0.6666666666666666, 0.6733333333333333, 0.6733333333333333, 0.68, 0.68, 0.6866666666666666, 0.6866666666666666, 0.7133333333333334, 0.7133333333333334, 0.7333333333333333, 0.7333333333333333, 0.74, 0.74, 0.7466666666666667, 0.7466666666666667, 0.7533333333333333, 0.7533333333333333, 0.76, 0.76, 0.7733333333333333, 0.7733333333333333, 0.9933333333333333, 0.9933333333333333, 1.0, 1.0]}, "pr_metrics": {"pr_auc": 0.6427626686736971, "precision": [0.5, 0.5016722408026756, 0.5033557046979866, 0.5016835016835017, 0.5033783783783784, 0.5043478260869565, 0.5065502183406113, 0.5087719298245614, 0.5110132158590308, 0.5132743362831859, 0.5111111111111111, 0.5089285714285714, 0.5112107623318386, 0.5135135135135135, 0.5158371040723982, 0.5181818181818182, 0.5205479452054794, 0.5229357798165137, 0.5207373271889401, 0.5231481481481481, 0.5255813953488372, 0.5280373831775701, 0.5258215962441315, 0.5283018867924528, 0.5308056872037915, 0.5333333333333333, 0.5358851674641149, 0.5384615384615384, 0.5410628019323671, 0.5436893203883495, 0.5463414634146342, 0.5490196078431373, 0.5517241379310345, 0.5544554455445545, 0.5572139303482587, 0.555, 0.5577889447236181, 0.5606060606060606, 0.5634517766497462, 0.5612244897959183, 0.5641025641025641, 0.5670103092783505, 0.5699481865284974, 0.5729166666666666, 0.5706806282722513, 0.5684210526315789, 0.5661375661375662, 0.5691489361702128, 0.5721925133689839, 0.5752688172043011, 0.572972972972973, 0.5706521739130435, 0.5683060109289617, 0.5659340659340659, 0.569060773480663, 0.5666666666666667, 0.5698324022346368, 0.5730337078651685, 0.576271186440678, 0.5738636363636364, 0.5771428571428572, 0.5804597701149425, 0.5838150289017341, 0.5872093023255814, 0.5847953216374269, 0.5882352941176471, 0.591715976331361, 0.5952380952380952, 0.5988023952095808, 0.5963855421686747, 0.593939393939394, 0.5914634146341463, 0.588957055214724, 0.5864197530864198, 0.5900621118012422, 0.59375, 0.5974842767295597, 0.6012658227848101, 0.6050955414012739, 0.6025641025641025, 0.6, 0.6038961038961039, 0.6078431372549019, 0.6052631578947368, 0.609271523178808, 0.6133333333333333, 0.610738255033557, 0.6148648648648649, 0.6122448979591837, 0.6095890410958904, 0.6137931034482759, 0.6111111111111112, 0.6153846153846154, 0.6126760563380281, 0.6099290780141844, 0.6142857142857143, 0.6187050359712231, 0.6231884057971014, 0.6204379562043796, 0.625, 0.6222222222222222, 0.6268656716417911, 0.631578947368421, 0.6363636363636364, 0.6412213740458015, 0.6461538461538462, 0.6511627906976745, 0.65625, 0.6614173228346457, 0.6666666666666666, 0.664, 0.6693548387096774, 0.6747967479674797, 0.680327868852459, 0.6776859504132231, 0.675, 0.680672268907563, 0.6864406779661016, 0.6923076923076923, 0.6896551724137931, 0.6869565217391305, 0.6929824561403509, 0.6902654867256637, 0.6964285714285714, 0.6936936936936937, 0.6909090909090909, 0.6880733944954128, 0.6944444444444444, 0.6915887850467289, 0.6981132075471698, 0.6952380952380952, 0.6923076923076923, 0.6893203883495146, 0.696078431372549, 0.7029702970297029, 0.7, 0.7070707070707071, 0.7040816326530612, 0.711340206185567, 0.71875, 0.7157894736842105, 0.7127659574468085, 0.7096774193548387, 0.717391304347826, 0.7252747252747253, 0.7222222222222222, 0.7191011235955056, 0.7159090909090909, 0.7241379310344828, 0.7325581395348837, 0.7294117647058823, 0.7380952380952381, 0.7469879518072289, 0.7439024390243902, 0.7407407407407407, 0.7375, 0.7341772151898734, 0.7307692307692307, 0.7272727272727273, 0.7236842105263158, 0.72, 0.7297297297297297, 0.726027397260274, 0.7361111111111112, 0.7464788732394366, 0.7571428571428571, 0.7681159420289855, 0.7794117647058824, 0.7910447761194029, 0.7878787878787878, 0.7846153846153846, 0.78125, 0.7777777777777778, 0.7741935483870968, 0.7704918032786885, 0.7666666666666667, 0.7627118644067796, 0.7586206896551724, 0.7543859649122807, 0.75, 0.7454545454545455, 0.7407407407407407, 0.7358490566037735, 0.7307692307692307, 0.7254901960784313, 0.72, 0.7142857142857143, 0.7291666666666666, 0.7446808510638298, 0.7391304347826086, 0.7555555555555555, 0.7727272727272727, 0.7674418604651163, 0.7619047619047619, 0.7560975609756098, 0.75, 0.7435897435897436, 0.7368421052631579, 0.7297297297297297, 0.7222222222222222, 0.7142857142857143, 0.7352941176470589, 0.7272727272727273, 0.75, 0.7419354838709677, 0.7333333333333333, 0.7241379310344828, 0.7142857142857143, 0.7037037037037037, 0.6923076923076923, 0.72, 0.7083333333333334, 0.6956521739130435, 0.6818181818181818, 0.7142857142857143, 0.7, 0.7368421052631579, 0.7222222222222222, 0.7058823529411765, 0.75, 0.7333333333333333, 0.7142857142857143, 0.7692307692307693, 0.75, 0.7272727272727273, 0.7, 0.6666666666666666, 0.625, 0.7142857142857143, 0.6666666666666666, 0.6, 0.5, 0.3333333333333333, 0.5, 1.0, 1.0], "recall": [1.0, 1.0, 1.0, 0.9933333333333333, 0.9933333333333333, 0.7733333333333333, 0.7733333333333333, 0.7733333333333333, 0.7733333333333333, 0.7733333333333333, 0.7666666666666667, 0.76, 0.76, 0.76, 0.76, 0.76, 0.76, 0.76, 0.7533333333333333, 0.7533333333333333, 0.7533333333333333, 0.7533333333333333, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.74, 0.74, 0.74, 0.74, 0.7333333333333333, 0.7333333333333333, 0.7333333333333333, 0.7333333333333333, 0.7333333333333333, 0.7266666666666667, 0.72, 0.7133333333333334, 0.7133333333333334, 0.7133333333333334, 0.7133333333333334, 0.7066666666666667, 0.7, 0.6933333333333334, 0.6866666666666666, 0.6866666666666666, 0.68, 0.68, 0.68, 0.68, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6666666666666666, 0.6666666666666666, 0.6666666666666666, 0.6666666666666666, 0.6666666666666666, 0.66, 0.6533333333333333, 0.6466666666666666, 0.64, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6266666666666667, 0.62, 0.62, 0.62, 0.6133333333333333, 0.6133333333333333, 0.6133333333333333, 0.6066666666666667, 0.6066666666666667, 0.6, 0.5933333333333334, 0.5933333333333334, 0.5866666666666667, 0.5866666666666667, 0.58, 0.5733333333333334, 0.5733333333333334, 0.5733333333333334, 0.5733333333333334, 0.5666666666666667, 0.5666666666666667, 0.56, 0.56, 0.56, 0.56, 0.56, 0.56, 0.56, 0.56, 0.56, 0.56, 0.5533333333333333, 0.5533333333333333, 0.5533333333333333, 0.5533333333333333, 0.5466666666666666, 0.54, 0.54, 0.54, 0.54, 0.5333333333333333, 0.5266666666666666, 0.5266666666666666, 0.52, 0.52, 0.5133333333333333, 0.5066666666666667, 0.5, 0.5, 0.49333333333333335, 0.49333333333333335, 0.4866666666666667, 0.48, 0.47333333333333333, 0.47333333333333333, 0.47333333333333333, 0.4666666666666667, 0.4666666666666667, 0.46, 0.46, 0.46, 0.4533333333333333, 0.44666666666666666, 0.44, 0.44, 0.44, 0.43333333333333335, 0.4266666666666667, 0.42, 0.42, 0.42, 0.41333333333333333, 0.41333333333333333, 0.41333333333333333, 0.4066666666666667, 0.4, 0.3933333333333333, 0.38666666666666666, 0.38, 0.37333333333333335, 0.36666666666666664, 0.36, 0.36, 0.35333333333333333, 0.35333333333333333, 0.35333333333333333, 0.35333333333333333, 0.35333333333333333, 0.35333333333333333, 0.35333333333333333, 0.3466666666666667, 0.34, 0.3333333333333333, 0.32666666666666666, 0.32, 0.31333333333333335, 0.30666666666666664, 0.3, 0.29333333333333333, 0.2866666666666667, 0.28, 0.2733333333333333, 0.26666666666666666, 0.26, 0.25333333333333335, 0.24666666666666667, 0.24, 0.23333333333333334, 0.23333333333333334, 0.23333333333333334, 0.22666666666666666, 0.22666666666666666, 0.22666666666666666, 0.22, 0.21333333333333335, 0.20666666666666667, 0.2, 0.19333333333333333, 0.18666666666666668, 0.18, 0.17333333333333334, 0.16666666666666666, 0.16666666666666666, 0.16, 0.16, 0.15333333333333332, 0.14666666666666667, 0.14, 0.13333333333333333, 0.12666666666666668, 0.12, 0.12, 0.11333333333333333, 0.10666666666666667, 0.1, 0.1, 0.09333333333333334, 0.09333333333333334, 0.08666666666666667, 0.08, 0.08, 0.07333333333333333, 0.06666666666666667, 0.06666666666666667, 0.06, 0.05333333333333334, 0.04666666666666667, 0.04, 0.03333333333333333, 0.03333333333333333, 0.02666666666666667, 0.02, 0.013333333333333334, 0.006666666666666667, 0.006666666666666667, 0.006666666666666667, 0.0]}, "loss": 0.35723733132630286}